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ABBREVIATIONS
The abbreviations, symbols and conventions recommended by 
the lÜPAG^ÏUB Commission on Biochemical Nomenclature and published 
in Biochem. J. (1973) 131, 1-20, have been used throughout this 
thesis•
In addition the following abbreviations have been used
GPB
EIA
HGG
LH
FSH
*Pergonal*
*Glomid*
SPS
CBG
BSA
S.D.
BBT
I.U.D.
Competitive protein binding.
Radio immunoassay.
Human chorionic gonadotrophin.
Luteinising hormone.
Follicle stimulating hormone.
Human menopausal gonadotrophin (supplied 
by Searle Scientific Services),
Glomlphene citrate (supplied by Morrell- 
National Laboratories Ltd., London W.l,), 
Standard protein solution.
Corticosteroid binding globulin.
Bovine serum albumin.
Standard deviation.
Basal body temperature*
Intra-uterine Device.
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STEROID NQMEHGLATURB
The lUPAC-mB 1967 Revised tentative rules for steroid 
•nomenclature have been used in this thesis. These appear in 
Biochem, J, (1969) m ,  5.
The trivial names set out in J. Endocrinol, (1972), 1-2,
have been used without definition. These include
c orticos terone 
cortisol
dehydrocpiandrosterone (DMA)
deoxycorticosterone (DOC)
oestrone
oestradiol
oestradiol-17c^
oestriol
progesterone
testosterone
l7o(“hydro!cyproses terone
*2.V
GONTEl'ÏTS Paso No,
Acknowl edgement 8 i
Abbreviations ii
Steroid Nomenclature lit
Chapter t General Introduction
NIstotical background 1
Background and scope of the present study 8
Chap.ter ,2 Materials and General Methods
Solvents 20
Chemicals 21
Radioactive chemicals 21
Steroids 22
Chromatography 22
Determination of radioactivity 23
Glassware 24
Equipment 25
Buffers and Solutions «
I) Competitive protein binding assay 26
ii) Radioimmunoassay 27
Measurement of cortisol 28
Measurement of LH 28
Measurement of F8H 29
Chapter .3 Development of GPB and RXA methods for
measurcm'ent of ".sterpicl hormmes
Introduction 30
Principle of Displacement analysis 31
A, Progesterone and 17o«.-Hydroxyprogesterone 33
1) Extraction of steroids from plasma 34
2) Purification of steroids 35
»v-
, Page No.
3) Recovery of [_H progesterone and 
ri-lj I Vot «hydroxy progesterone 37
4) The steroid binding solution 37
(a) Source of a suitable steroid
binding protein 37
(b) Preparation of the standard
protein solution - _ 30
3(c) Optimum pH for binding of H 
corticosterone to CBG 40
(d) Specificity of the CBG 40
5) Radioactive labelled steroid 41
6) Separation of free and protein bound 
steroid 42
7) Incubation times and temperatures 43
S) Measurement of the distribution of
steroid between free and bound fractions 44
9) Comparison of unknom samples with a
standard curve and calculation of results 44
10) Assessment of methodological interfering 
factors 45
11) Statistical assessment of the method
(a) Accuracy 46
(b) Precision 46
( c ) S ens i tivi ty 4 8
Assay of progesterone and 17(A-4iydroxyprogeaterone
by GPB 48
Oestradiol
1) Extraction of oestradiol from plasma
2) Purification of oestradiol
3) Recovery of oestradiol
4) The oestradiol binding solution
(a) Production of a suitable antiserum
(b) Optimum dilution of antiserum
(c) Specificity of antiserum
51
51
52
52
53
53
54 
54
*vi‘
Page Ho.
5) Radioactive labelled oestradiol 56
6) Separation of free and protein bound 
oestradiol 56
7) Incubation times and temperatures 58
8) Measurement of the distribution of 
oestradiol between free and bound 
fractions 59
9) Comparison of unknown samples with a 
standard curve and calculation of results 59
10) Assessment of metlioddogical interfering 
factors 60
11) Statistical assessment of the method
(a ) Accuracy 60
(b) Precision 60
(c) Sensitivity 61
Assay of oestradiol by RXA 61
ier 4 Steroid and gonadotrophin hormone patterns 
throughout menstrual cycles of volunteer 
subjects
Introduction 63
Results
Part I »
Hormone patterns in the normal menstrual 
cycle
(A) Mean hormone levels 67
(B) Hormone levels in individual cycles 70
(G) Summary of results in normal menstrual
cycles 77
Part II -
Hormone patterns in *Abnorraal* menstrual 
cycles 80
Summary of results in abnormal cycles 94
•vii«
Pâge Ho.
Chapter 5 Comparison of hormone patterns In menstrual 
cycles of Infertile and nomal women
Introduction 95
Results
Individual cycles 97
Summary of results In Infertile patients 106
The mean cycle 108
Ghcipter 6 Hormone patterns in the menstrual cycle of
Infertile women aster tree Went with ’Clomid*
Introduction 111
Results 115
The mean treatment cycle and comparison
with the normal cycle 123
pter 7 Discussion 
Part I » GPB and RXA methods 126
The binding protein 127
Extraction and purification of steroids 137
Methodological interfering factors 143
Separation of free and bound steroid 145
General considerations and conclusions 149
Part XI - (a) The normal menstrual cycle 155
(b) AbnoOTal cycles and conditions 176
Part III- (a) Hormone patterns in infertile patients 186
(b) Effects of *Glomid* treatment 196
Part IV - (a) General comments 204
(b) Summary of results 207
(c) Future work 209
Page Ho*
References 212
M S â t o  234
a#leMsm 237
CHAPTER I
GENERAL INTRODUCTION
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GENERAL INTRODUCTION
Historical Background
Basic knowledge of the ovary as an organ of internal 
secretion stems from the demonstration of involutlonary changes 
in the uterus and vagina foXlo'çjing bilateral oophorectomy and 
their reversal by administration of active ovarian extracts 
(Marshall and Jolly, 1905). The oestrus-inducing properties 
of ovarian tissue were first demonstrated by Allen and Doisy 
(1923) who used the test of vaginal cornification in spayed 
rodents (Allen, 1922) as a specific index of oestrogenic activity. 
Chemical identification of the active principle in this material 
followed and the first preparation of oestrogens in crystalline 
form was accomplished simultaneously by workers in several 
countries (see reviews by Allen et al.» 1939 and Marrian, 1950), 
The physiological significance of the corpus luteum was 
first realised by Fraenkel (1903; 1910) who demonstrated that
this structure had an endocrine function and produced a secretion 
which was important for the protection of the fertilized ovum. 
Progesterone was first extracted from luteal tissue in sows * 
ovaries by Corner and Allen (1929) and shortly aftert?ards 
isolated and chemically identified,
A functional interrelationship betîfeen the ovary and the 
pituitary gland was recognised early in this century (e.g. Crowe
et al,, 1910) and readily confirmed with the technique of 
hypophysectomy (see Smith, 1939), Ovarian changes are continuous 
and norraally cyclical in nature and can he divided into two 
phases characterised by follicular development and formation 
of a corpus luteum, Following the observation by Smith (1927) 
of a follicular response to pituitary implants and the finding 
of Evans and Simpson (1923) that alkaline pituitary extracts 
induced lutéinisation, the existence of two separate gonado­
trophic factors was postulated (Wiesnor and Grew, 1930), At 
the same time, two fractions from the anterior lobe of the pituitary 
were prepared, one with follicle stimulating and the other with 
luteinizing properties (Fevold et al,, 1931). Thus the two 
factors, luteinizing hormone (LH) and follicle stimulating 
hormone (FSH) were discovered. It now became clear that the 
ovary formed part of the female reproductive system as a whole.
As such its functions could not be considered in isolation 
but in the context of a chain of organs extending from the 
pituitary to the external genitalia and linked by an intricate 
and closely integrated series of endocrine processes.
The major unexplained phenomenon was now that of the 
mechanism of the interaction of the ovary and the pituitary 
in producing a series of cyclical events which were repeated 
at regular intervals. It had been realised that some connection
existed between ovarian function and the nervous system.
Many factors suggested that the cycle of events in the mmmal 
lay primarily under nervous control. In lower maramals for 
example, the sex cycle of the ferret depended upon the length 
of daylight to Wiich the animal was exposed whilst in women, 
amenorrhea a was îcnom to develop under psychological stress.
The concept of nervous control of the anterior pituitary was 
postulated by Marshall (1937). The first evidence which showed 
this hypothesis to be feasible came from Green and Harris 
(1947) with the demonstration of the hypothalamo-hypophyseal 
portal circulation by which o connection was established 
between the hypothalamic nerve endings and the adenohypophysis. 
However, It was not until the 1960 s (Harris, 1961; Nilcitovitch- 
Winer, 1962) that direct evidence was provided in support of 
this concept. It is now well documented that gonadotrophin 
releasing factors are produced at hypothalamic nerve endings 
lying near the primary capillary plexus of the hypothalamo- 
hypophyseal portal system which carries them to the adenohypophysis 
causing gonadotrophin release. This is illustrated in Fig, 1. I.
It was now clear that all aspects of the ovarian cycle are 
controlled directly and the endocrine functions of the ovary 
indirectly by the FSH and LH of the anterior pituitary. The 
ovary in turn, by means of its steroid hormone secretions
Fig. 1. I SECTION THROUGH THE BASE OF THE HYPOTHALAîlUS AND
PITUITARY GLAND TO SHOW THE MECHANISMS CONCERNED 
IN THE REGULATION OF ANTERIOR PITUITARY ACTIVITY
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regulates the activity of the accessory sex organs and thus 
ultimately the sexual cycle. Furthermore, it was postulated 
that the gonadotrophic activity of the pituitary is itself 
related by a feed-back mechanism to the concentration of ovarian 
homones in the blood* An outline of these interactions is 
illustrated in Fig. 1. XI. To prove these hypotheses, and to 
investigate the nature of üiis feed-back mechanism in humans, 
measurements of the hormones produced by the ovary and the 
pituitary throughout the menstrual cycle vmre necessary*
The first quantitative assessments of ovarian function in 
the menstrual cycle were made by estimating oestrogens and 
progestogens in the urine. Much of the work on the estimation 
of oestrogen in urinary extracts prior to 1955 was performed by 
bioassay techniques which, although sensitive, wore relatively 
imprecise* By means of such procedures a considerable amount 
of clinical information was accumulated on oestrogen excretion 
in health (e.g. Smith et al., 1938) and disease (e.g. Pedersen- 
Bjerga«rd and Tj^ nnesen, 1951)* However, the results so obtained 
were often of doubtful quantitative significance. The intro­
duction of chemical methods for measurement of oestrogens gave 
rise to more precise results. These included techniques 
involving the Kober reaction, originally described by Kobev in 
1931, (e.g. BroTtvn, 1955a), fluorimetry (e.g. Preedy and Ai then,
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1.961) and gas chromatography (e.g. Menini, 1965), Studies by 
Brown (1955b) and Browi et al., (1958) showed that there was 
a peak in the urinary oestrogen excretion pattern at about the 
middle of the htiman menstrual cycle followed by a rapid decrease 
in oestrogen excretion, which was followed by a second oestrogen 
rise during the luteal phase of the cycle.
The first quantitative study of progestogen excretion was 
by Venning and Browne (1937) who measured urinary pregnaiiecliol, 
which was later shoxm to be exclusively derived from progesterone 
(see Eckstein, 1962) throughout the cycle. The technique of 
Venning (1937) was a gravimetric one and more recently pregnanediol 
has been measured by (am main methods, colourimetry (e.g.
Klopper ot al,, 1955) and gas chromatography (e.g. Goldsieher 
et al., 1967). Klopper (1957) showed that low levels of 
pregnanediol were (xtcreted in the follicular phase of the cycle, 
with levels rising from mid-cycle to a peak in the luteal phase.
It was realised however, that urinary pregnanediol determinations 
are not truly representative of endogenous progesterone production 
but only a reflection of the output of the hormone (Klopper 
and Dillewica, 1963). Macnaughton and Greig (1965) have shox-m 
that only between 6% and 15% of J progesterone injected
into pregnant or non-pregîîant Xfomen appears as pregnanediol in 
the urine. Thus methods involving the measurement of all hormones 
directly in the blood were sought.
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Measurements of oestrogens in blood were originally carried 
out using the sane type of technique as for urine; methods 
involved the Kober reaction (e.g. Roy and Brovm, 1960), gas 
chromatography (e.g. Hotis et al., 1967) and double isotope 
derivative formation (Baird, 1968), Progesterone in blood 
was measured by spectrophotometrie methods (e.g. Short, 1958), 
gas chromatography (e.g. Kumar et al., 1964) and isotopic 
methods (e.g. Woolever and Goldfien, 1963). Estimations in 
peripheral blood provided essentially the same information as 
urinary estimations. hoxfever, although these methods xmre 
specific they were relatively insensitive and large amounts of 
blood xmre required for assays. Thus samples were often pooled 
either within subjects or over several days in order to obtain 
sufficient blood. At the same time it was becoming obvious 
that the human menstrual cycle was characterised by marked 
fluctuations in endogenous hormone levels, so that little 
detailed information could be obtained from pooled or random 
samples. An accurate assessment of ovarian function in the 
reproductive cycle could only be obtained by serial sampling in 
individual subjects and to make this study o practical undertaking 
more sensitive methods of assay were required.
The study of pituitary function in the human menstrual 
cycle faced similar problems. The first measurements of 
pituitary gonadotrophins involved determination of 'total
gonadotrophin activity' by bioassays such as the mouse uterus 
test of Klinefelter et al., (1943), Procedures were soon 
introduced for the separate determination of FSH and LH involve 
ing bioassays carried out in urine; FSH was measured using 
the ovarian augmentation test (Steelman and Pohley, 1953) and LH 
by the ovarian ascorbic acid depletion test (Parlow, 1961).
Using these tests, a peak of LH excretion was reported to occur 
alxmys at mid-cycle and this peak was closely associated xfith 
ovulation as judged by urinary steroid assays (Brox^ m et al.,
1958; McArthur et al,, 1958), Bell et al., (1966) studying 
FSH output shot-red great variations in the pattern of FSH 
excretion from one woman to another. In some subjects levels 
did not alter throughout the cycle; in others levels xjere 
maximal at the time of ovulation, X7hilst in others the highest 
levels occurred in the follicular phase. Conversely, Fukushima 
et al,, (1964) claimed that the curve of FSH output during 
the cycle tended to be constant x-zith high levels in the follicular 
and luteal phases and lox? levels at mid-cycle.
Perhaps the greatest single breakthrough in the study of 
reproductive endocrinology was the introduction of the technique 
of displacement analysis. This technique xms first used by 
Bcrson and Yalow (1957) to assay insulin and later applied to 
the measurement of gonadotrophins (e.g. Bagshaxze et al,, 1966)
and steroid hormones (Murphy, 1964), The principle of this 
method xzill he described in detail in Chapter 3, Briefly, 
it depends on the displacement of a substance, X, labelled 
xzith a radioactive isotope, from a binding protein, by unlabelled 
X. Subsequent measurement of the bound and/or free isotopically 
labelled X alloxzs estimation of the mass of unlabelled X present 
by comparison x-zith standards. Such methods provide a high 
degree of sensitivity making them applicable to assay of hormones 
in small volumes of biological fluids. It is therefore noxf 
possible to assay steroid and gonadotrophin hormones in daily 
blood samples from individual subjects throughout entire 
menstrual eyeles,
Bactazound and Scope of the Present Study
Recent studies of ovarian and pituitary function and their 
interaction have involved the correlation of morphological 
changes xfith hormone secretion patterns in daily samples 
throughout the menstrual cycle. Three steroid homoxi.es, 
progesterone, 1 "At-liydroxyprogesterone and oestradiol, have 
frequently been studied, together with the gonadotrophins, LU 
and FSH, Each of the steroid hormones has been used to monitor 
certain aspects of ovarian function.
In vitro studies indicate that the major source of ovarian 
progesterone production is the granulosa cells (Ryan and Petro,
1966) which become luteinised and form the corpus luteum. The 
increased levels of progesterone found in the luteal phase of 
the menstrual cycle have thus been regarded as an index of 
ovulation and of corpus luteum function. There has been 
speculation as to the absolute level of progesterone xAich 
signifies an ovulatory cycle (Xsreal et al,, 1972; Black et 
ah, 1972). However, fezton (1973) has suggested that the 
area under the progesterone curve in the luteal phase of the 
cycle is perhaps a more accurate measure of corpus luteum activity 
and function. Increasing plasma concentrations of progesterone 
are reflected in increasing basal body temperatures (Davis and 
Fugo, 1948; Isreal and Sclmeller, 1950) and a biphasic basal 
body temperature curve has been regarded as a useful indicator 
of ovulation (Hartman, 1962),
The processes of corpus luteum function and follicular 
maturation however, must be examined separately as xzhilst 
development of a corpus luteum is usually linked with ovulation, 
the two processes may be dissociated. Such dissociation would 
be impossible to detect if evidence of ovulation was based 
solely on corpus luteum function through increased progesterone 
secretion, Strott et al,, (1969) have measured 17ot-hydroxy;)rogesterone 
in human plasma and showed that a peak occurs in the secretion
10
pattern on the day prior to, or the day of the LH mid-cycle 
peak and they suggested that this pre-ovulatory rise could 
be regarded as a measure of follicular maturation. The 
pattern of variation of 17o(“hydroxyprogesterone is similar to 
that observed by Fotherby (1962) for urinary pregnanetriol, 
thought to be derived from 17o(-hydroxyprogesterone.
Patterns of oestrogen secretion have been used to monitor 
follicular growth during the pre-ovulatory phase of the 
menstrual cycle. Oestradiol-17p is the major oestrogenic
product of the growing follicle, as shoim. by studies on 
ovarian vein blood (Mikhail, 1967), In vitro studies indicate 
that the theca cells of the developing follicle are the major 
site of synthesis of oestradiol (Ryan et al., 1968), The 
pattern of oestradiol in the luteal phase of the cycle closely 
resembles that of progesterone, which suggests that this oestradiol 
may be produced by the corpus luteum, or at least by the theca 
cells which persist within the corpus luteum (Fawcett, 1968),
If this were so, oestradiol may be useful as a marker of both 
follicular growth and corpus luteum function*
The relationship of these steroid hormones, each marking 
some aspect of ovarian function, to the gonadotrophins may 
indicate their role in mediating the pituitary response to 
morphological changes occurring during the cycle. Several
II
recenî: reviews describe bhe present state of Imowledge con» 
corning ovarian pituitary Interactions, gained by studies of 
hormone patterns in the menstrual cycle (Hensle and Segre,
1970; Ross el: al*, 1970; Vande Wide et al., 1970). They 
indicate that whilst there Is now much information available 
about Individual events, there is still much controversy over 
certain aspects of this interaction*
The most dramatic single event in the menstrual cycle is 
the mid-cycle surge of LI I, which precedes ovulation of a 
mature follicle. The pattern of FSH secretion is not so marked; 
higher levels arc found in the follicular phase than in the 
luteal phase. The follicular phase release of FSH appears 
to be required for stimulation of groxf:lng follicles resulting 
in an Increased output of oestradiol. A peak of FSH appears 
at mid-cycle, usually coincident with the LH peak. No role 
has yet been assigned to this mid-cycle peak. The ovarian 
steroids exert a negative feed-back effect on LH and FSH.
There is a strong inhibition of FSH secretion in 'fertile life'
- only r> - 10% of the levels found in oophorectomieed or 
post-menopausal women appear during the menstrual cycle.
This feed-back effect is smaller on LH, where only 30 - 40% 
inhibition, calculated from post-menopausal levels, occurs in 
the Tortile' period. However, at mid-cycle, for both gonado-
12
trophins a transient positive feed-back mechanism seems to 
function. It is possible that this changeover occurs through 
fluctuations in the levels of one, or more, steroid hormones.
Both oestrogens and progesterone have been implicated 
as triggers of the ovulatory surge of LII, Progesterone has 
been shorn to induce or to advance ovulation in rats (Nallar 
et al., 1966), Odell and Swerdloff (1968) studying plasma 
FSH and LH levels in castrates and menopausal women, whose 
elevated gonadotrophin levels had been depressed by the admin­
istration of oestrogens, showed that progesterone (10 mg 
given intramuscularly) will produce a sudden rise in LH and 
FSH, This, in conjunction with the fact that urinary pregnanediol 
excretion has been shomi to rise on the day before the LH 
peak (Goebelsmann et al,, 1969) makes progesterone a possible 
trigger of LH release. However, a rise in plasma progesterone 
prior to a rise in LH has not been demonstrated in women under 
normal physiological conditions.
There is also evidence which points to oestradiol as a 
trigger of LH release. Vorys et al,, (1965) and Kaiser et al,, 
(1956) report an increase in urinary gonadotrophin following 
administration of oestrogens. Using a radioimmunoassay to 
measure LH and FSH in blood, Swerdloff and Odell (1969) present
1.3
evidence that synthetic oestrogens will produce repeated bursts 
of LU hut not of FSH. Baird and Guevara (1969) found that 
plasma oestradiol levels rose continuously from at least the 
eighth day before the LH peak, and that the peak concentrations 
of LH and oestradiol were synchronous. However, other workers 
(Dufau et al., 1970) have found that in some cycles the peak 
of oestradiol falls before the LH peak so that oestradiol 
levels are decreasing as LH levels are Increasing.
This evidence poses several questions; is progesterone 
or oestradiol the trigger of LH release 5 is LH release triggered 
separately from FSH, although coincidentally ; could a falling 
level of oestradiol trigger LH release? Furthermore, other 
steroids may be involved in this mid-cycle gonadotrophin surge#
Ho role has yet been assigned to the mid-cycle peak of 17*- 
hydroxyprogesteroîie described by Strott et al,, (1969).
After reaching a peak on the day of, or the day preceding the 
LH peak, levels of this steroid decrease by about 50% and 
then increase in the luteal phase of the cycle. Progesterone 
and 17ot -hydroxyprogesterone therefore behave independently and 
Strott et al., (1969) suggest that ITx-hydroxyprogesterone is 
secreted independently of progesterone and probably by a different 
cell type. The fluctuations in 17*-hydroxyprogesterone parallel 
changes in oestradiol and Strott et al., (1969) suggest that
14 -
the 17o(”hjrdroxyprogest;erone may be secreted as an Intermediate 
in oestrogen biosynthesis. However, this seems unlikely as 
the levels of 17o(-hydroxyprogesterone in peripheral plasma are 
reported to be of the order of ten times those of oestradiol.
It seems unlikely that a precursor should be produced and sec­
reted in such large amounts unless it has some physiological 
role, Alteimatively, 17o<«hydroxyprogesterone coukl be produced
independently of oestradiol. In any case, this rise could 
represent physiologically important pre-ovulatory increases in 
progestogens.
Detailed investigation of this mid-cycle period could be 
made in experimental animals by frequent blood sampling or by 
artificially producing pituitary response to various experimental 
conditions. It has become increasingly obvious in recent years 
that experiments in animals may not be applicable to the situation 
in the human. However, methods of studying the human are 
obviously limited. There axe three main metliods which have 
been used to study menstrual cycle regulation in women; firstly 
by giving synthetic oestrogens or progestogens and monitoring 
pituitary response, secondly by following the chronological 
sequence of events in normal menstrual cycles and thirdly by 
studying cycles in infertile women, to detect the essential
- 15
features whiicîi may be absent and how they can be corrected using 
stimulatory drugs. The first method is of limited use because 
although thq ability of an organ to respond to a stimulus can be 
demonstrated, it cannot be proved that this event occurs under
I
physiological conditions. The second and third methods of
I
study give q more accurate picture of events as they occur in 
the ’intac t' cycle,
Infertility caused by absence of ovulation has most commonly 
been studied in this context as it is easily diagnosed cither 
by absence of menstruation or of a mid-cycle LH peak. The 
differences between anovulatory cycles and nomal cycles are 
likely to be very marked; stimulation of ovulation and subsequent 
pregnancy may show what features must be induced to produce the 
fertile cycle. However, an equally useful approach aiay be 
made by studying cycles in women who are infertile for no obvious 
reason, where normal menstruation occurs at regular intervals, 
and where all other aspects of reproductive function appear 
clinically normal, but pregnancy does not occur despite a high 
sperm count in the husband* Such cycles may have more subtle 
differences in comparison to normal cycles from which useful 
information may be obtained. This type of infertility also
16
presents a clinical problem and there are few reports of its 
successful treatment. Such a study may help to diagnose the 
condition. If it is assumed that this infertility is caused 
by some defect in ovarian or pituitary function or their inter­
action, treatment of these patients with a pituitary stimulatory 
drug may help to improve their cycles. Clomiphene citrate has 
been used by many Tzorkers as a pituitary stimulatory drug, although 
usually in the treatment of anovulation (e.g. Macgregor et al., 
1968). However, its mode of action is not clear. There is 
evidence that clomiphene citrate acts through the hypothalamic- 
pituitary axis to increase gonadotrophin secretion (Jacobson 
et al., 1968) while other studies Indicate that it acts by 
stimulating the ovary to produce oestrogen, which imy trigger 
LH release (Smith, 1966).
The present work therefore comprises a study of several 
ovarian hormones, progesterone, ITcC-hydroxyprogesterone, oestradiol 
and gonadotrophins, LH and FSH, in serial daily plasma samples 
throughout menstrual cycles from a number of normally menstruating 
women. Comparison of these hormone patterns to patterns in 
cycles from patients complaining of the type of infertility 
outlined above before and after treatment with clomiphene 
citrate may help to elucidate the problem of ovarian-pituitary 
interaction.
- 17
Xn order to undertake such a study, sensitive and precise 
methods are required for measurement of the hormones In small 
volumes of plasma. A competitive protein binding method for 
the estimation of progesterone has previously been developed in 
this laboratory (^ lartin et al., 1970). A useful adaptation 
of this method would be to incorporate the measurement of 17*- 
hydroxyprogesterone in the same sample of plasma. An extremely 
sensitive assay is required for the measurenent of oestradiol 
as this hormone is reported to be present in sub-picomole 
quantities per milliliter of plasma. A radioimmunoassay 
technique would be suitable in this context. Facilities are 
not available in this laboratory for assay of gonadotrophins 
so these hormones have been assayed elsewhere.
%%ile this work has been in progress several reports of 
measurements of these hormones in serial samples from normal 
menstrual cycles have appeared (Johansson et al., 1971;
Mishell et al., 1971; Thomeycroft et al., 1971; Abraham 
et al., 1972; Holmdahl and Johansson, 1972) using different 
methods from the present work. However, in only one of these 
studies (Abraham at al., 1972) were all the hormones measured 
simultaneously. From these reports, several concepts of
ovarian-pituitary regulation have been suggested and these
will be discussed in relation to the present study in Chapter 7, 
The principle aims of the study described in this thesis
were as followsî
1. To develop and evaluate precise and specific methods for 
the measurement of progesterone, 17<x -hydroxyproges ter one 
and oestradiol in human plasma*
2. To examine ovarian-pituitary interaction by studying the 
chronological sequence of events occurring in ovarian and 
pituitary hormone patterns throughout menstrual cycles in 
a number of normal volunteers.
3. To examine the chronological sequence of events in cycles 
from selected infertile patients, who apparently menstruate 
normally, and, after investigation, are found to have 
patent fallophn tubes and no^ mial secretory endometrium,
in order to detect subtle differences which may exist in 
hormone patterns or levels between such cycles and the normal 
cycle.
4. To G3camine the effect which the adminis tration of clomiphene 
citrate may have on these infertile cycles and to compare
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such treatment cycles with the normal cycle.
5. To thus examine the mode of action of clomiphene citrate 
in such patients and to assess its usefulness in the 
treatment of this type of infertility.
6. To assess the use of measurement of the steroid hormones 
studied as markers of the raorphological changes occurring 
in the normal menstrual cycle and in the infertile patient,
CHARTER 2
MATERIALS AHD GENERAL METHODS
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FiATERXALS AND GENERAL METHODS
Solvents
All solvents used were ’Analar’ grade except industrial 
acetone (BDIÎ Chemicals Ltd.) which was used without purification. 
The solvents were distilled using a 60 cm Vigreux column (Quiclcfit, 
Ltd.). The first and last 100 ml fractions in all distillations 
were discarded.
Ethyl acetate (BDH Chemicals Ltd.) and methanol (Burrough 
Ltd.) were distilled twice.
Diethyl ether (BDH Chemicals Ltd.) was distilled twice 
immediately before use and bottles were discarded for use in 
radioimmunoassay after half of their contents had been removed.
Light petroleum, boiling range 60^  - 80° C (BDH Chemicals 
Ltd.) was washed with concentrated sulphuric acid and distilled 
twice.
Pyridine (BDH Chemicals Ltd.) and acetic aniiydride (BDH 
Chemicals Ltd.) were distilled once.
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Water was passed through a de«lonising column (Permutit 
Co. Hark IX portable de-ioniser) and distilled immediately 
before use in a glass still (Aquator 60E, Andexman and Co.
Ltd., London).
Chemicals
Ethylenediaminetetra-acetic acid, disodium salt (EDTA), 
gelatine powder, di-sodium hydrogen orthophosphate (anhydrous) 
and sodium dihydrogen orthophosphate (21-1^0) were obtained from 
BDH Chemicals Ltd. *Analar' grade chemicals were used where 
available. Thimerosal (Grade II, sodium salt) and 'Trisma 
base' (reagent grade) were purchased from Sigma Chemical Go. 
Ltd.
Dextran T40 was obtained from Pharmacia Fine Chemicals, 
Uppsala, Sweden, Norit NK charcoal (Hopkin and Williams Ltd.) 
was washed tcvice with methanol, the 'fines*' being decanted each 
time, and dried thoroughly before use.
Radioactive chemicals
)1,2-^H I progesterone (33.5 Ci/mmol)
L J fa"!
hydroxyprogesterone (49.2 Ci/mmol), 11,2- II
1,2-^H 17d-
testosterone
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(45,0 Ci/raniol) and corticosterone (44.0 Ci/mmol) 
were purchased from New England Nuclear Corporation (Frankfurt, 
Germany). j^ 6,7-^ Hj oestradioX-17p (40 Ci/mmol) and
N-hexadecane (2.27 juCi/g) were purchased from the Radiochemical 
Centre (Amersham). All radioactive steroids were stored in 
solution in methanol (100 pCi/ml), at 4°G. The purity of these 
solutions was checked by paper chromatography before use. No 
impurities were detected.
Steroids
Progesterone, 17*-hydro:cyprogesterone, testosterone, 
(Steraloids Ltd.), oestradiol, oestriol and oestrone (Koch- 
Light Laboratories Ltd.) were purchased commercially, purified 
by paper chromatography and stored in solution in ethyl acetate 
or methanol at 4°G.
Chromatography
Nîiatman No.l chromatography paper from 27 cm wide rolls 
was cut into the required lengths, washed with methanol in a
2 litre Soxhlet extractor (Quickfit Ltd.) for 48 h, dried in
air and stored wrapped in aluminium foil in a dessicator. Before
use the lengths were cut into lanes as shoim in Pig, 2, I. and
rewashed by descending chromatography in methanol.
FIG. 2. I PREPARATION OF CHROMATOGRAPHY PAPER
continued to il
or ig in
lanes
shaded areas, 
removed
FIG. 2. II PREPARATION OF CHROMATOGRAPHY TANKS
developing solvent
paper liners
developing papers
stationary phase
mobile phase
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ChromatograpUy tanks (Airaor Ltd.) each held a ma^dmum of 
four papers. The tanks were lined with chromatography paper 
and the lids sealed with strips of sine oxide tape after pre­
paration for chromatography as shorn in Fig. Z, II. Chromato­
grams wore equilibrated overnight and the mobile phase added 
automatically at 06,00 h by means of a time clock and sample 
changer (The Central Ignition Co* Ltd., London). The chroma­
tograms were removed from the tanks at 09,30 h aiid lanes containing 
radioactive standards were scanned. The areas on the sample 
lanes corresponding to the standards were cut out and eluted with 
3 ml of methanol using the syringe and bent needle technique 
(Bominguea, 1967).
Determination of radioactivity
m -------fsi\ "H progesterone and \ H 17o^ -hydroxyprogesterone used 
as chromatography standards were located using a Paclîard Model 
7200 radiochromatogram scanner.
Non-aqueous samples for scintillation counting were dissolved 
in 8 ml of NE 233 (Nuclear Enterprises Ltd., Edinburgh) liquid 
scintillant and aqueous samples in 8 ml of NS 250 (Nuclear 
Enterprises Ltd., Edinburgh) liquid scintillant. Samples 
were determined for radioactivity in a Nuclear Chicago "Tsocap
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300* liquid scintillation spectrometer in which aqueous samples
were counted with an efficiency of 49% for \ J and non
is 1aqueous samples with an efficiency of 57% for | HJ . Efficiency
- f  1 ^ 1  -  jwas checked regularly using a standard stock solution of
N-hexadecane.
Blanks (vial and scintillant only) gave values of below 
10 cpiu consistently and samples were not corrected for this 
background. Nlieaton glass scintillation vials (low background) 
were used for all samples.
Glassware
Stoppered Bl4 tubes (I# 24/1/5, Quickfit Ltd,) were used 
for extraction of plasma and extracts were transferred to conical 
tubes (BC 24/G14T, Quickfit Ltd.) prior to chromatography. 
Disposable glass tubes, 12,5 cm by 1.5 cm (Samco Ltd.) were 
washed in distilled, de-ionized water before use for competitive 
protein binding assay and radioimmunoassay. Standard flasks 
wore grade B glassware (E-mil). Blow out graduated pipettes 
(E-mil) were used for measuring plasma samples (1.0 ml and 0,2 
ml) and for removing aliquots for radioactivity determinations 
(0.2 ml and 0.5 ml).
Used scintillation vials were emptied, rinsed with industrial 
acetone and then, together with all other radioactive glassware,
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soaked overnight in Decon 75 (Medical Pharmaceutical Developments 
Ltd., Sussex) cleaned in an ultrasonic bath (Mettier Electronics) 
for 30 min, rinsed ten times with cold tap water, a further ten 
time with de-ionised, distilled water and dried at 100°C. All 
tubes used in assays were stored in polythene bags prior to use.
A refrigerated centrifuge (MSE, 6L) with a multi-load head, 
capable of carrying up to 96 tubes was used for centrifugation 
of charcoal.
"*l'Jhirlimixers’ (Fisons Scientific Apparatus Ltd.) were used 
for routine mixing after addition of reagents.
A magnetic stirrer (Toyo, supplied by Chem Lab* Instruments 
Ltd.) was used to stir suspensions of dextran coated charcoal to 
ensure homogeneity of sampling.
•Repettes* (10.0 ml and 2,0 ml), supplied by Jencons Ltd., 
were used for repeated additions of reagents in the competitive 
protein binding and radioimraunoassay methods. Attaclment of a 
fine gauge needle to the 2.0 ml *repette' was found convenient 
for additions of 100 jLil volumes in the radioimmunoassay.
A 10 «1 repeating Hamilton syringe (V.A. Howe, Ltd.) was
fa  1used for addition of \ H internal standards to plasma prior 
to extraction.
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Bufforo and Solutions 
1. Competitive protein binding assay
0.01M“Tris, O.OOIM-EDTA buffer was prepared in distilled, 
de-ionised water and the pH adjusted as required with 2M-HC1.
Bextran coated charcoal (0.25% charcoal, 0*025% dextran) 
and 0*5% gelatine solutions were prepared in the above buffer.
Stock solutions of progesterone and 17d-hydroxyprogestorone 
(lOng/ml) were prepared in ethyl acetate*
Standard Protein Solution (SPS)
The protein was contained in the plasma of a post-menopausal 
woman after treatment with 1*25 mg of ethinyl oestradiol per day 
for fourteen days together with 2.0 mg per day of dexamothasone 
for the final idiree days* This plasma was stored in 0,5 ml 
aliquots at «20^ 0, The binding capacity was not affected by 
thawing and re-freesing up to three times* This plasma was 
used to assay progesterone and 17ot"hydro:cyprogesterone at dilutions 
of 1 in 500 and 1 in 1000 respectively.
4 yuCi of 1^ 1,2 - corticosterone were pipetted into a 
100 ml standard flask and the solvent removed by evaporation 
under nitrogen* About 50 ml of tris "“EDTA buffer, pH 8,0 were 
added and the flask was incubated 45^ C for five minutes, the 
appropriate amount of plasma was then added (0,2 ml for the pro­
gesterone SPS and 0.1 ml for the I7o^ -hyd:coxyprogesterotie SPS)
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and the solutions were made up to 100 ml with buffer. The 
solutions were equilibrated at 4°C overnight before use. 
These solutions could be stored for at least four weeks at 
4°C without reduction in their binding capacity*
2.
0.05 M « phosphate buffer, pH 7,0, containing 0.01% (w/v) 
thimerosal, was prepared from di-sodium hydrogen orthophosphate 
and sodium dihydrogen orthophosphate in de-ionised, distilled 
water.
Gelatine containing dextran coated charcoal (0.125% charcoal, 
0,025% dextran, and 0,100% gelatine), 0,5% gelatine solution 
and 0*1% gelatine solution were prepared in the buffer.
A stock solution of oestradiol (Ing/ml) was prepared in 
methanol. This solution was freshly prepared every four weeks 
as deterioration occurred on storage,
A solution of ^6,7«\J oestradiol containing approximately 
25,000 dpm in 100 ^ il of solution was prepared in 0.1% gelatine 
solution.
An antiserum raised to oestradiol-17^ -6(0-carboxyinethyl)oxiTne* 
bovine serum albumin (Dean et al,, 1971; Exley et al., 1971), a
gift from Dr. D. Exley, was used to assay oestradiol. The 
antiserum was obtained as a I in 5 dilution following Rivanol 
treatment and was stored in 0,05 ml aliquots at -20°C. Its 
properties were not affected by thawing and re-freezing or by 
storage for at least a year at *-20°C. 0.01 ml of the antiserum
was diluted to 50 ml with 0.1% gelatine solution, giving a 1 
in 25,000 dilution of the original serum. This solution could 
be stored for up to four weeks at 4®C without appreciable 
reduction in binding capacity.
Measurement of Cortisol
Cortisol was assayed by the competitive protein binding 
method of Murphy (1967) under the supervision of Dr. R, Fraser, 
M.R.C. Blood Pressure Research Unit, Western Infirmary, Glasgow.
Measurement of Luteinizing hormone (LH)
In most cases LH was determined by radioiimunoassay based 
on the method of Greenwood et al., (1963), using an antiserum 
prepared against human chorionic gonadotrophin. The Medical 
Research Council Human Pituitary LH reference preparation 48/50 
was used as the LH standard. These estimations were carried out 
by Mr. Crawford Ferguson, Research Department, the Royal Maternity 
Hospital, Glasgow.
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Xn tt-70 cycles presented in Chapter 4 (Subject K,B,, cycle 
I5 Fig, 4,VII and subject M.F., Fig* 4,VIII) LH was determined 
by radioimmunoassay using the 2nd IRP of HOG as the standard.
These estimations were carried out under the supervision of 
Dr. J*W, Crawford, Department of Obstetrics and Gynaecology, 
University of Dundee.
Measurement of Follicle Stimulating hormone (FSH)
FSH was determined by radioimmunoassay using an antiserum 
prepared against FSH. The World Health Organisation International 
Reference Preparation of Human Menopausal Gonadotrophins (FSH 
and ICSH), 2nd IRP established 1964, was used as the FSH standard. 
These estimations wore carried out by Searle Scientific Services, 
High Wycombe, under the supervision of Mr. Alan Craig.
CHAPTER 3
DEVELOPMENT OF COMPETITIVE PROTEIN BINDING 
m o  HADXOBMNOASSAY ElETHODS FOR MEASUREMENT 
OF STEROID HORMONES
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DEVELOPMENT OF COMPETITIVE PROTEIN BINDING (CPB)
AND RADIOBfî-IÜNOASSAY (RIA) MTHODS
FOR MEASUREMENT OF STEROID HORMONES
INTRODUCTION
Until 1964 only bioassays and chemical assays requiring 
large volumes of plasma or urine because of their insensitivity 
were available for measurement of steroid hormones, Murphy 
(1964) suggested the general application of displacement
analysis, aîid in particular competitive protein binding, to the 
assay of small quantities of steroid hormones in biological 
fluids.
CPB analysis utilises the fact that many hormones in vivo 
are strongly bound to naturally occurring proteins. IRiere the 
hormone is antigenic, or may be rendered antigenic, it is possible 
to produce antibodies to the hormone of some degree of specificity. 
Utilisation of these proteins in displacement analysis is radio­
immunoassay, The first substance to be measured by RIA was 
insulin by Berson and Yalow (1957). Unger et al., (1961) 
used the technique to determine glucagon and Hunter and Greenwood, 
(1962) reported the measurement of growth hormone by RIA. The 
principle of CPB has been applied to the measurement of much
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smaller molecules than these such as thyroxine (Hurphy and Pattee, 
1964a) and vitamin (Barakat and Ekins, 1961). Cortisol 
was the first steroid to be measured by this method (Murphy et 
al., 1963; Murphy and Pattee, 1964b).
PRINCIPLE OF DISPLACEMENT ANALYSIS
Displacement analysis depends upon the competition of two 
forms of the same molecule for reactive sites on a second mole­
cule of lower concentration. One of the forms of the compound 
being assayed (a radio-active isomer) remains constant in amount 
while the other varies. Displacement of the isomer by increasing 
amounts of the variable, non™radioactive form allows the construction 
of a standard curve.
In applying this principle to CPB and RIA of steroids, one 
form of the steroid (the radioactive isomer) must first bind, 
with high affinity, to a limited amount of its specific binding 
protein in such a way that the binding sites on the protein 
are just saturated. If unlabeBed steroid is then added to the 
system It will compete for the same binding sites so that the 
amount of radioactive steroid bound to the protein will be reduced 
due to its displacement by the unlabelled form. This dis­
placement will be dependent upon the weight of unlabelled steroid 
added. Separation of free and protein bound labelled steroid
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and quantisation of either allows estimation of the degree of 
displacement of labelled steroid. Using standards of increasing 
weight, a standard curve to which unknovm saaples may be related 
can be constructed.
Application of those principles to the assay of steroid 
hormones in plasma is dependent upon the fulfilment of several 
important criteria, Tliese are s-
1* Extraction of the steroid of interest from plasma,
2, Purification of the steroid; the amount of purification 
required is dependent upon the specificity of the binding 
solution.
3, Determination of the recovery of the steroid through the 
extraction and purification procedures,
4, High affinity binding of the steroid to a specific binding 
solution,
5, Availability of the steroid labelled with a radioactive 
isotope in high specific activity.
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6* Separation of free and protein bound steroid,
7, Optimum incubation times and temperatures to achieve binding 
of radioactive steroid to protein, displacement of radio™ 
active steroid by "cold* steroid and separation of free
and protein^bound steroid,
8, Measurement of the distribution of the steroid between free 
and bound fractions,
9, Comparison of unknom samples with a standard curve and 
calculation of results, with recovery corrections.
10, Assessment of methodological interfering factors,
11, Assessment of accuracy, precision and sensitivity.
Tlie way in which these criteria have been applied to the 
measurement of progesterone, l%&«hydro%yprogestorone and oestradiol 
in plasma will be described in the following sections.
A . PROGESTm om  A m  17o<."HYDR0}!:YPRQGESTER0ME
Antoniades (1961) suggested tîiat hormones are transported
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:tn the blood in association with specific carrier proteins.
Such proteins might play an important part in the transport of 
substances by increasing their solubility in plasma and by pre­
venting their loss through the kidney, Murphy (1964) suggested 
the use of the protein CBQ, an ot,-globulin present in all vertebrate 
species examined (Seal and Doe, 1966)^  for the measurement of a 
number of steroids, including progesterone, because of its 
ability to bind these steroids in a reversible manner. Many 
CPB methods developed for the measurement of progesterone and 17oO- 
hydroscyprogesterone have utilised this protein (Neill et al.,
1967; Yoshimi and Lipsett, 1968; Johansson, 1969; Martin et 
al,, 1970), In the present study, the method of Martin et al., 
(1970) for progesterone was modified to make it quicker and more 
reliable and extended to combine the estimation of both progesterone 
and IT^-hydroxyprogesterone in the same sample of plasma,
1, Extraction of steroids from plasma. Extraction of 
the plasma with an organic solvent precipitated the protein, 
including any steroid binding globulin, which was present. 
Diethyl ether was found to be superior to ethyl acetate 
(Martin et al,, 1970) as an extracting solvent firstly 
because of the efficiency of the steroid extraction (99%
3% SD. , n =3 200, of the progesterone and l%&-hydroxyprogesterone
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were extracted In one extraction step) and secondly because 
of ease of evaporation. Decanting off the ether layer 
after freezing the aqueous layer in solid GO^  gave a 
reproducibly more efficient extraction than did removal 
of the ether layer with a pasteur pipette.
2, Purification of Steroids. CBG is capable of binding all 
4~ene, 3-ane steroids to a greater or leaser extent, thus 
necessitating some purification of the steroids which were 
to be measured*
Paper partition chromatography was described in theory 
by Martin and Synge (1941) and solvent systems such as those 
described by Bush (1952) have proved most successful in 
separation, and purification of steroid homones, A "Bush- 
type* system utilising an aqueous stationary phase was 
developed in the present study for the separation and 
partial purification of progesterone and l%A-hydroxyprogesterone. 
The Rp values of various steroids in this system, light 
petroleum (boiling range 60^  - 80^ C) -methano1-water (10:7:3, 
v/v) are sho;m in Table 3.1. A band from 0.05 to 0.15 
was consistently removed for 17c<.-hydroxyprogesterone and a 
band from 0.55 to 0.70 for progesterone.
17c<.-hydro>:yprogesteroiie was not adequately separated
TABLE 3.1 VALUES OF STEROIDS IN TME SYSTEM LIGHT 
PETROLED M (BOILING RANGE 6 8 O^ G^)-METHANOL* 
WATER (10:7:3, v/v)
STEROID STEROID
PROGESTERONE 0,65 17oC-HVDR0XYPREGNSN0L0NE 0
17o^ »HYDR0XYPR0GESTER0NE 0.07 16oC-HmOXYPREGNENOLONE 0
11 «-HYDROXYPROGESTERONE 0.04 20 ot-I-lYDROXYPREGNSNOLONE 0
20«<-HYDROXYPROGESTERONE 0.23 20 p-HYDROXYPREGNENOLONE 0
20 ^-HYDROXYPROGESTERONE 0.45 DHA 0.27
6f*.HYDR0XYPR0GE8TER0m 0,02 16c{-HYDR0XY DHA 0
16 t^ -HYDROXYPROGESTERONE 0.01 PREGNANOLONE 0,89
TESTOSTERONE 0.10 PREGNANEDÏONE 0.94
ANDROSTEWEDIONE 0.41 PREGNANEDIOL 0
OESTROm 0.13 OESTRONE ACETATE 0.86
OESTR^miOL 0.03 OESTRADIOL ACETATE 0.89
OESTRIOL 0 OESTRIOL ACETATE 0.80
AHDROSTENEDÏOL 0 TESTOSTERONE ACETATE 0.85
CORTISOL 0.02 \^NDROSTENEDIOL ACETATE 0.79
CORTICOSTERONE 0.03 11 c<-HYDROXYPROGESTERONE ACETATE 0.20
11 -DE, OXYCORTICOSTEROm 0.13 6Î-ÜYDR0XYPRQGESTER0NE ACETATE 0.60
PREGNENOLONE 0.46 CORTISOL ACETATE 0.02
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from testosterone by a single chromatography step in the 
above system (Table 3,1) and as this compound might inter­
fere in the CPB assay the 17eC“hydroxjrprogesterone must be 
separated from it. Separation of the two steroids was 
achieved following acétylation. Testosterone acetylated 
under mild conditions whilst the 17d-hydro:i:yproge8terone 
did not, presumably because of the 'protective* effect of 
the side chain at the 17-position. An acetylating mixture 
consisting of 1 drop of pyridine and 1 drop of acetic 
anhydride was used and suitable conditions of time and 
temperature for complete acétylation of testosterone were 
investigated. The results of these investigations are 
shomi in Table 3,2.
Two sets of conditions gave complete acétylation of 
testosterone without acétylation of 17c*,-hydroxyprogesterone, 
incubation for 5 h at room temperature or for 18 h at 4^ C.
The former was chosen as the more convenient for incorporation 
into the assay. The addition of 1 ml of methanol after 
the acétylation assisted in the removal of the excess 
reagents.
The testosterone acetate thus produced ran to an value 
of 0,85 when rechromatographed in the same system and was 
thus well separated from the unchanged 17oO"hydroxyprogesterone-
TâBLE 3. 2 RESULTS OBWIBD FOLLOWING ACETYLATION OF A 
MIXTURE OF testosterone (T) AND 17o<-HYÎ)R0XY- 
PROGESTERONE <17 OHP) WITH ONE DROP OF PYRIDINE 
AND ONE DROP OF ACETIC ANHYDRIDE FOR VARIOUS 
TIMES AND AT DIFFERENT TEmERATURES
<-i’ indicates presence of compound) 
(•* indicates absence of confound)
TIME TEÎÎP CONSTITUENTS OF ACETYLATED MIXTURE
h T ™ ' a S t S e ’ " 17 OHP 17 OHP ACETATE
I 4
.f *!■•
20 4'
2 4 '1* 4-
20 4- 4-
5 4 4" 4" 4-
20 - 4- 4^
4 4* 4-lo 20 4' + 4'
I _ _ _ _ _
37
H
and
Recovery of M progesterone and '4] 1%4-
iror-ryproges ter<3ne, Solutions of [3h picoges terone
H 17dv-hydroxyprogosl:erono in benseiie-ethanol 
(9:Ip v/v) (lOjiîl; approximately 6,000 dpm; less than 
0,02 ng of each) were added to the plasma prior to 
extraction. These internal standards were used to 
monitor recovery of the steroids throughout the extraction 
and purification procedures. Recoveries of 81,17.5% 
[8,D.,(n •- 200) for progesterone and 54,9 4; 7,9% 8.D.,
(n K: 200) for 17oi-%iydroxyprogesterone were obtained,
4, The steroid binding solution.
a) Source of a suitable steroid binding protein. CBG
has been shovm to increase in concentration during pregnancy
or during oestrogen administration (DeMoor et al., 1962),
In the present study the administration of ethinyl oestradiol 
to a post-menopausal woman was used to produce plasma with 
a high concentration of this specific binding protein.
The administration of dexamethasone was used to suppress 
the adrenal glands,to prevent saturation of the binding 
globulin with adrenal steroids (Lipsett et al,, 1970),
The CBG used by Martin et al., (1970) was obtained from
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dogs treated with ethinyl oestradiol and megestrol acetate. 
One of the most crucial points in the method was the 
production of a sufficiently sensitive CBG. Mayes and 
Nugent (1968) and Reeves et al., (1970) 
noted that in order to obtain sensitivity, precision and 
accuracy at 1.0 ng and below (which is required in the 
assay of 17o(.-hydro:syprogesterone in 1 ml of plasma) the 
binding protein must show a 25% change in bound radio­
active isomer for I ng of "cold* steroid added. Dog 
CBG will not yield a curve as sensitive as this, but this 
sensitivity was easily achieved with this human CBG.
Reeves et al., (1970) have also shovm that CBG from patients 
treated with oestrogen and dexaniethasone appeared to be more 
sensitive than CBG from patients treated with oestrogen 
alone.
b) Preparation of the standard protein solution (SPS).
The binding of corticosterone to CBG is highly specific 
but steroids also bind to albumin. Although the latter 
binding is weak and non-specific it is nevertheless important 
because of the large concentration of albumin in plasma. 
However, albumin binding can be decreased by dilution of 
the plasma (Murphy, 1964). The determination of the
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optimum dilution of plasma to obtain sensitivity over 
the required range for 1 -liydroxyprogesterone is shoxm 
in Fig. 3, X, At dilutions of 1 in 500 for progesterone 
and 1 in 1,000 for lYo^ -hydroxyprogesterone the albumin 
effect was negllble and maximum sensitivity was achieved 
through specific binding to a small concentration of CBG. 
A 1 in 500 dilution was chosen for assay of progesterone 
since this dilution gives a suitable initial binding and
percentage displacement o; Steroid over the range
0 - 15 ng. A 1 in 1,000 dilution was chosen for the I?*- 
hydroxyprogesterone assay because this dilution gave a 
more sensitive curve over the range 0 » 4 ng.
Theoretically the CPB method relies on the ability of 
a steroid to displace its radioactive isomer from a binding 
protein. However, in practice steroids with the 4-ene,
3-one grouping vary in their binding affinity and hence in 
their ability to displace others from CBG (Reeves et al., 
1970; Rossner, 1969). This explains the finding that 
better initial binding and displacement over the desired
M
by progesterone or 17o^ «hydroxyprogesterone than when
range was obtained when | H| corticosterone was displaced
3,H
progesterone or H 17c<"hydro::yprogesterone was used as
the bound steroidL. j^ H corticosterone xfas therefore
FIG* 3. I, DETERMINATION OF THE OPTBM DILUTION OF HUMAN
POST-MENOPAUSAL PLASMA FOR THE MEASUREMENT OF 17oi- 
HYDROXYPROGESTERONE. THE PERCENTAGE OF _H 
CORTICOSTERONE (C) BOUND IS PLOTTED AGAINST MASS OF 
'COLD' 17o<-HYDROXYPROGESTERONE (17 OH PROGESTERONE)
FOR VARIOUS DILUTIONS OF PLASMA FROM 1 IN 40 TO I IN 1000
1:40100
1:80
e 1:100
Bound
1:200
'01 :300  
'•*1:400  
-o  1:500 
_ *  1:1000
Progesterone
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used in the preparation of the standard protein solutions. 
There will be further discussion of this phenomenon in 
Chapter 7.
Examples of the standard curves obtained at optimal 
dilutions for progesterone and 17<A"hydroxyprogesterone 
are shomi in Fig. 3, II and Fig. 3* III respectively*
c) Optimum pH for binding of corticosterone to
CBG* During preliminary experiments on the binding
3of H corticosterone to CBG it was observed that the 
percentage bound using a buffered solution at pll 8*0 was 
higher than that observed in deionized, distilled water 
(used by Martin et al,, 1970 and Joliansson, 1970), The 
results of further investigations of the effect of pH 
on binding are shox-m in Fig, 3. IV. The optimum binding 
occurred at pH 8,0, All subsequent work using CBG was 
performed in Tris-HCl-EDTA buffer at pH 8,0, De Moor 
et al*, (1963) have also shorn that the binding of cortico* 
steroids to CBG is dependent on the pH of the solution, 
a maximum value having been observed at pH 8.0,
d) Specificity of the CBG. The 4-ene 3-one configuration 
in ring A of the steroid nucleus is essential for binding
FIG. 3. II A TYPICAL STANDARD CURVE FOR THE PROGESTERONE ASSAY 
OBTAINED USING A I IN 500 DILUTION OF HUMAN POST­
MENOPAUSAL PLASMA, THE PERCENTAGE OF CORTI­
COSTERONE (C) BOUND IS PLOTTED AGAINST MASS OF 'COLD' 
PROGESTERONE
70-
60.
Bound
50.
40 .
30.
20
4 8
ng Progesterone
12 16
FIG. 3. Ill A TYPICAL STAKDARD CURVE FOR THE 17c<-HYDROXYPROGESTERONE 
ASSAY OBTAINED USING A 1 in 1000 DILUTION OF HUMAN 
POST-MENOPAUSAL PLASMA. THE PERCENTAGE OF 
CORTICOSTERONE (C) BOUND IS PLOTTED AGAINST MASS OF *COLD* 
17^ -HYDROXYPROGESTERONE (17 OH PROGESTERONE)
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THE EFFECT OF pH ON THE MAXIMUM BINDING OF H 
CORTICOSTERONE (C ) TO CBG,STANDARD PROTEIN SOLUTIONS 
(1  IN  1000 D ILU TIO N S) WERE PREPARED IN  BUFFERS OF
VARYING pH AND THE BINDING OF H C TO THE CBG
DETERMINED IN  THE ABSENCE OF 'COLD' STEROID,
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to GBG (Rossner9 1969? Sandberg et al., 1966? Reeves 
et al., 1970). Binding affinity is increased by the 
presence of hydroxyl groups in the lip, 1 7 and 21 
positions* The only steroid laiomi to be present in human 
plasma which would compete for binding sites and would 
not be sufficiently separated from progesterone or 
hydroxyprogesterone in the initial chromatography is 
testosterone (see Table 3*1). Fig* 3.V* compares the 
standard curves obtained by displacement of corti«
cos terone with 17</,«hydroxyproges terone alone and in the 
presence of testosterone. Testosterone increased the
displacement of H corticosterone and would there­
fore interfere in the assay of 17c^ -hydroxyprogesterone 
if it were not removed from the 17ot-hydroxyprogesterone 
fraction.
5, Radioactive labelled steroid. In order to achieve 
sensitivity in the assay, the steroid used for initial 
binding must be labelled with a radioactive isotope of 
high specific activity, to ensure that the mass added was 
not large in relation to the amount of steroid being
measured. Hence the Steroid was used as
steroids are of low specific activity.
FIG. 3. V COMPARISON OF STANDARD CURVES OBTAINED FOR lycK-HYDROXY­
PROGESTERONE (17 OH PROGESTERONE) AND FOR 17o(-HYDROXY­
PROGESTERONE TO WHICH AN EXCESS (2 x) OF TESTOSTERONE 
WAS ADDED AT EACH POINT. THE PERCENTAGE OF CORTI­
COSTERONE (C) IS PLOTTED AGAINST MASS OF 'COLD* STEROIDS.
O 17(A-hydroxyproges terone
4* 17o(~hydroxyproges terone -H 
excess testosterone (2 x)
•8-
G
0
ng 17 OH Progesterone
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6. Separation of free and protein bound steroid. Various 
agents have been used to separate free and protein bound 
steroid in CPB assays including Sephadex (iCato and Horton,
1968), saturated anunonium sulphate solution (Mayes and 
Nugent, 1968), Plorisil (Murphy, 1967; Frick and Kind,
1969), Fuller's earth (Murphy, 1967) and dextran coated 
charcoal (Roaenfield et al*, 1969), Martin et al.,
(1970) employed florisil in their assay but since publication 
of this work they have experienced difficulty in obtaining 
batches of florisil which will adequately reproduce this 
separation (Martin, 1970a), De Sousa et al., (1970) 
and Strott and Lipsett (1968) have also reported similar 
problems with florisil, Dextran coated charcoal was 
therefore employed in the present study. This material, 
first used by Miller (1957), gave reproducible separation 
under the conditions of the assay. Addition of 0*5% 
gelatine solution prior to the dextran coated charcoal
increased the percentage of ii corticosterone bound
in the absence of 'cold* steroid by 10%. The role of the 
gelatine was uncertain but it appeared to give protection 
against 'stripping* of steroid bound to protein by the 
charcoal.
Tlïe dextran coated charcoal was stored at 4*^G over­
night before use and stirred continuously during use to 
ensure homogeneity of sampling in order to achieve good 
duplication*
7. Incubation times and temperatures* The incubation
times and temperatures used in the CPB assay were the
same as those used by Martin ot al*, (1970).
3,The SPS containing H corticosterone was incubated
with the 'cold* steroid initially for 5 minutes at 45^ C
to obtain maximum dissociation of protein and
Steroid and then at 4^C for 10 minutes. There is 
evidence that greater dissociation occurs between corti­
costerone and CBG at temperatures around 40°C (Westphal,
1970) wliile lowering the temperature to 4^C increases the 
association constants ahd thus enhances CBG binding to 
steroid (Murphy, 1964). In the second incubation, there­
fore, a new equilibrium was established in which 
corticosterone was replaced on the CBG by increasing weights 
of progesterone or 17<^ -hydroxyprogesterone. After addition 
of dextran coated charcoal to separate free and protein 
bound steroid, the mi:cture was incubated for 10 minutes at 
4°C. This was a suitable incubation time for obtaining
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adsorption of free steroid without 'stripping* of the 
steroid bound to the protein,
8. Measurement of the distribution of steroid between free 
and bound fractions. After addition of dextran coated 
charcoal and incubation for 10 minutes at 4 C^, the samples 
were centrifuged at 1,400 g for 10 minutes to precipitate 
the free steroid which had been adsorbed by the dextran 
coated charcoal. The steroid bound to protein remained
& corticos terone
&
in the supernatant. The percentage of 
remaining bound to protein after displacement by 'cold* 
steroid was calculated by estimating the radioactivity in 
an aliquot of supernatant and comparison with the total 
corticosterone. This was determined by measuring 
the radioactivity in an aliquot of SPS in the absence of 
'cold* steroid and dextran coated charcoal,
9, Comparison of unlmo^m samples with a standard curve 
and calculation of results. A range of standard samples 
were prepared in duplicate for progesterone (0«15 ng) 
and 17oi-hydro:cyprogesterone (0 - 4 ng) from stock solutions 
in ethyl acetate (10 ng/ml, v/v) and the solvent evaporated.
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The staîxdard samples were processed in the CPB assay 
together with unknox-jii samples. The percentage of 
corticosterone bound was determined, as described above, 
for the standard and nnknoim samples. Standard curves 
were constructed by plotting the percentage of {^ Ilj 
corticosterone bound against corresponding weights of 
'cold* steroid. The weights of steroid in unknot-m 
samples were determined by comparison with the standard 
curve. Results were expressed in ng/ml of plasma after 
correcting for procedural losses and volumes* Details 
of the calculation are presented in the A^ondix (p.234).
10. Assessment of methodological interfering factors.
A suitable blank substance was assayed with each batch of
samples to ensure that methodological interfering factors
3,H cortr-did not cause significant displacement of 
costerone from GBG. Choosing a suitable blank substance 
was complicated. Plasma from a gonadectomised, adrenalec- 
tomised female might have been of use but this had two 
main disadvantages. Firstly, such plasma was&fficult 
to obtain in amounts sufficient for routine use. Secondly, 
it was possible that such drastic treatment might have 
altered the composition of the plasma, thus invalidating
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the blank.
Charcoal treated plasma has been used (Lipsett et al.,
1970) but it cannot be claimed that this is equivalent 
to steroid-free plasma as, in addition to removing steroids, 
charcoal adsorbs many other low molecular weight substances 
which may contribute to blank values.
A third possible blank substance was water, which was 
used in this study. This was not the perfect choice but 
gave an estimate of interference due to methodology.
The blank values obtained for 5 ml of deionised, distilled 
water were 0,02 j; 0,05 ng S.D, (n “ 56) for progesterone 
and 0.02 4 0.03 ng S.D, (n - 56) for 17p^ -hydro:iyprogesterone.
11, Statistical assessment of the method.
a) Accuracy. Ten replicate samples each of 17c<-hydroxy- 
progesterone (2 ng) and progesterone (2 ng, 5 ng and S ng) 
were added to blanks and assayed. The results obtained 
are shOT-m in Table 3.3. Accuracies of 96.5% for 2 ng
of 17ot.-hydroxyprogesterone and 106% (2 ng), 100% (5 ng) 
and 104% (8 ng) for progesterone were obtained.
b) Precision, From the figures given in Table 3.3, the 
intra-assay coefficient of variation for 2 ng of 17*^ -
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hydroxypi'ogesterone was j; 8.8% and those for progesterone 
were j; 11.8%, 4 10.4% and 5.5% for 2 ng, 5 ng, and 3 ng, 
respectively.
The inter-assay coefficient of variation was determined 
by assaying, in duplicate, a quality control plasma sample 
with each assay. The results for these samples were 1*62 
0,16 ng S.D. (n ~ 50) for 17cA.”hydroxyprogesterone and
4.0 jb 0.46 ng S.D, (n - 50) for progesterone. These 
figures gave an inter-assay coefficient of variation at 
these levels of j; 9.9% for 17<x-hydroxyprogesterone and
4- 11,5% for progesterone.
TABLE 3.3 RESULTS OP TIIE ASSAY OF 17(<-RYDR0XYPR0GESTER0NE 
AND PROGESTERONE ADDED TO BLANK SAî-IPLES
STEROID ADDED
RTEXGHT
ADDED
<ng)
RESULT 
(ng 4 S.D.)
17c^ -hydroxyproges terone 2 1.93 ^ 0.17
Progesterone 2 2,12 ±  0.25
Progesterone 5 5.00 ±  0.52
Progesterone 8 8.30 -h 0.46
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c) Sensitivity, The blank value plus one S.D. was used 
as an estimate of the lowest level of detection of the 
steroid. Hence from the figures given in section 10,
(p. 46 ) the lowest level of detection of progesterone
was 0.07 ng and of 1%^ -hydroxyprogesterone, 0.05 ng 
per sample.
The method finally developed for the assay of progesterone 
and 17^ -hydroxyprogosterone) incorporating these criteria 
is summarised below.
Assay of progesterone and 17e<-hydroxyprogesterone by CPB. 
Solutions of piij progesterone and 17ok-hydro:cy-
progesterone in bensene-ethanol (9î1 y/v) (10 ^î1; approximately
6,000 dpm, less than 0,02 ng of each) were added to the plasma 
to be assayed (I ml) and the samples diluted to 5 ml with 
deionised, distilled water. The plasma was extracted by 
shaking with 5 ml of diethyl ether in stoppered tubes for 45 
seconds. After allowing the layers to separate the tubes were 
placed in crushed solid CO^ î theaqueous layer was froaen 
rapidly and the ether layer decanted into conical tubes. The 
solvent was removed by evaporation under nitrogen, the tubes 
washed dom with I ml of ether and again taken to dryness.
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The plasma extracts were dissolved in a few drops of ethyl 
acetate and applied to pre-washed chromatography papers cut 
into lanes as previously described (p. 22 )• Standards of 
progesterone and 17<A-hydroxyprogesterone (0.5 yaCi) were applied 
to two lanes on each paper. The papers were chromatographed in 
a descending system of light petroleum (boiling range 60^  «
80^ C) « methanol-water (10:7:3, v/v) for three-and-a-half 
hours at room temperature, after equilibration overnight.
They were removed from the tanks, dried and the standard lanes 
on each paper were scanned using the radiochromatogram scanner.
The bands corresponding to progesterone and 17o<-hydroxyprogesterone 
standards on each sample lane were cut out and eluted with 3 ml 
of methanol. The eluates were evaporated to dryness under 
nitrogen.
The 17c<-hydro2cyproges terone dried eluates were acetylated 
with 1 drop of pyridine and 1 drop of acetic anliydride for 5 
hours at room temperature, 1 ml of methanol was added and 
the reagents were removed by evaporation under nitrogen in a 
water bath at a temperature below 30^ G. The acetylated l7o<- 
hydrojiyprogesterone bands were re-chromatographed in the same 
system and the 17o<«hydroxyprogesterone, which was now separated 
from testosterone acetate was eluted from the paper with 3 ml 
of methanol and the solvent evaporated.
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1 ml of ether was added to the dried eluates of both 
progesterone and 17c<-hydro2cyprogeaterone, and 0.2 ml removed 
from each for radioactivity determination to monitor the recovery 
throughout the extraction and purification steps. The remaining
0.0 ml of ether was evaporated and the dried residues were 
assayed by CPB together with standard samples.
The range of standard samples was prepared in duplicate 
from 0 « 15 ng for progesterone and 0 « 4 ng for ITek-liydro^ ty- 
progesterone using 10 ng/ml solutions in ethyl acetate and the 
solvent evaporated under nitrogen.
Standard protein solution (1 ml) was added to all unknoim 
samples and the standard samples and contents of the tubes were 
mixed and incubated at 4°C for 3 minutes. The tubes contents 
were mixed again and the tubes put into an ice/water bath for 
10 minutes, 0.5 ml of 0.5% gelatine solution and 0.5 ml of 
dextran coated charcoal suspension were added to each tube, 
except tCTO tubes, referred to as 'no charcoal* tubes which 
contained no *cold* steroid and 0,5 ml of buffer in place of the 
dextran coated charcoal. The tubes were shaken gently, left 
in ice for 10 minutes and then centrifuged at 1,400 g for 10 
minutes, 0.5 ml of the supernatant was removed for radioactivity
3
determination. Results ifere calculated as percentage H 
corticosterone remaining bound after displacement by 'cold*
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steroid using the *no charcoal* tubes to estimate the total
amount of corticos terone,
Blanks consisting of 5 ml of deionised, distilled water 
and quality control plasma samples were processed with each assay.
The extraction and purification steps and GPD assay are 
outlined in flow sheets (Fig. 3. VI and Fig, 3, VII).
B. OBSTRADIOh
The most specific type of binding proteins, antibodies, 
were used in the assay of oestradiol. This hormone is present 
in non-pregnant human female plasma in sub-nanogram amounts 
per ml, necessitating a highly sensitive method for its measure' 
ment in small volumes of plasma. Radio immunoassay could 
provide this high level of sensitivity. The method developed 
was a modification of that described by V7u and Lundy (1971) 
using a different antiserum,
1. Extraction of oestradiol from plasma. Diethyl ether 
was found to be the most suitable extracting solvent 
giving recoveries of 100 j; 2% S.D. (n - 30) of 
oestradiol added to plasma. In the assay, no
FIG. 3. VI FOT SHEET OF THE EXTRACTION AND PURIFICATION 
OF PROGESTERONE (P) AND Uol-HYDROXYPROGESTERONE 
(17 ÔHP)
Plasma v tracer H P an d H 17 OHP
Extract 1 K 5 ml ether
I Plasma extract
Paper partition cltromatographyi light petroleum 
(b.range 60^“• 30°C)î methano 1 swater (10:7:3) PCI
17 OHP 4- Testosterone
.ation and 
in PCI
17 OHP
1/5 for 
Radioactivity
determination
1/5 for
radioactivity 
d e termination.
4/5 for CPB 
assay
assay
FIG. .3, VII FLOW SHEET OF CFB ASSAY FOR PROGESTERONE 
AND I7ol*“HYDR0XYPR0GESTER01TE
Dried unknot-m samples and standard curve samples
Add 1 ml SPS and mi:
Incubate 45°c for 5 min
Mix
Incubate 4 C^ for 10 min.
Add 0.5 mlj 0,5% gelatine soln,
4" 0,5 ml de:ctran coated charcoal
4^ 0 for 10 min
Spin at I400g for 10 min
Remove 4  ^ ' 0.3 ml supernatant for radioactivity
de temination,
Incubate
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tracer of oestradiol was added to the plasma as preliminary 
studies showed that the extraction was reproducible and 
quantitative.
2. Purification of oestradiol. As the antibody used was 
specific for oestradiol (see p. 55 ) it was theoretically 
possible to set up a specific assay without a chroma to-* 
graphic purification step. In preliminary escperiments 
samples were assayed without chromatography and compared 
to identical samples subjected to chromatography on 
Sephadex LH20 (Wu and Lundy, 1971) to separate oestradiol 
from oestrone and oestriol. The results of these assays 
are shorn in Table 3, 4. There is no significant 
difference betrreen the results obtained by methods (i) 
and (ii) (paired t, 0,49, 0,7>p>0,6) and therefore 
chromatography was not included in the assay procedure.
j 3  ,
3. Recovery of I Hi oestradiol. As mentioned in section 
1 above, no internal standard of oestradiol was 
added to the plasma, since the extraction was quantitative 
and no chromatography step was involved. Recovery was 
assumed to be 100% in all samples.
W L E  3. 4 COMPAEXSON OF THE RESULTS OBTAINED .FOR THE 
ASSAY OF oestradiol IN NORMAL MENSTRUAL 
CYCLE PLASMA (1) WITHOUT CHROMATOGRAPHY AND 
(ii) WITH CHROmTOGRAPHY ON SEPHADEX LH 20
DAY OF CYCLE (i) OESTRADIOL (pg/ml)
(ii) OESTRADIOL 
(pg/ml)
1 90 85
2 40 50
5 45 45
7 80 95
9 65 50
13 200 250
14 70 70
15 75 60
16 100 120
17 140 120
19 200 215
20 215 200
21 155 200
22 175 150
23 65 75
26 95 70
Mean f S.D, 113.1 ±  58,8 115.1 ^ .66.9
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4. The oestradiol binding solution.
a) Production of a suitable anticerum. There have been
many reports recently of the production of suitable 
antibodies for RXA of oestrogens (Perin et al., 1968;
Abraham, 1969; Mikhail et al., 1970; Dean et al.,
1971). Since steroids alone are non«antigenic (Lieberman 
et ai., 1959) it is necessary to attach the steroid to a 
large "foreign* protein molecule such as bovine serum 
albumin (BSA) before injection into an animal. The 
point of conjugation of the steroid to BSA is important 
with regard to the specificity of the antiserum produced. 
Greatest specificity has been obtained for the steroid 
by attacliment of the protein so that the functional groups 
of the steroid molecule are free. This promotes production 
of antibodies specific for these groups (Dean et al.,
1971). Oestradiol antibodies of greater specificity have 
been established by linking the steroid to the BSA through 
the Opposition (Exley et al., 1971) than linking through 
the 17-position (Wu and Lundy, 1971) or through the 3- 
position (Thomeycroft et al., 1970), of the steroid nucleus.
A mixed population of antibodies is produced both to 
the steroid and BSA and the latter can be selectively
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removed to produce a very high titre antiserum. Addition 
of BSA removes BSA antibodies (Campbell et al., 1964;
Exley et al., 1971) whilst treatment with Rivanol (diamino 
lactate) can be used to remove serum proteins (albumin and 
(Kand p globulins) which might otherwise take part in 
non-specific binding (Horesjl and Smetana, 1956; Abiraham,
1969).
b) Optimum dilution of antiserum* The results of eimeri- 
ments to determine the optimum dilution of antiserum for 
use over the range 0 - 300 pg are shown in Fig. 3. VIII.
1 in 25,000 was chosen as a suitable dilution and was 
prepared in 0.05M»phosphate buffer, pH 7.0.
c) Specificity of antiserum. The cross reaction with 
other compounds was examined in the following way.
Standard samples of oestradiol were prepared together 
with standard samples of the cross reacting substance and 
samples of oestradiol to which the cross reacting substance 
had been added. These three sots of standards were assayed 
together and the results compared. In the case of 
substances likely to be found in the plasma in greater
FIG. 3. VIII STAMDAED CURVES OBTAINED FOR OESTRADIOL USING VARIOUS
DILUTIONS OF ANTISERUM. THE PERCENTAGE OF H
OESTRADIOL (E^ ) BOUtB IS PLOTTED AGAINST llASS OF 'COLD' 
OESTRADIOL.
(a) I in 10,000
(b) 1 in 20,000
(c) 1 in 25,000
(d) 1 in 30,000
Bound
300200100
‘ Py O ssifc id î
“ -
concentration than oestradiol? larger amounts of the 
test substance than oestradiol were added when the standards 
were prepared. Fig. 3, DC compares curves obtained for 
oestradiol3 oestrone and oestriol. The results, indicated 
that oestrone and oestriol gave a small displacement of
3
H oestradiol from the antiaerum when they were present 
alone. However, when oestrone and/or oestriol were added 
to oestradiol in equal concentration, the results shown in 
Fig. 3, X were obtained. The curves did not differ 
significantly, indicating that neither oestrone nor oestriol, 
when present with oestradiol, caused further displacement
of II oestradiol from the antiserum. Table 3. 5 
shows the percentage cross reaction of various substances 
with the oestradiol antiserum. Calculation of the cross 
reaction was made using the formula of Abraham (1969):
FIG. 3. IX COMPARISON OF STANDARD CURVES OBTAINED FOR OESTRADIOL
OESTRONE AND OESTRIOL WITIi THE OESTRADIOL ANTISERUM
(1 in 25,000 DILUTION), THE PERCENTAGE OF OESTRADIOL
(E^ ) BOUND IS PLOTTED AGAINST MASS OF 'COLD* OESTROGEN.
(a) oestrone
(b) oestriol
(c) oestradiol
Bound
300
pg O e s tro g e n
FIG. 3. X
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COMPARISON OF STANDAEID CURVES OBTAINED FOR OESTRADIOL 
ALONE AND IN COMBINATION WITH OESTRONE AND/OR OESTRIOL, 
USING THE OESTRADIOL ANTISERUM. THE PERCENTAGE OF [^h] 
OESTRADIOL (E^ ) BOUND IS PLOTTED AGAINST MASS OF 'COLD' 
OESTROGEN.
O
+
X
o oestradiol
4“ oestradiol oestriol
® oestradiol + oestrone
X oestradiol + oestrone 4* 
oestriol
X
+
o
o
X
+
100 200
pg O e s t ro g e n
o
+
300
TABLE 3. 5 PERCENTAGE CROSS REACTION OF VARIOUS 
COÎÎPOUNDS WITH OESTMDXOL ANTISERUM
COMPOUND CROSS-REACTION (%)
OESTRADIOL-1? p 100
-A- OESTRIOL 1,0
oestrone 0.9
4- 6-KET0-0ESTRADI0L-17 p 110
* TESTOSTERONE < 0.01
* PROGESTERONE < 0.01
* l7(A“HVDR0}tYPR0GESTER0NS < 0.01
4" 0E8TRADI0L-17^ 2.0
* gloMxphene citrate 0
4- DEHYDROEIPANDROSTERONE < 0.01
4" CHOLESTEROL < 0.01
4- CORTISOL <0.01
* Personally determined
4- Figures quoted from Exley et al., (1971)
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Hass OGStracUol required to displace 50% of bound 
oestradiol
Mass of cross reacting substance required to displace
3.-.
50% of bound oestradiol « y
% cross reaction - x 100
7
The figures indicated that providing the concentration 
of oestrogenic compounds, substituted at the 6*position 
of the steroid nucleus in the sample to be assayed for 
oestradiol was low (Exley et al., 1971) the antiserum 
was sufficiently specific to be used for direct RIA on 
organic extracts of plasma samples.
5. Radioactive labelled oestradiol. Exley et al., (1971), 
reported no difference between the binding of 6,7- H
oestradiol and [^ 2,4,0,7 oestradiol to this oestradiol
antiserum, oestradiol was used in the present
study,
6. Separation of free and protein bound oestradiol.
Several methods have been reported for separation of free 
and antibody bound hormone in RIA, These include ammonium 
sulphate precipitation, (Chard et al,, 1971) double antibody 
technique (Midgley, 1966), dry coating of plastic tubes
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with antisera (Catt ancl Tregear, 1967) chromatoelectro- 
phoresis (Saxena et al,, 1968) and dextran coated charcoal 
(Wu and Lundy, 1971). Dextran coated charcoal was 
used in the present study. Separation of free and 
hound steroid was achieved successfully using half the 
concentration of charcoal described previously for the 
CPB assay.
The time of contact of charcoal with the RIA 
€cyiilibrium mixture was found to be critical. Table
3
3,6 shows the apparent decrease in percentage H 
oestradiol bound with increasing 'contact* time with 
charcoal. It was therefore necessary to centrifuge 
the tubes immediately after the addition of charcoal.
This could give rise to problems of inconsistency 
betifoen the first and the last additions if the number 
of tubes handled was large. To attempt to eliminate 
the errors involved in this procedure, in practice, 
the charcoal suspension was added to one of each of 
the standard curve samples, then to the unknown samples 
and finally to the duplicate of each of the standard 
Gurve samples. A typical standard curve, treated in 
an assay in this way, is shomi in Fig, 3. XI*
Duplication of the points was good, showing that little
FIG. 3. XI A TYPICAL STANDARD CURVE OBTAINED FOR THE OESTRADIOL 
ASSAY, USING A 1 IN 25,000 DILUTION OF THE ANTISERUM.
IN OBTAINING THIS CURVE, THE DEXTRAN COATED CHARCOAL 
SUSPENSION WAS ADDED TO ONE OF EACH OF THE STApARD 
CURVE SAMPLES AND THEN TO THE UNKNOW SAMPLES BEFORE 
ADDITION TO THE DUPLICATE OF EACH OF THE STANDARD CURVE 
SAMPLES. THE PERCENTAGE OF 
IS PLOTTED AGAINST MASS OF 'COLD' OESTRADIOL.
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error was introduced in this procedure when up to 
thirty^siK tubes were handled in an assay.
TABLE 3. 6. THE EFFECT OF CHARCOAL •COÎÎTAGT TIME' ON THE 
APPARENT MAXÎÎCM BINDING OF 
TO Am'ISERmi.
.Vi i.
N OESTRADIOL
CHARCOAL 'CONTACT TIME' (min) APP/aElTF MAXXl« BINDING (%)
2 75
5 55
10 28
7. Incubation times and temperatures. In a preliminary 
ezcporiment, incubation of standards vrâtli the antiserum
solution and H oestradiol, at 4 G, was carried
out for 0, 5, 10, 15, 20, 25, 30 minutes and 1, 2, 3,
H oestradiol5, 17 and 24 hours. The percentage 
bound when no 'cold* oestradiol was present and the 
percentage bound when 300 pg of 'cold* oestradiol 
were present, at various incubation times, are sIiottu 
in Pig. 3. XII.
On the basis of these results, 20 minutes was chosen
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as a suitable incubation time* Maximum binding and
displacement of H oestradiol (by 300 pg of "cold* 
oestradiol) were achieved in this time. The 20 
minutes incubation was most practical in the assay 
and more convenient than a 2 hour incubation (Wu and 
Lundy, 1971).
8. Measurement of the distribution of oestradiol 
between free and bound fractions* This measurement 
was made by determining the radioactivity in an aliquot 
of supernatant, obtained after charcoal precipitation 
and centrifugation, and comparing this with the total
amount of H oestradiol present as for the CPB
assay (p. M  ).
9, Comparison of unknomi samples with a standard curve 
and calculation of results. A range of standard samples 
was prepared in duplicate (0 to 300 pg) from the stock 
(1 ng/ml) solution of oestradiol in methanol and the 
solvent evaporated, Unknomi samples were determined
H oestradiolby direct comparison of percentage 
bound with the standard curve. Results were expressed 
in pg/ml of plasma. No recovery corrections were made.
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10. Assessment of methodological interfering factors.
The problems of assessment of oestradiol methodological 
blanks were identical to those for progesterone and 
17<A-Iiydroxyprogesterone (p. 45 ). Water (0.2 ml)
was used in the present study to determine the method
blank. To minimise this blank it was particularly 
important to use freshly washed tubes and recently 
distilled ether. A bottle of ether which had been 
open for several days gave significantly high blank 
values. The method blank obtained was 3 4 2 pg S.D,
(n = 50).
11. Statistical assessment of the method.
a) Accuracy. Ten replicate samples each of 20 pg and
60 pg of authentic oestradiol were added to blanks
and assayed. Accuracies of 93.5% (20 pg) and 108.9%
(60 pg) were obtained.
b) Precision. The intra-assay coefficient of variation 
for 20 pg of oestradiol was 4 22.8% and for 60 pg 4 
10.2%.
The inter-as8ay coefficient of variation was obtained
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by assaying several samples from a quality control 
plasma pool with each assay* The results for these 
samples (n - 50) gave a value of 4 11.3% at the 60 pg 
per 8maple level.
c) Sensitivity. The lowest level of detection of 
oestradiol was estimated at 5 pg per sample (blank 
plus one S*0.),
The method developed for the assay of oestradiol 
incorporating these criteria is summarised below;-
Assay of oestradiol by RIA.
Plasma (0.2 ml) was extracted once with 3 ml of ether 
by shaking for forty-five seconds, the tubes placed 
in crushed, solid GO^  and the ether layer decanted 
into disposable assay tubes after freezing of the 
aqueous layer. The ether was evaporated and the samples 
subjected to RIA.
A range of standard samples was prepared from 0 - 300 
pg, in duplicate, using the stock.solution of oestradiol 
(1 ng/ml) in methanol and the methanol evaporated.
FIG. 3. XIII FLOW SHEET OF THE EâBXOMüHOASSAY 
OF OESTRADIOL
Plasma
Extract 1 X 3 ml ether
Plasma extract
Add 0.1 ml anti serum soln.
Mix
Add 0.1 ml [^iij oestradiol soln.
Mix
Incubate \/ 4 C for 20 min,
Add 0.1 ml, 0,5% gelatine soln*
Mi::
Add 1,0 ml Dextran coated charcoal 
Mix for 5 sec*
Spin immediately, l400g for 10 min.
i
Remove 0.5 ml supernatant for radioactivity 
determination
“ G2 “
0,1 ml of antiserum solution was added to all imkiiox-Tn 
samples and the standard smaples and the contents of
H oestradiolthe tubes mixed gently, 0,1 ml of 
(25,000 dpm) was added and the tubes* contents were 
again mixed gently. After incubation at for 
tizenty minutes, 0.1 ml of 0.5% gelatine solution was 
added to each tube and the contents mixed gently, 1 ml 
of dextran coated charcoal was then added to each tube, 
(except the *no charcoal* tubes) the contents were 
mixed porously for five seconds and centrifuged 
immediately at 1400 g for ten minutes. 0.5 ml 
of the supernatant was removed for radioactivity 
determination.
Results were calculated as percentage H oestradiol
remaining bound after displacement by *cold* oestradiol,
using the results obtained for the 'no charcoal*
II oestradioltubes to calculate the total amount of 
present. Unknown samples were compared with the standard 
curve. Fig, 3* XIXÏ, is a flow sheet of the assay 
procedure.
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STEROID AND GONADOTROPHIN HORMONE PATTERNS 
THROUGHOUT MEHSTRUAJ^  CYCLES OF VOLUNTEER SUBJECTS
INTRODUCTION
Plasma levels of steroid and gonadotrophin hormones 
throughout menstrual cycles from apparently normal volunteers 
were established in this study for several reasons.
Firstly, it was important to establish the sequence of 
hormonal events in the normal cycle. Secondly, confirmation 
of the reliability of the assay methods was obtained by 
comparison of the hormone levels found in the normal cycle 
with those reported by otiier workers* Finally normal 
ranges for hormone levels were established for comparison 
with cycles from infertile subjects. This comparison may 
be important in defining the cause of infertility since 
small differences betizeen normal and infertile cycles in 
hormone levels or patterns may be significant.
Whilst mean levels of hormones throughout normal 
cycles are not only useful for establishing a normal range 
but necessary for comparison with 'infertile* cycles, 
much important information may be lost if cycles are not 
studied individually. Examination of individual cycles
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shows the pattern of each hormone in the same cycle and 
allows a more direct study of possible inter-relationships 
between hormones to be made. In this thesis therefore, 
the hormone levels are presented not only as the mean 
of all the cycles for each homione, but also as the hormone 
patterns in each individual cycle.
Problems arise in defining a 'normal* cycle. Certain 
broad criteria must be laid dom when selecting subjects 
and cycles for inclusion in a normal series. Ideally, 
perhaps, the subjects should be of proven fertility but 
such volunteers, who are not practising contraception, are 
difficult to find. Nineteen cycles from fourteen women
have been studied. These women were apparently normal,
aged 18 to 26 years, unmarried and nulliparous. The 
criteria used initially in selecting normal subjects were :
1) A history of regular menstrual cycles of betifeen 
27 and 32 days.
2) No history of general medical or gynaecological 
abnormality.
3) No history of oral contraception.
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'Normal* cycles were definedj for the purposes of 
this study, as
1) Cycles having a luteal phase of at least 13 days 
(Rock, 1949s Vende Niele and Turksoy, 1965) 
measured from the day of the maximum LH value 
until the onset of the following menses.
2) Cycles being obtained from subjects having no 
knovm abnormalities or special peculiarities.
Using this definition only 8 of the 19 cycles studied could 
be strictly classified as 'normal*.
In presenting the data, the onset of menses was used 
as a reference point to ma^k the beginning and end of 
sample collection periods. The LH mid-cycle peak, which 
is traditionally considered to be the "most accurate indicator 
of the phases of the menstrual cycle" (Ross et al., 1970) 
has been used as a marker on which to base data. This was 
especially useful when calculating means and defining 
intervals in order to eliminate the effects of varying cycle 
length and time of ovulation. The scheme used for presenting
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cycles in this, and the following chapters is shown in 
Pig, 4. Ï. The day of the LII mid-cycle peak was desig- 
noted as day 0.
Daily blood samples were collected from an a m  vein 
at 09.00 hours each morning throughout 19 menstrual cycles, 
into lithium heparin tubes. The subjects were sedentary 
during this procedure. The plasma was separated immediately 
by centrifuging for 10 minutes in a bench centrifuge.
Aliquots were removed for LH and FSH determinations and 
the remainder was frosen at -20^ C. until assays of steroid 
hormones were carried out.
Progesterone and 17<A«hydroxyprogesterone were assayed 
in the same 1 ml sample of plasma by the CPB method and 
oestradiol in 0,2 ml of plasma by the RÏA method which 
have been described in Chapter 3 and summarised in Pig. 3.
VI and VII and Pig. 3* XIII respectively. LH and in 
some cycles, FSH, were measured in other laboratories as 
previously described (p. 28 )• Aliquots of the same
sample were used for all estimations and samples from an 
entire cycle were determined in a single assay. The areas 
under the progesterone, l7c<“hydroxyprogeaterone and oestradiol 
curves in the luteal phases of the cycles were measured.
FIG. 4. I THE SCHEME USED FOR PRESENTING MENSTRUAL CYCLE DATA,
THE DAY OF THE LH MID-CYCLE PEAK IS DESIGNATED AS
DAY 0.
LH
PEAK
FOLLICULAR
PHASE
LUTEAL
PHASE
EARLY
etc."”1 0 4! etc.
DAY RELATIVE TO L H PEAK
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The areas trader the curves were defined as the total amount 
of plasma steroid measured from day 4-1 to the day on which 
the next menstrual bleeding began inclusive. In some 
cycles, basal body temperature (BBT) was recorded, orally, 
by the subjects themselves before rising each morning 
throughout the cycle studied. No restrictions were 
placed upon physical activities or diet. Neither endo­
metrial nor ovarian biopsy was performed in these subjects. 
Brief details of the subjects studied are presented in 
Table 4. 1.
RESULTS
The results are presented in two parts. The cycles 
which are considered nonml are presented in Part X and 
the remaining 11 cycles in Part IX, where the reasons 
for their separate presentation will be discussed,
PART I
HORMONE PATTERNS IN THE NORMAL MENSTRUAL CYCLE
A. MEAN HORMONE LEVELS
Fig, 4. XX shows the mean LH pattern 4- S,D. (n - 6).
TABLE 4. I. DETAILS OF THE APPARENTLY NORMAL 
VOLUNTEER SUBJECTS STUDIED IN CHAPTER 4.
NAME AGE CYCLE LENGTH LUTEAL PHASE LENGTH
KB 22
Cycle 1 31 13
Cycle
PH
2
23
32 10
Cycle 1 24 14
Cycle 2 27 14
Cycle 3 26 14
DIP 25 31 14
SR 25 29 12
MA
JG
20
26
28 11
Cycle 1 30 9
Cycle 2 30 14
KIC
BN
25
20
29 17
Cycle 1 31 12
Cycle 2 30 10
cw 21 27 12
SH 22 28 15
BP 20 27 13
HG 22 32 14
DB 24 29 16
MMc 22 28 15
Calculated from 1st day of LH rise
FIG. 4. II THE MEAN LEVELS OF LH + S.D. (n = 6) THROUGHOUT 
THE NORMAL MENSTRUAL CYCLE. DAYS ARE NUMBERED 
RELATIVE TO THE LH PEAK IN THIS AIR) SUBSEQUENT 
DIAGRAMS
mean level (n = 6) 
+ one S.D.
30
20
LH
mm
10
0
O-G,
0
■12 8 4
DAY RELATIVE TO PEAK
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Levels began at 4 m.i.u./rnl on day “12 and showed a down­
ward trend to 2 m.i.u./ml on day -6. From then, levels 
began to rise steadily until day «2 and then sharply to a 
mid-cycle pealc (day 0) of 22 ^ 7  (S.D,) m.l.u./ml. Levels 
then dropped steeply until day -12 and more gradually until 
day -15 whence they remained steady until the end of the 
cycle. Peak values ranged from 15 ra.i*u*/ml to 32 m.i.u/ml. 
Fig. 4. Ill shows the mean FSH pattern j; S.D, (n - 5). 
Levels began at around 18 m,i.u,/ml on day -13, They 
then dropped gradually to 6 m,i,u,/ml by day -5, The 
FSH mid-cycle peak was not as well defined as the LH 
peak and peak levels e:ctended over 3 days from day -1 to 
day -11. Levels then dropped gradually reaching a second 
nadir on day -110, A sharp rise occurred, on day -114, to 
a level comparable to that at the beginning of the cycle.
The standard deviation was very large throughout. Mid­
cycle peak levels (day -1) ranged from 10 - 21 m.i.u,/ral*
Fig, 4. IV shows the mean progesterone pattern ^  S.D.
(n = 8), The mean follicular phase level was around 1 ng/ 
ml and remained steady throughout this phase. Levels rose 
significantly from day -11 onwards and continued to rise 
consistently to a peak value of 8 ng/ml on day 15,
FIG. 4. Ill THE MEAN LEVELS OF FSH ± S.D, (1 1= 5) THROUGHOUT
THE NORMAL MENSTRUAL CYCLE
30
20 
FSH
m iu|m l
10
0
mean level (n = 5)
«I» «n vtr one S #D ,
-12 -8 “4 12 16
DAY RELATIVE TO L H PEAK
FIG. 4. IV THE MEAN LEVEL OF PROGESTERONE (P) + S.D, (n = 8)
THROUGHOUT THE NORMAL MENSTRUAL CYCLE.
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Levels remained high until day -18 when they dropped, reaching 
1 ng/ml hy day -115, The standard deviation was large, thus, 
for example luteal peak levels on day -15 ranged from 4*5 to 
11.5 Cig/ml and early follicular phase levels ranged from 
around 0.5 to 1.5 ng/ml.
Fig* 4. V. shows the mean 17d-hydroxyprogesterone 
pattern 4 S.D. (n » 8), Mean levels began at 0,8 ng/ml
and showed a dotmward trend to 0,4 ng/ml on day -11. They
then rose but remained below 0,8 ng/ml until day -1 when a 
significant increase occurred culminating in a discrete peak 
with a mean value of 1,5 ng/ml on day 0. A drop of approx­
imately 15 “• 20% was observed on day -t-l, followed by a 
steady rise to a luteal phase plateau of around 2,4 ng/ml 
between days 5 and 8, Levels dropped consistently to a 
mean value of 0.6 ng/ml on day 4-14 but rose to around 1.0 ng/ml
by the end of the cycle. The standard deviation was again
large in both follicular and luteal phases.
Fig, 4. VI shows the mean oestradiol“17p pattern S.D.
(n " 8), Mean levels began at just below 100 pg/ml and 
fluctuated between 100 and 150 pg/ml until day -5 when a 
steady increase began culminating In a peak of 320 pg/ml 
which occurred on the day before the LH peak (day «1).
FIG. 4. V THE MEAN LEVEL OF 17c/,-HTDR0XyPR0GESTER0NE (17 OHP) +
S.D. (b = 8) THROUGHOUT THE NORMAL MENSTRUAL CYCLE,
mean level (n = 8)
+ one S,D
4
3
17 O H P
ng/ml
2
1
0
-1 6 - 8  - 4  0 4 8
DAY R E L A T IV E  TO  L H  P E A K
FIG. 4. VI THE MEAN LEVEL OF OESTRADIOL (E^ ) + S.D. (n = 8)
THROUGHOUT THE NORMAL MENSTRUAL CYCLE.
mean level (n = 8) 
+ one S.D.500
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Levels dropped steeply to about 60% of the peak value and 
then rose In the luteal phase, reaching a plateau between 
days 45 and 410. This luteal peak (220 pg/ml) was always 
of less magnitude than the mid-cycle one. Levels dropped 
steadily after day 410 reaching 70 pg/ml on day 415, The 
standard deviation was again large in both the follicular 
and luteal phases,
B. HORMOm LEVELS IN XNPtVXDUAL CYCLES
Hormone patterns in the Individual nonnal cycles which 
comprise the mean cycle are presented in dlagramatic form. 
Outstanding features of these cycles which were less well 
defined or absent in the mean cycle are described in the text.
Subject KB (Cycle 1)
This subject was the only one included in the study 
who, in a later cycle, became pregnant and was therefore 
the only one of proven fertility. She was admitted 
for therapeutic abortion at 12 week gestation and blood 
samples were collected tlirougliout a cycle (cycle 2) 
some months ffter this, which will be presented in Part IX 
of this chapter.
The results for Cycle 1 are shorn in Fig, 4, VII,
M -. - VJLJL ù i I l . K U l U  A IN U  U U L N A U U T K U j. ' 'H lJ N  t lU t lM U iN J i  F A T T l i K J N b  J.JN X H i i :
m m A L  MENSTRUAL CYCLE.
SUBJECT K.B., Cycle 1.
based on 2nd IRP,HCG
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A possible relationship existed between FSH and oestradiol 
in the follicular phase of the cycle. An FSH pealc on 
day "13 preceded an oestradiol peak on day -11 and a 
second FSH peak on day «8 preceded a second oestradiol 
peak on day -6, A third FSH peak on day -A preceded a 
rise in oestradiol on day «3 which culminated in the 
mid-cycle peak of oestradiol, occurring on the same day 
as the LH peak. A mid-cycle FSH peak occurred on the 
day before the LH and oestradiol peaks. No discrete 
17oC-hydro3cyprogesterone peak was present but a rise 
occurred on day 0 and was sustained into the luteal 
phase. All three steroid hormones reached luteal 
phase peaks on day -l-S and their patterns were similar in 
the late luteal phase; the three hormones dropped by 
50% of their value between days -MO and day 4-11. The 
BBT curve was biphasic, the temperature rise being 
apparent on day -!-2.. The areas under the progesterone, 
17o<-hydroxyprogesterone and oestradiol curves in the 
luteal phase of the cycle %mre 70,2 ng, 34.6 ng and 
3150 pg respectively.
Subject MF
The results for this subject are shomi in Fig. 4. VIII,
FIG. 4. VIII STEROID AND GONADOTROPHIN HORMONE PATTERNS IN THE
NORMAL MENSTRUAL CYCLE,
SUBJECT M.F,
based on 2nd IRP, HCG. 
(see p. 29 )
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Tî'7o major oestradiol peaks occurred in the late follicular 
phase of the cycle, one on day -A and the second on day 
«2, two days before the LH mid-cycle peak. However, 
oestradiol remained at peak levels until day -1 when 
the first rise in LH occurred. Oestradiol levels 
dropped on day H  by 75% of their mid-cycle peak value 
and rose in the luteal phase to a peak on day -Vl which 
was higher in relation to the mid-cycle peak than in 
the mean cycle. A discrete 17o^ «hydro2cyprogesterone 
peak occurred on day 0. The BBT curve was bi-phasic 
and showed a significant increase in temperature on day 
41., The areas under the progesterone, 17o(-hydro3cy- 
progesterone and oestradiol cruves in the luteal phase 
of this cycle were 68.2 ng, 24.7 ng and 1865 pg respectively,
Subject KK.
The results for subject KR are shoim in Pig, 4. XX,
This cycle had a short follicular phase (10 days) and a 
long luteal phase (17 days). However, It followed the 
mean pattern in most respects. The mid-cycle oestradiol 
peak occurred on the day before the LH peak and a 
discrete 17o<.-hydro2cypr oges ter one peak occurred on the 
day of the LH peak. Progesterone showed a small but
FIG. 4. IX STEROID AND GONADOTROPHIN HORI'IONE PATTERNS IN THE
NORMAL MENSTRUAL CYCLE.
SUBJECT K.K.
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significant rise from day -2, coincident: with the LH 
rise and before the LH peak, which was sustained into the 
luteal phase# The BBT curve was bi-phasic, showing 
a significant increase in temperature on day f3. The 
areas under the progesterone, 17o(.-hydroxyprogesterone 
and oestradiol curves in the luteal phase of the cycle 
were 102.8 ng, 48.5 ng and 3270 pg respectively#
The results are shorn in Fig, 4, X, A peak of FSH 
occurred on day -9 and an oestradiol peak on day -8,
The mid-cycle oestradiol peak, the value of which was 
above one S.D. of the mean cycle, occurred on the same 
day as the LH peak and the mid-cycle FSH peak occurred 
on day -M. The LH peak value was also above one S.D, 
of the mean cycle. There was no discrete mid-cycle 
17o(~hydroxyprogesterone peak but levels rose from day 
“1 to day -!-2, and the rise continued into the luteal 
phase. Both progesterone and 17i>;>-hydroxyprogesterone 
levels were low in the luteal phase and showed a similar 
pattern, both reaching peaks on day 4-8. The areas 
under the progesterone, ITd-hydroxyprogesterone and 
oestradiol curves in the luteal phase were 39.3 ng, 11.1 
ng and 3000 pg respectively.
FIG. 4. X
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The results are shomi in Fig. 4. XX. FSH levels 
were consistently high from days -12 to -7 whexi they 
dropped dramatically. The first rise of oestradiol 
was concomitant with this drop. Mid-cycle peaks of 
oestradiol and FSH occurred on day «1. 17o^ -hydroxy- 
progesterone reached a small peak on day -1, Patterns 
of steroid hormones were similar in the luteal phase, 
although progesterone levels were high, whilst 17^ r 
hydroxyprogesterone and oestradiol levels were low,
FSH rose at the end of the cycle on day -M3, when the 
steroid hormones had returned to base-line levels.
The areas under the progesterone, ITdrhydroxyprogesterone 
and oestradiol curves in the luteal phase were 68,4 ng, 
8.9 ng and 1565 pg respectively.
Subject PH
This subject gave daily blood samples throughout three 
cycles. Some months after the first cycle (Cycle 1) 
she developed amenerrhoea, following a period of dieting 
associated with taking 2 x 10 mg *Ponderax* tablets 
per day. Daily samples were collected during part of 
this period, presumably of anorexia nervosa, which
FIG. 4. XI STEROID AND GONADOTROPHIN HORMONE PATTERNS IN THE
NORMAL MENSTRUAL CYCLE,
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lasted approximately four months, and the results ^ill 
be presented in the second part of this chapter. Six 
months after the return of normal menstruation she 
gave blood for two consecutive cycles (Cycles 2 and 3),
Cycle 1 - is shorn in Pig. 4. XII. This was a short
cycle (24 days) but nevertheless had a 14 day luteal 
phase. Oestradiol levels were high at the beginning 
of the cycle and a peak occurred on day «8 which was 
not accompanied by an increase in LH, FSH results 
were not available for this cycle. The mid»cycle 
oestradiol peak fell on the day before the LH peak. 
Oestradiol levels dropped by about 90% of their peak 
value on day 4-1 before the luteal phase rise began. 
There was no discrete mid«cycle 17ak-hydroxyprogesterone 
peak, but a gradual rise began on day ~5 and was 
continued into the luteal phase* There was a rise 
in progesterone on day «2, but a drop occurred on 
day 0 before the luteal phase rise began. The luteal 
phase patterns of the three steroid hormones were 
similar. The BBT curve was bi-phasic. The areas 
under the progesterone, 17ck"hydroxyprogesterone and 
oestradiol cruves were 56,6 ng, 33.1 ng and 2830 pg 
respectively.
FIG, 4. XII STEROID AND GONADOTROPHIN HORMONE PATTERNS IN THE
NORMAL MENSTRUAL CYCLE.
SUBJECT P.H., Cycle 1.
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Cycle 1 - is shorn in Fig. 4. XIII. This cycle 
was longer than the previous one, being 27 days but 
also with a 14 day luteal phase. Mid-cycle peak 
levels of oestradiol and FSH occurred on day «1 and 
FSH remained at its peak level until 4 days after the 
LH peak. The luteal phase levels of oestradiol were 
higher in relation to mid-cycle levels than in the mean 
cycle and they reached luteal peak levels on day -tS,
A discrete 17c<-»hydroxyprogesterone peak occurred on 
the day of the LH peak. 17(^ "hydro3:5^ progesterone and 
oestradiol patterns were similar in the luteal phase.
The areas under the progesterone, 17<A-hydroïîyprogesterone 
and oestradiol curves in the luteal phase were 69.6 ng,
19.5 ng and 1220 pg respectively.
Cycle 3 - is sho^ -m in Fig, 4. XIV. This cycle was 
similar in length to the previous one and again longer 
than Cycle 1, being of 26 days duration with a luteal 
phase of 14 days. It was interesting to note that in 
three cycles from the same subject, the luteal phase 
was constant in length whilst the follicular phase 
varied, A peak of oestradiol occurred on day -8
FIG. 4.
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though this was not associated with a change in 
gonadotrophin levels. The mid-^ cycle oestradiol 
peak occurred on day -1 and the mid«cycle FSH 
peak on day 0, A rise in 17(A"hydro3cyprQgesterone 
occurred on day 0 and continued into the luteal 
phase. The patterns of the steroid hormones 
were similar in the luteal phasei however, pro- 
gesterone levels were high whilst 17o^ ."hydroxyprogesterone 
and oestradiol levels were lower than the mean.
The areas under the progesterone, I7o<»,**hydr05î:yprogesterone 
and oestradiol curves in the luteal phase were 103.1 
ng, 12*7 ng and 1200 pg respectively.
C. SMÎARY OF RESULTS IN NORMAL MENSTRUAL CYCLES
Certain major features xfere common to apparently ovulatory 
cycles. Other features were less well defined and differed 
greatly in individual cycles.
A peak of oestradiol secretion always either preceded 
by one or two days or was coincident with the mid-cycle peak 
of LH. In either case, levels of oestradiol were always 
beginning to rise at least one day before LH began to rise, 
and LH always rose before oe8ttn,&lol levels began to decline. 
There appeared to be no correlation between peak heights of
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oestradiol and peak heights of LH, For example in subject Pli 
(Cycle 1), Fig. 4. XXX, the LH peak height was low and was 
preceded by a high level of oestradiol; in subject EP (Fig.
4. X) both LH and oestradiol levels were high; in subject 
PH (Cycle 2) the LH level was high but was preceded by a low 
peak of oestradiol • The peak height of LH did not appear to 
be associated with the 'quality* of lutéinisation as reflected 
by progesterone secretion; in subject EP (Fig. 4. X), LH 
levels wore high but luteal progesterone levels low, whilst 
a very low LH peak, in subject I#Ic (Fig. 4* XI) was followed 
by high luteal progesterone levels.
Mean FSH levels were high in the early follicular phase. 
The mid-cycle peak of FSH was not as well defined as the LH 
peak. In individual subjects there appeared to be some 
correlation between FSH secretion and oestradiol secretion, 
as in subject HB (Fig. 4. VII). These peaks of oestradiol 
were not associated lylth peaks of 17Xrhydroxyprogesterone.
A discrete mid-cycle peak of 17o^ -hydroxyprogesterone was 
not always apparent but in all cases levels had risen above 
the follicular phase baseline on the day of the LH peak.
Mid-cycle peaks of FSH and LH were not always synchronous 
and often differed by one day. Transient rises in oestradiol 
were not usually followed by LH release, even though these
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transient increases were sometimes large (Subject îCB, Fig,
4. VII). Only when a sustained rise in oestradiol occurred 
was LII released. The mid-cycle rise in FSIi did not begin 
until the oestradiol rise was established.
Levels of each hormone varied greatly from cycle to cycle 
and even in the same individual in successive cycles* The 
nomal range for each hormone was therefore large. Patterns 
of the three steroid hormones were often similar in the 
luteal phase, suggesting that they were all produced by the 
corpus luteum but the relative levels of the three hormones 
were often very different. For example, in subject KB (Fig.
4. VII) and subject KK (Fig. 4. IX), all three hormones
were high in the luteal phase; in subject EP (Fig. 4, X) oestradiol
was high but 17o^ -hydroxyprogcsteronc and progesterone were
low; in subject MMc (Fig. 4. XI) and subject PH, cycle 3
(Pig. 4. XXV), progesterone was high whilst 17c*,-hydroxyprogesterone
and oestradiol were low.
The oestradiol rise in the luteal phase was usually about 
50% of the mid«cycle rise. The BBT curve was always hi- 
phasic, the temperature increase becoming apparent Td-th increasing 
production of progesterone.
The areas under the luteal phase curves for progesterone, 
17drhydroxyprogesterone and oestradiol are compared to their
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peak heights in Table 4.2, For each hormone there was good 
correlation het^ reen peak height and area; in general the 
greater the peak heights the greater the area under the 
curves. However, both these factors appeared to be independent 
of the length of the luteal phase.
The results of hormone assays in the nomml cycle thus 
showed great variability both in pattern and level. The 
results for cycles which were not considered 'normal* in 
terms of this study can now be eicamined in the light of this 
broad outline of 'normal' characteristics.
PART II
HORMONE PATfERHS IN 'ABNORMAL* l^ IENSTRUAL CYCLES
In this section, hormone patterns are studied in cycles 
which were not considered to be entirely normal and were 
therfore not included in the normal series. The cycles 
presented are divided into two groups
1, Cycles which show certain abnormalities, although 
obtained from apparently normal subjects*
2. Cycles from subjects who have some special condition or 
circumstances.
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Group 1 consists of s«
a) Cycles from subjects BH (2 cycles, although 
not consecutive) and GW, all having luteal phases 
of less than 13 days.
b) 2 cycles from subject JG (not consecutive) and one 
from subject SH, which have short luteal phases 
and/or certain other abnormalities.
Group 2 consists of
a) A cycle from subject SR who had an intra-uterine 
device inserted immediately prior to this cycle.
b) A cycle from subject KB, after termination of 
pregnancy.
c) A cycle from subject HG, who became ill during the 
cycle and took regular doses of an aspirin con­
taining compound for several days during thh luteal 
phase.
d) A cycle from subject DB. This cycle was considered 
abnormal because of the magnitude of the LH peak, 
which was almost twice the value of those found in 
the 'normal* cycles.
e) Samples from subject PH during a period of amenorr- 
hoea presumably due to anorexia nervosa.
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GROUP 1 (a)
Subject M  - The résulta are shown :tn Pig, 4. XV.
This cycle had an 11 day luteal phase* Oestradiol 
levels were low in the early follicular phase and they 
rose consistently from day *5, reaching a plateau on 
day "1 and 0. Levels dropped on day -M and a luteal 
rise began on day f2, culminating in a peak on day 46,
A discrete mid-cycle ITd-hydroxyprogesterone peak 
occurred on day 0, M  early peak also occurred in the 
follicular phase on day -11 but this was not associated 
with a rise in oestradiol or LH, The BBT curve was 
bi-phasic. The areas under the progesterone, 17dr 
hydro:-cyprogesterone and oestradiol curves in the 
luteal phase were 05.4 ng, 30,1 ng and 1730 pg respect­
ively, FSH results were not available for this cycle.
Subject BW (Cycle 1) - The results are shovmi in Fig,
4, }CVX. This cycle had a 12 day luteal phase, FSH 
levels began low and rose to a peak on days -14 and 
"13, Peaks of oestradiol and 17<A~hydroxyprogesterone 
also occurred on day -14. FSH levels dropped on day 
“10 and reached peak values again on day "8, A rise in 
progesterone also occurred on day -8, Levels of FSH
FIG. 4. XV STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A*SHORT*
LUTEAL PHASE CYCLE.
SUBJECT M.A.
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FIG. 4. XVI STEROID AM) GONADOTROPHIN HORMONE PATTERNS IN A
'SHORT' LUTEAL PtIASE CYCLE.
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were g till high on day «5 and a peak of 17o^ "hydro5ry" 
progesterone occurred on day »*4. A rise in progesterone 
occurred he Ween days -7 and «4. Tlie mid«cycle FSH 
and oestradiol peaks occurred on day -!• A rise in 
17e<“hydroxyprogeGterone began on day 0 and continued 
into the luteal phase• The BBT curve was biphasic,.
The areas under the progesterone, 17o<;«Iiydro:cyprogesterone 
and oestradiol curves in the luteal phase were 46.5 ng
18.5 ng and 1855 pg respectively.
(Cycle 2) « The results are shoim in Fig. 4. XVII.
This cycle had a 10 day luteal phase. FSH levels 
fluctuated in the follicular phase, but those changes 
were not associated with fluctuations in oestradiol 
levels. Progesterone levels began relatively high in 
the early follicular phase but dropped on day -11 to the 
normal range. The mid-cycle oestradiol peak occurred 
on day »1 and the mid-cycle FSH peak on day 0.
Oestradiol levels reached a peak value before the sharp 
rise in LH occurred. Both oestradiol and LH were 
high in relation to the 'normal range* at mid-cycle. 
Unlike the 'normal*cycle oestradiol levels were higher
FIG, 4. XVII STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A
'SHORT* LUTEAL PHASE CYCLE,
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in the luteal phase than at mid-cycle. A peak of 
17c^ -hydro2î:yprogesterone occurred on day -4 but this was 
not associated with an increase in oestradiol or 
progesterone. Tliere was no discrete mid-cycle peak 
of 17o<-liydroxyprogesterone. Patterns of all three
steroid hormones were similar in the luteal phase, 
especially oestradiol and progesterone, which both 
dropped from their peak luteal values to baseline in 
tzfo days. The areas under the progesterone, 17oi- 
hydro2cyprogesterone, and oestradiol curves in the luteal 
phase of the cycle were 51.4 ng, .i 11.3 ng and 3310 pg 
respectively*
Subject C¥ « The results are sho^ jn in Fig. 4. XVIII.
This cycle had a 12 day luteal phase. Progesterone 
levels were just above the normal range in the early 
follicular phase, but fell to within the normal range 
on day -5, Oestradiol reached a mid-cycle plateau on 
days -2 and -1. The LH and FSH mid-cycle peaks were 
synchronous. A discrete mid-cycle peak of l?^ - 
hydroxyprogesterone occurred on day 0, The luteal phase 
patterns of all three steroid hormones were similar, 
each reaching a peak on day 46. The areas under the
FIG. 4. XVIII STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A
’SHORT* LUTEAL PHASE CYCLE.
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progesteroneJ 170^ -hydroxyprogesterone and oestradiol 
carves in the luteal phase of the cycle were 42.6 ng, 21.4 
ng and 1705 pg respectively.
GROUP 1 <b)
Subject JG (Cycle 1) - The results are shox-jn in Fig.
4. XIX. This cycle had a 9 day luteal phase and had 
several interesting features. Oestradiol and FSH 
levels fluctuated markedly throughout the cycle. A 
peak of FSH on day «15 was accompanied by an oestradiol 
peak, and a peak of FSH on day *"8 was followed by a 
sharp rise in oestradiol on day -6, This oestradiol 
peak was not followed by a rise in LH. However, a 
further sharp rise in oestradiol to a peak of equal 
magnitude (day -2) was followed by a rise in LH.
This rise in LH was in fact not apparent until oestradiol 
levels were dropping. A sustained high level of oestradiol 
did not, in this cycle, precede LH release. The mid- 
cycle FSH peak fell on day 41 and was of equal magnitude 
to the follicular phase peak on day -S. 17oC-hydro:îy- 
progesterone rose by day 0 and the rise was sustained 
into the luteal phase. Peak oestradiol levels in the 
luteal phase were higher in relation to the mid-cycle
FIG. XIX
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STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A
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peak than in the normal cycle* A sharp drop occurred 
on day 45 followed by a second luteal peak on day 48,
A similar drop occurred in IT -^hydroxyprogesterone 
levels. Progesterone levels were above the normal 
range throughout the follicular phase of the cycle and 
fell just within the lower limits of the range in the 
luteal phase. Levels of oestradiol and 17<A-hydroxy- 
progesterone on the other hand were high in the luteal 
phase. The BBT curve showed a bi-phasic pattern 
although the temperature increase occurred on day -6 
and was not associated with a rise in progesterone 
levels. The areas under the progesterone, 17<a- 
hydroxyprogesterone and oestradiol curves in the luteal 
phase of the cycle were 37.3 ng, 27.2 ng and 2150 pg 
respectively.
(Cycle 2) - The results are shomi in Fig. 4. 301.
Tliis cycle had a normal length luteal phase (14 days) 
but showed certain other abnormalities when compared 
to the normal cycle. Oestradiol levels rose consistently 
from day -6 and reached a mid-cycle plateau from day 
"2 to day 41, An FSIÏ mid-cycle peak, of equal magnitude 
to follicular phase levels, occurred on day 41. 17dr
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FIG. 4, XX STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A CYCLE
SHOWING CERTAIN ABNORMALITIES,
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hydzozypKogestetOno levels rose by day 4-1 and the rise 
continued into the luteal phase. Peak LH levels were 
sustained for tvjo days. Progesterone levels were 
below the normal range in both the follicular phase and 
tîic luteal phase. Oestradiol levels were higher in the 
luteal phase, in relation to mid«cycle levels than in 
the normal cycle, A sharp drop occurred in both 
pTo^csterone and 17ok«hydroxyproges terone levels on day 
4“ 7, The areas under the progesterone, l7o<«hydro2£y« 
progesterone and oestradiol curves in the luteal phase 
of the cycle were 29.1 ng, 15,1 ng and 1790 pg respect­
ively.
Subject SH - The results are shown in Fig. 4, 5DCI.
This cycle was considered to be abnormal because the mid­
cycle LH 'peak* esctended over 4 days* It was there­
fore difficult to calculate the length of the luteal 
phase. The day of the first LH elevation was designated 
as day 0, FSH levels were high in the follicular phase 
and dropped by day -2, whence oestradiol levels rose to 
a mid-cycle plateau on days -1 and 0. The mid-cycle 
FSH peak occurred on day -M, A significant rise in l7ot- 
hydroxyprogeoterone occurred on day 0 and was continued
FIG. 4. XXI STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A CYCLE
WITH AN ABNORIHAL LH MID-CYCLE 'PEAK\
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into the luteal phase. A rise in progesterone levels 
occurred on day '^2, before the first rise in LH became 
apparent. The progesterone levels dropped to baseline 
before the luteal phase rise began. The LH levels at 
mid-cycle were below the normal range, as were oestradiol 
levels at mid-cycle and in the luteal phase. Progesterone 
and 17ot-hydroxyprogesterone levels fell within the normal 
range throughout the cycle. The areas under the progester­
one, 17^-hydroxyprogesterone and oestradiol curves in the 
luteal phase were 77,3 ng, 22.2 ng and 590 pg respectively,
GROUP 2
a) Subject SR ■» This subject had an intra-uterine contra­
ceptive device inserted inmediately prior to the cycle in 
which samples were collected. The results are shomi in 
Fig. XXXI, The cycle had a 12 day luteal phase. The 
mid-cycle oestradiol peak occurred on day -1, Peak levels 
of both LH and oestradiol were above the normal range, A 
peak of 17ok-hydroxyprogesterone occurred on day -3, and a 
mid-cycle peak, above the normal range, occurred on day 0. 
Progesterone levels fell within the normal range throughout 
the cycle. The BBT curve was biphasic, the temperature 
increase being apparent by day -K:-. The areas under the
FIG. 4. XXII STEROID Aim GONADOTROPHIN HORMONE PATTERNS IN A
CYCLE FROM A SUBJECT WITH AN INTRA-UTERINE DEVICE.
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progesterone, 17c<.«hydro>:yprogesterone and oestradiol 
curves in the luteal phase of the cycle were 58.2 ng,
24.3 ng and 2075 pg respectively.
b) Subject 10) (Cycle 2) - This subject, who was studied in 
Part I of this chapter, subsequently became pregnant and 
was therefore the only one of proven fertility. Pregnancy 
was terminated at 12 weeks gestation by extra-amniotic 
infusion of prostaglandin E^ . Five months after the 
termination, when normal menstruation had been resumed for 
three months, daily blood samples were collected throughout 
a cycle.
No systemic study appears to have been undertaken of 
comparison of plasma homone patterns throughout cycles 
from nulliparous and parous women. Information is there­
fore not available as to whether pregnancy alters hormone 
production during ensuing cycles either in peak values or 
in patterns. This cycle was not considered for inclusion 
in the normal serieê, but was interesting to examine with 
regard to the possible effect of pregnancy and prostaglandin 
administration on subsequent menstrual cycles.
The results are shot-Tn in Fig. 4. Mill. Although of 
32 days duration the cycle had only a 10 day luteal phase.
FIG. 4. XXIII STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A CYCLE 
AFTER TERMINATION OF PREGNANCY.
SUBJECT K.B., Cycle 2.
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Oestradiol levais bogan to rise, at mld^cycle from day "*3 
onwards and reached maîdmum levels on day -!• Ho drop 
occurred after this, as In the nonml cycle, but elevated 
levels continued Into tlie luteal phase, until day d-4 when 
levels dropped to 50% of the peak value. A peak of 
equal magnitude to the mld«cycle peak occurred on day 4-7 # 
17^rhydroxyprogesteronc levels rose significantly by day 0, 
the rise continuing into the luteal phase. Two peaks 
of progesterone occurred in the follicular phase on days 
"14 and «9. Levels of all steroid hormones were low in 
the luteal phase, compared to the mean normal cycle* The 
P8H mid^cycle peak occurred on day 0* FSH and LH 
levels at mid-cycle were above the normal range, whilst 
oestradiol levels were below the normal range. In the 
luteal phase, FSH levels rose on day -i7 before progesterone 
and oestradiol levels fell. The areas under the 
progesterone, 17o<-hydronyprogesteronG and oestradiol 
curves in the luteal phase of the cycle were 32.1 ng, 12.8 ng 
and 1.015 pg respectively.
This subject becane ill during the cycle in
91
which blood was colloctcd* Largo doses of an aspirin 
containing compound were administered from days 4-2 to 46, 
inclusive* The results are shoim. in Fig. 4* XXIV, The 
baseline levels of the steroid hormones were low in the 
follicular phase, and FSH levels were also low during this 
time, A peak of oestradiol occurred on day «13. Mid- 
cycle levels of oestradiol were low, a peak occurring on 
day 0. LH and FSH mid-cycle peaks were synchronous and 
above the normal range. Luteal phase levels of progester­
one and 17oi-hydroxyprogestcrone were below the normal 
range* No increase in FSH occurred towards the end of 
the cycle. The areas under the progesterone, l7<i«hydroxy- 
progesterone and oestradiol curves in the luteal phase 
of the cycle were 50,0 ng, 8,0 ng and 990 pg respectively*
d) Subject DB » This cycle is shown in Fig, 4, XXV. Mid­
cycle peaks of FSH and LH were synchronous and both were 
well above the normal range, especially LH which was twice 
as high as peaks found in normal cycles. The mid-cycle 
peak of oestradiol however was below the normal range, and 
occurred on day -1* FSH levels were within the normal 
range in the follicular phase, but were accompanied by low 
levels of oestradiol, A rise of 17cA«hydroxyprogestorone
FIG. 4. XXIV STEROID AND GONADOTROPHIN HORMONE PATTERNS IN A CYCLE 
DURING WHICH ASPIRIN WAS ADMINISTERED FROM DAY 42 TO 
46 INCLUSIVE 
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FIG. 4. XXV STEROID AND GONADOTROPHIN HORMONE PATTERNS THROUGHOUT
A CYCLE WITH AN ABNORMALLY HIGH LH PEAK
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occurred on day 0. Levels of all three steroid hormones 
were below the normal range in the luteal phase of the 
cycle. The areas under the progesterone, 17o(-hydroxy- 
progesterone and oestradiol curves in the luteal phase 
of the cycle 50,1 ng, 9,7 ng and 1165 pg respectively.
e) Subject PII » Blood samples were collected from this subject 
during a period of amenorrhoea associated with dieting 
(see p. 74 ), Cortisol was measured, as described on 
p. 28 , in these samples, along with the usual steroid 
and gonadotrophin.'hormones. The results are shox-m in 
Fig* 4. X}[VI. The subject had not menstruated for 12 
X'jeeks prior to collection of the first blood sample. 
Menstruation then occurred six days after collection of 
the last sample.
Very high levels of progesterone were found at the beginning 
of the sampling period, but the levels dropped to the 
follicular phase range by the 13th day. Levels rose again 
from day 30 to reach levels similar to those found in the 
luteal phase of a normal cycle by the end of the collection 
period. 17oL“hydro:cyprogesterone levels were low and 
did not fluctuate until day 32 when a peak occurred. A
FIG. 4. XXVI STEROID AND GONADOTROPHIN HORMONE PATTERNS THROUGHOUT 
A PERIOD OF AMENNORtlOEA, PRESUMABLY DUE TO ANOREXIA 
NERVOSA.
SUBJECT P .H .
FSH
miu ml
L H 
miu |ml
C O R T IS O L  
ng I ml
100
p g |m
200
17 OH P
ng
/\
ng[ml
D A Y
93
drop occurred on day 31 followed by a further rise co« 
incident with the progesterone rise. The levels of 17oC- 
hydroxyprogesterone were similar to those found at mid" 
cycle and In the luteal phase of a normal cycle.
Oestradiol levels were around 200 pg/ml. at the beginning 
of the collection period and dropped gradually to 60 pg/ral 
on day 16. A peak occurred <500 pg/nil) on day 22 and 
further peaks on day 27 (300 pg/ml), 32 (400 pg/ml) and 38 
(500 pg/ml). The peak on day 27 coincided with the 17<à - 
hydrojsyprogesterone peak and that on day 38 with the pro­
gesterone and 17c(.«hydroîïyprogostGrono rises,
LH levels were very low until day 24 when they rose 
to 9 m.i,u,/ml on day 31, Unfortunately LH results 
were not available for the remaining days.
FSH levels were within the normial range throughout the 
collection period and fluctuated greatly. A peak of 
similar magnitude to the mid-cycle peak in the normal 
cycle occurred on day 31, coincident with the LH rise. 
Levels then dropped and remained steady for the remaining 
days of the collection period.
Cortisol levels were within the normal range throughout 
(Fraser, 1973).
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SUHbîAEY OF RESULTS XH 'MNORMAL' MENSTRUAL CYCLES
A large number of cycles from apparently normal subjects 
had some abnormality when studied closely. In general short 
luteal phase cycles appeared normal In most other respects.
The cycles from subjects having some special abnormality must 
each be considered separately in order to correlate hormonal 
patterns with that abnormality. Full discussion of these 
cycles will be presented in Chapter 7, The areas under the 
progesterone, I7pI“hydrosiyprogesterone and oestradiol curves 
are related to hi teal peak heights for each of the subjects 
studied in this section in Table 4.3, Again there was reasonably 
good correlation between peak height and area under the curve; 
in general, for each hormone, the greater the peak height, 
the greater the area under the curve. However, there was 
no correlation between peak height or area for one hormone and 
that for another hormone in the same cycle.
CHAPTER 5
COî-B?ARISON OF HORMONE PATTERNS IN
MENSTRUAL CYCLES OF INFERTILE MD
NORMAL WOMEN
95
COMPARISON OF MQBlîONE PATTERNS IH MNSTRUAL 
CYCLES OF INFERTILE AND NORMAL WOMEN
INTRODUCTION
The previous chapter established that a wide variation 
exists in hormone levels and patterns in the apparently normal 
menstrual cycle. From these results it was possible to define 
a broad set of characteristics which were common to all normal 
cycles, although many minor features were specific for individual 
cycles. Subtle differences may exist in homone patterns 
between the normal cycle and cycles in women wlio are infertile 
for no apparent physiological reason. Investigation of such 
cycles by comparison ^ -Tith the normal cycle may Indicate which 
features are essential for fertility and may also help to 
characterise this type of infertility.
Infertile women included in this study were defined as 
women who had :~
a) been attempting to conceive for at least two years,
b) normal menstrual rhythm.
c) been investigated and found to have ovaries of normal
96
appearance (by laparoscopy), patent fallopian tubes 
and secretory endometrium in the second half of the 
cycle.
d) husbands with sperm counts of not less than 15 million 
per ml.
The nature of this infertility and hence its treatment, 
poses a major problem. Anovulatory infertility is more easily 
diagnosed and its successful treatment has frequently been 
reported (e.g. MacGregor et al*, 1968; Adamapoulos et al,, 
1972). However, no attempt has been made to classify or 
diagnose infertility in which ovulation apparently occurs. 
Established treatment is therefore not currently in use. nor 
can be attempted until some understanding of the condition is 
achieved.
The aims of this investigation were tifofold; firstly to 
investigate the mechanism of regulation of the menstrual cycle 
by comparison of normal with infertile cycles and secondly to 
obtain a fuller understanding of the reason for the infertility 
and to attempt to treat the condition.
Six women who fulfilled the conditions outlined above were 
Included in the study. Daily blood samples were collected at
- 97
09.00 hours each morning from an arm vein, whilst the patients 
were sedentary, throughout a menstrual cycle. Plasma levels 
of progesterone, 17o(“hydrosyprogesteronQ, oestradiol, Lli and 
in some cases FSH were determined as previously described.
The hormone levels throughout the cycles of these women were 
compared individually to the normal ranges,
RESULTS
INDIVIDUAL CYCLES 
Mrs. B, - This patient was 24 years old, nulliparous and 
complaining of infertility. She had patent tubes, 
secretory endometrium and a history of regular menstrual 
cycles of between 32 and 35 days. Ovarian biopsy on day 
19 of her cycle revealed that the capsule of the ovary was 
slightly thickened, that numerous primordial follicles 
were present, that two atretic Graafian follicles were 
present but that there was no evidence of a corpus luteum 
or corpus albicaiis to indicate a recent ovulation.
The hormone levels throughout a menstrual cycle were 
compared to the normal range and are shorn in Fig, 5, I. 
The cycle was of 28 days duration with a 16 day luteal 
phase.
FIG. 5, I. COMPMISON OF HORMONE PATTERNS IN INFERTILE WOMEN WITH
NORMAL MENSTRUAL CYCLE RANGES.
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The LH patterns appeared normal in all respects.
Levels were within the normal range throughout, although 
towards the lower limits of this range in the follicular 
phase and in the late luteal phase. Oestradiol levels, 
on the other hand, did not show such a normal pattern.
Levels were very low in the follicular phase, fallingat 
some points below the normal range. A mid-cycle peak 
occurred on day 0, the peak value being normal. The 
LH and oestradiol rises occurred simultaneously. In the 
luteal phase, oestradiol levels were again low and took 
longer to reach peak values #ay 410) than in the normal 
cycle. The 17A-hydro%yprogesterone pattern appeared normal g 
a mid-cycle peak occurred on day 0 of magnitude just within 
the normal range whilst the luteal rise was similar to the 
normal range in pattern and levels. Progesterone levels 
were at the high end of the normal range in the follicular 
phase. Levels in the luteal phase were at the low end of 
the normal range, and similarly to oestradiol, took longer 
to reach peak values (clay *t8) than in the normal cycle.
The cycle was apparently ovulatory, on the basis of the 
LH mid-cycle peak (Abraham et al., 1972) and the luteal 
phase progesterone rise. However, this cycle was shorter
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than the patient's previous history records and on the 
basis of biopsy reports ovulation had not occurred Immed­
iately prior to this cycle.
Mrs, R." This patient was 2.5 years old, nulliparous and 
complaining of infertility of 3 years duration. She had 
patent tubes, a secretory endometrium and a history of 
regular menstrual cycles of between 26 and 28 days.
The hormone levels throughout a menstrual cycle were compared 
to the normal ranges and are shovm in Fig, 5. II.
The cycle was 27 days long with a 14 day luteal phase*
LH levels appeared noianal throughout the cycle. FSH 
levels were low in the early follicular phase (oUys -12 
to -9). The levels and patterns of FSH appeared normal 
throughout the rest of the cycle, though a steep rise in 
the late luteal phase did not occur, Oestradiol levels 
were at the high end of the normal range in the follicular 
phase and in the pre-ovulatory peak which occurred on day 
"1. The luteal phase levels appeared normal, 17.1- 
hydrojsyprogesterone levels were normal in the follicular 
phase, but there was no discrete mid-cycle peak or significant 
rise at mid-cycle. Luteal phase levels were in the normal 
range, Progesterone levels were above the normal range
FIG, 5. XI
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COMPARISON OF HORMONE PATTERNS IN INFERTILE WOMEN WITH
THE NORMAL MENSTRUAL CYCLE RANGES.
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on the first day of the cycle but fell to within the normal 
range on day -11. Levels were steady until the luteal 
rise, where levels fell just within the lower limits of 
the 'normal range ezccept of days 46 and 4-8 when they dropped 
below normal levels. Progesterone levels took longo'r to 
reach peak values than in the normal luteal phase.
Ovulation appeared to occur normally in this cycle 
as Judged by the mid-cycle LH surge and luteal progesterone 
rise.
Mrs. C. » This patient was 32 years old. She was nulli­
parous and complaining of infertility of six years duration. 
She had patent tubes, a secretory endometrium (on day 19) 
and a history of a regular cycle of 28 days. Ovarian 
biopsy (tlay 19) revealed several Graafian follicles under­
going atresia and some primordial follicles in the right 
ovary* A degenerating corpus luteum was present on the 
left ovary. The hormone patterns throughout a menstrual 
cycle were compared with the normal range and are shotm in 
Fig. 5. III. The cycle was of 28 days duration with a 
15 day luteal phase.
LH levels were normal in the follicular phase but the mid* 
cycle peak was above the normal range, as was the FSH peak.
FIG. 5. Ill COMPARISON OF HORMONE PATTERNS IN INFERTILE WOMEN WITH
THE NORMAL MENSTRUAL CYCLE RANGES.
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Luteal phase levels of both were normals though FS1Î 
showed no early follicular and late luteal phase elevations, 
Oestradiol levels were low In the follicular phase and 
below the nomal range from days «8 to ~2. The sample on 
day “1 was not collected, but the oestradiol mid-cycle 
peak was likely to have occurred on this day* However, 
levels usually rise at mid-cycle from day -4 onwards and In 
this case no significant rise had occurred by day -2* 
Oestradiol levels were well below the normal range in the 
early luteal phase and reached a late peak (ciay *M0) 
just within the normal range. ITü-hydroxyprogesterone 
levels were normal In the follicular phase. A mid-cycle 
rise was present although the day of the peak could not be 
Identified. Levels fell within the normal range through­
out the luteal phase. Progesterone levels were low in 
the follicular phase but fell just witïiin the normal range 
on most days. The rate of progesterone increase in the 
luteal phase was retarded, peak values being reached on 
dlay 410. Levels were below the normal range in the early 
luteal phase. A significant drop occurred on day 47, but 
levels rose into the normal range In the late luteal 
phase.
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Ovulation appeared to occur in this cycle as judged by 
the LH mid-cycle surge and the luteal phase progesterone 
rise.
Mrs. Me.- This patient was 31 years old and had one child 
six years previously. She had been attempting to conceive 
again since that time. Some of her cycles were short 
(14 days) but the cycle in which she was examined was of 
27 days duration, She had patent fallopian tubes and 
secretory endometrium. Ovarian biopsy on day 14 of her 
cycle revealed primordial follicles in the ovary but no 
Graafian follicles. An old corpus albicans was present.
The hormone patterns throughout a menstrual cycle were 
compared to the normal ranges and are shoxm in Fig. 5, XV,
The cycle was of 27 days duration with a 14 day luteal 
phase,
LH levels were low in the follicular phase lying at 
the low end of the normal range. Peak levels on day 0 
wore just within the normal range, and the peak value persisted 
for tt'?o days. Levels were normal in the luteal phase.
FSH levels were within the normal range throughout, but the 
early follicular, mid-cycle and late luteal phase rises 
which are associated with the normal cycle did not occur.
FIG, 5. IV COMPARISON OF HORMONE PATTERNS IN INFERTILE WOMEN WITH
THE NORMAL MENSTRUAL CYCLE RANGES.
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Oestradiol levels were normal In the follicular phase and 
at the high end of the normal range at mid-cycle. In 
the luteal phase, the oestradiol levels fluctuated, showing 
sharp drops on days+4,i*8 and+11. Levels were nevertheless 
t«7ithin the normal range. 17dk-hydroxyprogesterone levels 
were at the low end of the normal range in the follicular 
phase, and fell below the normal range from days «-4 to 0. 
Neither a discrete mid-cycle peak nor a significant rise 
of 17ck"hydroxyprogesterone occurred by day 0, Levels fell 
just within the normal range in the luteal phase. Pro­
gesterone levels began above the normal range but fell 
within that range from day -9 onwards. Luteal phase levels 
were within the normal range but the pattern showed a 
slightly retarded rise, peak levels not being attained 
until day +9,
Mrs. T. - This patient was 31 years old and had been 
attempting to conceive for 4 years. She had a history of
regular cycles of 28 days duration. She had patent
fallopian tubes and a secretory endometrium. Biopsy of 
the ovary on day 21 of her cycle revealed adequate pri­
mordial follicles, a developing Graafian follicle, a corpus 
albicans, which indicated previous ovulation, and a large
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atretic Graafian follicle of the type seen in an ovulatory 
cycle. The hormone levels throughout a cycle were compared 
to the normal range and are shorn in Fig. 5. V. The 
cycle was of 29 days duration with a 15 day luteal phase.
LH levels were within the normal range for most of the
follicular phase and just within the normal range at mid­
cycle. In the luteal phase levels were above the normal
range from days -î‘2 to 44 but within that range for the
remainder of the cycle. FSH levels were nomal throughout. 
Oestradiol levels were very low in the follicular phase 
and although they increased prior to the LH peak, mid- 
cycle peak levels were below the normal range. Levels 
dropped sharply by day 44 and rose in the luteal phase 
but did not reach the normal range until day 4-9. l7tA~ 
hydroscyprogesterone levels were within the normal range 
in the follicular phase and displayed a peak on day 0.
Luteal phase levels were within the normal range and reached 
peak values by day 48. Progesterone levels were low in 
the follicular phase but rose to within the normal range 
in the luteal phase, reaching peak values by day 47, two 
days later than in the normal cycle.
FIG. 5. V COMPARISON OF HORMONE PATTERNS IN INFERTILE WOMEN
WITH THE NORlylAL MENSTRUAL CYCLE RANGES.
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Mrs. 0. “ This patient was 25 years old, nulliparous and 
had been attempting to conceive for four years. She 
had a history of cycles of 28 days with occasional short 
cycles of 21 days. She had patent fallopain tubes. At 
lap&roscopy a corpus luteum was visible on the right ovary 
indicating previous recent ovulation. She had a proliferative 
endometrium on day 13 of her cycle. Hormone patterns 
throughout a cycle were compared to the normal range and 
are shoTJn in Fig. 5, VI. The cycle was of 22 days duration.
No LH peak was present and hence the days of the cycle 
are numbered relative to the LH peak of the normal range.
LH levels were above the no?anal range in the first half 
and in the second half of the cycle and rose steeply on 
the last day of the cycle. FSH levels dropped sharply 
on day -4 but were generally within the normal range.
Oestradiol levels were below the normal range throughout 
and showed no fluctuations, 1 Vc^ '^ hydr oxyp r o ges ter one 
levels were within the normal range in the first half, 
showed no mid»cycle rise, and no rise in the second half 
of the cycle. Progesterone levels were within the normal 
range in the first half of the cycle but did not rise in 
the second half.
This cycle lacks the characteristics of a normal cycle 
and is presumably anovulatory. It therefore differs from 
the other cycles.
FIG. 5. VI COMPARISON OF HORMONE PATTERNS IN INFERTILE WOMEN WITH 
THE NORMAL MENSTRUAL CYC^E RANGES.
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SMIARY OF RESULTS IN INFERTILE PATIENTS
From the results obtained in these patients, it appeared 
that» apart from the anovulatory patient, they could be classi­
fied into two groups. Firstly, those who sïiowed low levels 
of oestradiol in the follicular phase followed by either low 
progesterone levels in the luteal phase, or levels which took 
longer to reach peak values than in the normal cycle, (Mrs.
T., Fig. 5. V; Mrs, C., Fig. 5. Ill; Mrs. B., Fig. 5. I), 
secondly, those who had normal oestradiol levels in the 
follicular phase and at mid«cycle but still exhibited retarded 
hormone patterns in the luteal phase (Mrs, R., Fig. 3. II;
Mrs. Me. Fig. 5, IV).
CROUP I
Mrs. T.p Mrs. G. and Mrs. B. - In each of these cycles LH 
peaks were within, or in one case, (Mrs. C,), above the 
normal range. Oestradiol levels were below the normal 
range in the follicular phase and showed little or no 
fluctuation in levels. Mid-cycle peaks occurred (not 
proven in Mrs, G.) with levels in one case below the 
normal range (Mrs* T.). The mid-cycle increase began 
later than in the normal cycle*
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lldt-hyclroxyprogestoroîie showed normal patterns throughout. 
Mrs, T, Mrs. B, and Mrs. G. had mid-cycle peaks. Progesterone 
levels were normal in the follicular phases but in two 
cases (Mrs. G, and Mrs. B.) levels barely reached the noiaml 
range in the luteal phase. In all three cycles progesterone 
took a longer time to reach peak levels than in the normal 
cycle.
GROUP 1
Mrs. R. and Mrs. Me. - In both these cycles the LH pattern 
was normal throughout. Oestradiol levels were within the 
normal range in the follicular phase and showed typical 
patterns, rising to mid-cycle peetcsat the high end of the 
normal range. Levels fluctuated in the luteal phase. 
Neither cycle had a mid-cycle llt^ -hydroxyprogesterone peak 
nor significant rise before the LH peak. In the luteal 
phase levels were within the normal range. In both cycles 
progesterone levels were high on the first day of the cycle, 
but normal for the remainder of the follicular phase.
The luteal rise barely reached normal levels in one case 
(Mrs. R,) and in both cycles took longer to reach peak 
levels than the normal cycle.
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Further evidence was obtained from these cycles to suggest 
the peak value of LH was entirely independent of the peak 
value of oestradiol.
It interesting to note that these cycles all had normal 
length luteal phases.
The area under the progesterone, 17ck-hydroxyprogesterone 
and oestradiol curves in the luteal phase was related to luteal 
peak value of the steroids (Table 5. I). There was good 
correlation bettmen peak height and area; in most cases, the 
greater the peak height the greater the area under the curve. 
However, there was no correlation bet^ jeen peak height or 
area of one Iiormone and that of another hormone in the same 
cycle,
THE mm CYCLE
As the cycles showed many individual features, it raay be 
invalid to compare the mean levels in the infertile series 
with the normal mean levels* However, when this was done, 
an overall picture of the differences between the infertile 
and normal groups was obtained (the results for Mrs. 0, were 
omitted from calculations of mean levels since this cycle was 
apparently anovulatory).
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The mean LH levels 4; 8,D. (ti 5) were compared to the 
normal range and are shorn in Fig. 5, VII. The Infertile 
range was higher than the normal range in the follicular phase 
and the. mean infertile level at mid-cycle was slightly higher 
than the normal mean, level. In the luteal phase, the ranges 
were similar*
The mean FSH levels j; S.D* (n 5) were con^ared to the 
normal range and are shomi in Fig, 5. VIXÎ. Levels tended to 
he lower than the normal mean in the early follicular phase 
(days “12 to -9). Levels at mid-cycle were similar to the 
normal range, and the luteal phase pattern closely followed 
the normal cycle.
The mean oestradiol levels 4; S.D, (n « 5) were compared 
to the normal range and are shomi in Fig. 5. DC. the
follicular phase, the infertile mean was lower than the normal 
mean and did not show such marked fluctuations in levels. 
Mid-cycle peak ranges ware not significantly different* In 
the luteal phase the infertile mean was below the normal mean 
(from days 4-2 to 4-8) and comparison of the two ranges showed 
that oestradiol levels in the normal cycle peaked 3 days before 
those in the infertile cycle*
The mean 17dL«hydroxyprogesterone levels 4 8.D. (n ” 5) 
were compared to the normal range and are shomi in Fig. 5. X.
FIG. 5. VII THE MEAN LEVELS OF LH IN INFERTILE WOMEN + S.D. (n = 5)
COMPARED TO THE NORMAL RANGE
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FIG. 5. VIII THE mm LEVELS OF FSH IN INFERTILE WOMEN + S.D. (n = 4)
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FIG. 5. IX THE MEAN LEVEL OF OESTRADIOL (E^) IN INFERTILE WOMEN
+ S.D. (n = 5) COMPARED TO THE NORMAL RANGE
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FIG. 5. X THE MEAN LEVEL OF 17<X-HYDR0XYPR0GESTER0NE (17 OHP)
IN INFERTILE WOMEN + S.D. (n = 5) COMPARED TO THE
NORMAL RANGE,
MEAN LEVEL (n  
+  ONE S . D .
= 5)
NORMAL RANGE
4
3
OH P 
ng| ml
2
1
V / '
>©:
e-9
0
DAY RELATIVE TO LH PEAK
FIG. 5. XI THE MEAN LEVEL OF PROGESTERONE (P) IN INFERTILE WOMEN
+ S.D. (n = 5) COMPARED TO THE NORMAL RANGE.
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The ranges wore not significantly different at any point and 
showed similar patterns throughout.
The mean progesterone levels 4 S.D, (n - 5) wore compared 
to the no'mal range and are shorn ±n Fig, 5. XI. The ranges 
were similar in the follicular phase. In the luteal phase, 
the infertile range was slightly below the normal range. 
However, the most marked difference In the ti-ro patterns was 
the rate of progesterone increase in the luteal phase. The 
progesterone normal range rose more steeply and reached peak 
values several days before that of the infertile range.
CHAPTER 6
HOMONi!; PATTERNS IN THE MENSTRUAL
CYCLES OF INFERTILE NOMEN AFTER
TREATMENT WITH *CLOMXD'
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HORMONE PATTERNS IN THE MENSTRUAL CYCLES OF INFERTILE 
WOMEN AFTER TREATMENT WITH *CLOMID*
INTRODUCTION
The results presented in the previous chapter indicated 
that whilst most of the normal hormonal events occurred in 
the menstrual cycles of these infertile women, subtle differences 
did exist beti^ een levels and patterns of hormones in the 
infertile series and those in the normal series* Five 
patients who fulfilled the criteria desired in the study were 
apparently ovulatory and one was not. However, hormone patterns 
in the follicular and luteal phases suggested abnormalities in 
ovarian function, FSH tended to be lower in the early 
follicular phase in infertile women and follicular phase 
levels of oestradiol were low in some cases. In spite of 
this, in five women LH was released and a corpus luteum was 
apparently produced with a retarded rate of hormone production*
It must be emphasised however, that these cycles did not all 
show the same abnormalities. The patterns were very individual 
which suggested that the reason for infertility was not necess­
arily the same in each subject.
There are two main therapeutic methods of treating anovulatory 
infertility; by injection of human pituitary or menopausal
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gonadotrophin, 'Pergonal*, followed by chorionic gonadotrophin 
or by oral administration of 'Clomid** Both of these pre­
parations have previously been used in anovulatory or ollgo- 
ovulatory conditions, "Pergonal* is used in cases of pituitary 
failure, as a substitute for endogenous gonadotrophins, and 
treatment must be carefully monitored on a daily basis to 
prevent hyper-stimulation and the possibility of a multiple 
pregnancy. "Clornid* on the other hand, is a synthetic 
compound used when the pituitary is capable of producing gonado­
trophins on stimulation, 'Pergonal* was unlikely to be 
useful in the treatment of these patients as their pituitary 
function was apparently normal. There was evidence however, 
to suggest that *Glomld* would help to produce normal ovarian 
function,
Glomiphene citrate is chemically
p « (2 - chloro “ 1, 2 « diphenyl vinyl) phenoxy 
triethylamine dihydrogen citrate and its structure is shorn in 
Fig, 6. I,
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FIG. 0. I.
The structure of clomlphene citrate
Cl
(CJI.)  ^ N CIL CH. 0-  C C—  C,H.O^r  5' 2 *2 2 7
Initial experiments in rats showed the drug to be an 
inhibitor of gonadotrophin secretion and to have direct blasto- 
toxic effects in fertilised ovum (Holtkamp et al., 1960).
This suggested that it might be employed as an oral contraceptive, 
However, when administered to women, it was found to induce, 
rather than prevent ovulation.
Its mode of action is not clear (Loraine and Bell, 1968; 
Papanicoloau et al., 1970). There is some indication that
the site of action of the drug is at the hypothalamo-pituitary 
level and that it acts to increase gonadotrophin secretion 
(Jacobson et al., 1968; Ross et al., 1970), The effects 
which *Glomid’ has on hormone levels in urine and plasma have
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been shomi to vary markedly and other investigators provide 
evidence to suggest that the compound has a direct action on 
the ovary (Smith 1966; Papanicoloau et al., 1970), Urinary 
oestrogen excretion increases consistently following 'Cloraid* 
therapy (Dickey et al., 1965) and levels often exceed those 
found in the normal cycle, this being observed within 48 hours 
after beginning treatment (Smith et al., 1963). Urinary 
excretion of pregnanediol is sometimes greater following 
ovulation induced by 'Clomid* than during the luteal phase of 
the normal cycle, and improvement in patients with an inadequate 
luteal phase has been reported (Roy et al., 1963), Herrmann 
(1963) was able to produce further increases in pregnanediol 
excretion by starting administration after ovulation had 
already occurred. It appears therefore that 'Clomid* may 
stimulate corpus luteum function as well as induce ovulation, 
•ciomld* may be useful in the treatment of these patients, 
to increase follicular growth and subsequently to improve 
corpus luteum function. Ovulation may be induced by *Glomid* 
therapy in the anovulatory patient (Mrs, 0), Treatment from 
days 1 to 5 in each cycle may increase the early follicular 
phase levels of FSH and/or early follicular growth.
The six wmen who had previously been studied returned at 
the beginning of their next but one cycle, 'Clomid* was
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administered orally from days 1 to 5 in four patients (Hre. B., 
Mrs. Me., Mrs. T., and Mrs. 0.) and days 6 to 10 in Wo patients 
(Mrs. R., and Mrs. C*). Blood samples were collected daily 
as before and levels of progesterone, 1?R'^ hydroxyprogesterone, 
oestradiol, LH and FSH were estimated as described previously. 
The results for these cycles were divided into tarn groups on 
tlie basis of the pre*^ treatment results as described in the 
previous chapter (p. 106 ), The anovulatory pa tint was 
considered separately,
RESULTS 
GROUP X
Mrs. B. " The hormone levels before and after treatment are 
shown in Fig. 6. II. Pre-treatment FSH results were not 
available. After treatment FSH levels lay within the 
normal range but lacked the early follicular phase and 
late luteal phase elevations seen in the normal cycle. 
Levels of LH at mid-cycle were higher after treatment than 
before treatment. However, the most marked effects were 
on the steroid hormone levels, especially oestradiol and 
progesterone. In the treatment cycle, oestradiol levels 
began to rise consistently from the fourth day of treatment
FIG. 6. II PLASMA HORMONE LEVELS IN MENSTRUAL CYCLES FROM INFERTILE
WOMEN.
Mrs. B. (a) Before treatment
(b) During treatment with 'Clomid' (50mg/day)
Treatment days are indicated by vertical arrows 
in this and subsequent diagrams.
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reaching peak values between days -4 and -1, The peak 
value was no higher thaii in the pre-treatment cycle but 
was maintained for a longer period. Luteal phase levels 
of oestradiol wore not altered after treatment although 
peak values were reached several days earlier. 17c*n- 
hydroxyprogesterone levels began to rise from day «2 
ommrds and this elevation was continued into the luteal 
phase. Levels wore slightly increased in the treat­
ment cycle both at mid-cycle and in the luteal phase* 
Progesterone levels rose on the day of the LH peak and the 
rise was sustained into the luteal phase. Luteal phase 
values were greatly increased after treatment5 peak 
values were reached on day 4-2 and were maintained for 5 
days. However, levels dropped sharply on day+7,
. C. « The hormone levels before and after treatment
are shown in Fig# 6. III. This patient was treated 
from days 6 to 10 of her cycle. There was a rise in 
FSH on the fourth day of treatment and a peak was reached 
on the day following the last treatment day. The mid­
cycle FSH peak (day 4-1) however, was lower than the pre­
treatment mid-cycle peak. There was no difference in
FIG, 6. Ill PLASMA HORMONE LEVELS IN MENSTRUAL CYCLES FROM INFERTILE
WOMEN.
Mrs. C. (a) Before treatment
(b) During treatment with 'Clomid* (50mg/day)
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pattern or mid-cycle level of LH before and after treat­
ment* Oestradiol levels began to rise from the second 
treatment day, reaching peak vaines (550 pg/ral) on day -1. 
Unfortunately, the pre-treatment sample for this day ^ ms 
not available but in view of the level on the preceding
day it seemed likely that the corresponding (mid-cycle)
value in the pre-treatment cycle would have been consider­
ably lower. Luteal phase levels of oestradiol were 
elevated above pro-treatment levels and reached a peak 
on day 4*6 which was above the normal range, 174-ïiydroxy- 
progesterone was not altered in the follicular phase after 
treatment. However? the mid-cycle and luteal phase levels 
were elevated, A sharp drop occurred on day 46 in the 
luteal phase but peak levels were regained by day -!*7,
A rise in progesterone levels was observed on day 0 
which continued into the luteal phase. Levels in the 
luteal phase were greatly elevated after treatment reaching 
a peak value of 20 ng/ml which was well above the normal 
range. Levels above the normal range were reached by
day 4 5. The luteal phase patterns of progesterone and
ly^ A-hydrojcyprogesterone were similar in both the pro-treat­
ment and the 'Clomid* treatment cycles.
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Mrs. T» - The honnoiae levels before and after treatment 
are shorn In Fig. 6. XV. FSH levels in the early 
follicular phase were generally higher in the treatment 
cycle than in the pro-treatment cycle. However, the 
higher value on day 1 of treatment could not have been a 
result of treatmeiit since this sample was collected 
imiediately before the first dose of 'Clomid* was admin­
istered. Mid-cycle levels of F^Mwere also elevated in 
the treatment cycle, whilst the normal late luteal phase 
rise was absent. The level of LH at mid-cycle was not 
significantly altered in the treatment cycle. Oestradiol 
levels began to rise consistently from the fourth day of 
treatment onwards, reaching a peak on day -I, which was 
higher than in the pro-treatment cycle. This peak 
value was maintained into the luteal phase. The drop 
which normally occurred after the LH peak was absent.
Peak luteal phase levels were maintained until day *f3 when 
they began to decrease. Luteal phase levels, in general, 
were slightly higher than in the pro-treatment cycle. 
17d-hydro%yprogesterone levels were lower, at mid-cycle, 
in the treatonent cycle than in the pre-treatment cycle. 
Luteal peak levels, however, were reached earlier (day 4-5) 
in the treatment cycle, although the levels were similar
FIG. 6, IV PLASMA. HORMONE LEVELS IN MENSTRUAL CYCLES FROM INFERTILE
WOMEN.
Mrs,_ T. (a)Before treatment
(b)During treatment m t h  'Clomid* (50 mg/day)
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in both eyclos, htiteal phase peak progesterone levels 
were elevated in the treatment cycle, although a level 
above the normal range was maintained for only one day.
This peak level was not reached until day -f7, as in the 
pre-treatment cycle.
GROUP 2
Mrs# R. - The hormone levels before and after treatment 
are shorn in Fig* 6* V, Comparison of the pre-treatenent 
results with the results after treatment with 50 rag of 
'Clornid* from days G to 10 indicates that in this patient 
levels of each hormone were depressed following •Cloraid* 
treatment. Blood samples were not collected until the 
last treatment day. FSH results were not available for 
this treafâaent cycle. UÎ levels at mid-cycle were lower 
after treatment. Oestradiol mid-cycle levels were lower 
and 17c4-hydro3:yproges terone levels were lower in the luteal 
phase. Because of this lack of response to treatment, the 
dose was increased to 100 mg per day from days 5 to 9, of 
the following cycle. The results are shotm in Fig* 6* V (c), 
FSH levels in idie early follicular phase were higher than 
in the pre-treatment cycle, although this elevation was 
apparent before treatment began. Mid-cycle and luteal
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phase levels of FSH weire enalteired fi’om the pre«treatment 
cycle. LH was restored to the original^  prO“treatment 
mid-cycle level. A rise in oestradiol occurred after the 
final clay of treatment and a mid-cycle peak, of greater 
magnitude than in the pre-treatment cycle was observed on 
day 0. A luteal phase peak of oestradiol occurred on 
day 4'3, which was higher than in the pre-treatment cycle, 
but this peak level was not maintained. The l7<&-hydro%y- 
progesterone level at mid-cycle was elevated but the 
luteal phase levels were similar to those of the pre­
treatment cycle. Progesterone levels rose above normal 
levels in the follicular phase on the third clay of treatment 
and showed a significant rise one clay before the X.H peak. 
Luteal phase levels were elevated above pre-treatment levels 
and rose above the normal range by day 40, Progesterone 
levels dropped steadily from day 47 to the end of the cycle.
Mrs. Me." The hormone levels during cycles before and 
after treatment %-zith *Clomid* from days I to 5 are shoxm in 
Fig, 6, VI. Unfortunately, the patient only attended on 
alternate days to have blood samples removed during the first 
half of her treatment cycle.
FIG. 6. VI PLASMA HORMONE LEVELS IN MENSTRUAL CYCLES FROM INFERTILE
WOMEN.
Mrs. Me (a) Before treatment
(b) During treatment m t h  ’Clomld* (50 mg/day)
C lom id
Ils
FSH
m i u j m l
L H 
miu I ml
^2
p g |m l
ng jm l
P
ng I ml
....................1
...----/
1 . k  /WVj '~Mi
I
/1 . ,
1 ..... . -
1
1
1
1
1
/  ’ \
1 \
f
• v / V - y
n  ^
J  y \
1
.
..."
y  K\
' 1 
1 
1 
1 
1
1 ' .
L
\
* -
1
1
1
i
1i A v .  
1 .
0 8 -8 0 8
DAY RELATIVE TO L H PEAK
121
FSH levels in the early follicular phase of the treat­
ment cycle imre higher than in the pre-treatment cycle. 
However j this elevation was not clue to treatment as the 
level was high in the sample taken before the first dose 
of ’Clomid* was administered. A sharp drop in FSH 
levels occurred by the final day of treatment and levels 
again rose reaching a mid^cycle peak, which was higher than 
in the pre-treatment cycle. Levels dropped* as in the 
normal cycle, in the early luteal phase and then rose in 
the late luteal phase. The pattern mid mid-cycle level 
of LH was similar in both treatment and pre-treatement 
cycles. Oestradiol levels, conversely, were vastly elevated 
in the treatment cycle. The mid-cycle rise began after 
the last day of treatment and culminated in a peak above 
the normal range falling between days «2 and 0, Luteal 
phase levels of oestradiol were also higher in the treat­
ment cycle, 17oi-hydro%yprogesterone showed a mid-cycle 
rise In the treatment cycle which x-7as not apparent in the 
pre-treatment cycle. Luteal phase levels of 17<A-hydroxy- 
progesterone were similar in the two cycles. Progesterone 
levels rose significantly two days before the LH peak in 
the treatment cycle. The luteal phase peak levels, 
although of similar magnitude in the tîra cycles, were
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reached on day 4-5 of the treatment cycle, compared to day 
4*9 of the pre«treatment cycle.
MOVÜLATOEY PATIENT
Mrs. 0. - The hormone levels before and after treatment
W/iAa-.mki#' ■ t
are shown in fig. 6. VII, This patient, the only one who 
was apparently anovulatory, becmae pregnant on treatment 
with ’Clomid*. Blood samples were collected for only 
21 days of tlie treatment cycle,
FSH levels, in the treatment cycle, were higher in Uie 
early follicular phase than at mid-cycle* the mid-cycle 
peak occurred on day 4*1, In the treatment cycle, a mid- 
cycle peak of LH was present, Oestradiol levels rose by
the fourth day of treatment. They reached a mid-cycle
peak within the normal range on the day of the LH peak, 
llJL-hydroKyprogesterone levels were not altered in the 
follicular phase of the treatment cycle. Levels rose on 
the day of the LH peak and the rise was continued into the 
luteal[hase. Progesterone levels rose progressively from 
day 4*2 onwards. Both progesterone and 17ot.-hydro3cyprogesterone 
reached normal range luteal peak levels by 4 days after 
the LH peak. The pregnancy has so far been clinically 
uneventful.
FIG. 6. VII PLASMA. HORMONE LEVELS IN_ MENSTRUAL CYCLES FROM INFERTILE
WOMEN.
Mrs. 0. (a) Before treatment
(b) During treatment with *Clomid’ (50mg/day)
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The areas under the progesterone, 17ck«hydro3£yprogee terone 
and oestradiol curves in the luteal phases of the treat­
ment and pre-treatment cycles are compared in Table 6,1.
The luteal phase peak heights of progesterone  ^17 
hydroxyprogesterone and oestradiol in the treataient and 
pro-treeWent cycles are compared in Table 6,2.
THE i m n  TREATMENT CYCLE AMD GOHPAEXSOH 
WITH THE NOmm CYCLE
The patients varied in their response to 'Clomid' but 
nevertheless comparison of the mean treatment levels xfitli the 
normal levels gave an indication of the general effects of 
treatment.
In calculating mean levels, all treatment cycles were 
included except that of Mrs, R* (cycle 2).
The mean LH levels ^  S.D, (n - 6) were compared to the 
normal range and are shorn in Fig, 6. VIII^  The treatment 
range was similar, although wider than the normal range in the 
follicular phase* The mean level at mid-cycle was higher in 
the treatment cycle than in the normal cycle. The ranges were 
similar in the luteal phase.
The mean FSH levels 4- S,D. (n ™ 6) were compared to the
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FIG. 6. VIII THE MEAN LEVELS OF LH + S.D. (n = 6) IN INFERTILE
WOMEN DURING A *CLOMID* TREATMENT CYCLE COMPARED
TO THE NORMAL RANGE.
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normal range and are shown in Fig, 6, IX* The treatment range 
tended to be lower than the normal range In the early follicular 
and the late luteal phase. The treatment range was very td.de 
at mid*^ cycle and tdie mean treatment level was higher than the 
normal mean level.
Tlie mean oestradiol levels f S.D, (n ™ 6) were compared 
to the normal range and are shox-m in Fig. 6, X. Follicular 
phase levels were similar in the two ranges. The mean mid­
cycle peak height was greater in the treatment cycle than the 
normal cycle. In the luteal phase$ the mean peak height was 
greater in the treatment cycle than in the normal cycle. Peak 
levels were reached by the same day in the txjo ranges. The 
treatment range was wider than the normal range in the luteal 
phase.
The mean 17,A"hydroxyprogesterone levels 4 S.D. (n ” 6)
xfore compared to the nomal range and are shoxm in Fig, 6, XI,
The ranges x-7ere similar throughout and did not differ markedly 
at any point.
The mean progesterone levels j; S.D, (n « 6) xmre compared 
to the normal range and are shoxm in Fig, 6. XIX, The levels
in the txvo ranges Xizere similar In the follicular phase. The
mean tree Went level rose significantly by day 0, a rise which 
was not apparent in the normal mean cycle. The rate of
FIG. 6. IX THE MEAN LEVELS OF FSH + S.D, (n = 6) IN INFERTILE
WOMEN DURING A *CLOMID* TREATMENT CYCLE COMPARED TO
THE NORMAL RANGE,
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FIG. 6. X THE MEAN LEVELS OF OESTRADIOL (E^) ± S.D. (n = 6)
IN INFERTILE WOMEN DURING A *CLOMID* TREATMENT CYCLE
COMPARED TO THE NORMAL RANGE.
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FIG. 6. XI THE MEAN LEVELS OF 17o^ -HyDROXYPROGESTERONE (17 OHP)
+ S.D. (n = 6) IN INFERTILE WOMEN DURING A * CLOMID’
TREATMENT CYCLE COMPARED TO THE NORMAL RANGE,
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FIG. 6. XII THE MEAN LEVELS OF PROGESTERONE (P) + S.D. (n = 6)
IN INFERTILE WOMEN DURING A * CLOMID* TREATMENT CYCLE
COMPARED TO THE NORMAL RANGE.
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pyogeatGZone increase in the luteal phase was similar in the 
two rangess peak heights being attained by the same day. 
Howevers the mean peak levels in the treatment cycle were 
higher than in the noiatial cycle, Mean treatment levels were 
higher than mean normal levels on the final day of the cycles,
CHAPTEE 7
DISCUSSION
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DISCUSSION
PAET I 
GPB à m  RIA MEEHODS
The reliability of a displacement analysis method is 
generally assessed in terns of four basic criteria; precision, 
accuracy? sensitivity and specifii#:y. The most difficult of
these four criteria to evaluate is perhaps specificity. This 
la also the most important criterion since a method with in-» 
sufficient specificity W.11 be of limited value even if it is 
satisfactory ^ vlth regard to all other criteria. Sensitivity 
is an important consideration in the development of assays 
for homones which are present in relatively small quantities 
in the fluid to be assayed. Precision and accuracy are 
important for reliability and reproducibility and must be 
attained through standardisation of conditions and constantly 
assessed when the method is in routine use.
The key to achieving specificity and sensitivity lies 
jointly in the choice of à binding protein and in the steps 
taken to purify the hormone prior to assay. The separation 
of free and protein bound hormone constitutes an important 
step in displacement analysis procedures and must be adequate
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and reproducible in order to obtain acceptable sensitivity and 
precision. Methodological *blanl^ * has been traditionally the 
greatest single problem in development of such assays and must 
be insignificant if all four criteria are to be satisfactory.
THE BINDING PROTEIN
The most important consideration in the development of 
a displacement analysis is the production and isolation of a 
suitable binding protein. This protein should be capable of 
binding reversibly to one compound or to a group of chemically 
related compounds* There are Uiree main sources of such 
proteins for the measurement of steroid hormones, the plasma, 
which contains specific proteins for hormones (Antonlades,
1961), extracts of tissue from steroid hormone target organs 
and antibodies raised to steroid«protein conjugates. The 
plasma proteins are easily obtained and have been used in the 
assay of several hormones, for example corticosteroids (Murphy 
et al., 1953), progesterone and 17<A-hydroxyprogesterone (Strott 
and Lipsett, 1968), testosterone (Rosenfield et al,, 1969). 
However, the poor specificity of the binding to such proteins 
has led to the development of methods using more specific pro­
teins from steroid target organs. Uterine cytosol, for example,
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has been used to measure oestrogens (Corker et al., 1970|
Korenman et al,, 1970). Such proteins however, are difficult 
to prepare without loss of binding activity and are often 
unstable on storage, Antibodies have been utilised in recent 
years for the assay of many steroid hormones since they combine 
specificity and sensitivity with stability on storage. Once 
a suitable antiserum has been produced, a single bleed may 
provide sufficient antiserum for many assays over several 
years. In the present work, two of these groups of proteins 
have been utilised, the plasma protein, CBG, to measure 
progesterone and 17oC<-hydroxyprogesterone and an antiserum 
riased to oestradioI-17jS«6 (O'“carboxymethyl)o2dme"'bovine 
serum albumin to assay oestradiol-17^ . These two proteins 
have advantages for their chosen uses
CBG is theoretically capable of binding reversibly all 
4"one, 3-one steroids. However, different animal GBG's bind 
with different affinity to different steroids, and the choice 
of species must depend to some extent on the steroid being 
measured (Murphy, 1967). Westphal (1961) suggested a 'polarity 
rule* for binding of steroids to CBG, In theory the greater 
the polarity of the steroid, the greater is its binding affinity 
to CBG. In practice, however, this rule is not always obeyed. 
The association constant of the progesterone complex with human
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CBG at 37^ 0 is about three times as great as that of the similar 
cortisol complex, but progesterone interacts with rabbit CBG 
at 4°C with an affinity of approscimately 40% of that shoxm 
by cortisol (Westphal, 1967), Guinea-pig CBG binds progesterone 
much more strongly than cortisol (Westphal, 1967).
Tenterature also affects the binding between CBG and 
steroid. Evidence of greater dissociation at 37°C than at 4°C 
for the cortisol-himian C B G  complets was first reported by 
Slaunwhite and Sandberg (1959), Since then it has been shoim 
that the association constants for corticosteroid complexes 
with human, rabbit and rat CBG are approximately twenty times 
greater at 4^C than at 37^ 0 (Muldoon and Westphal, 1967;
Chader and WestphaX, 1968a; Chador and IJestphal, 1968b).
Murphy (1970) suggested that assays should bo conducted between 
4 C^ and 6 G^ because of the higher association constants at these 
temperatures and that temperatures should be controlled for 
reproducibility. In the present work, a temperature of 45°C 
has been used successfully to obtain dissociation of steroid 
from protein to allow the formation of a new complex, which 
then has a maximum association at 4^ G (see p. 43 ).
The binding affinity between the corticosteroid hormones 
and CBG is also dependent upon the pH of the solution, a mmcimum
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value being observed at approximately pH 8.0 (De Moor et al., 
1963). The present work (Fig. 3, IV) confirms this obser­
vation, Daughaday and Maris (1961) and Seal and Doe (1962) 
have reported irreversible dénaturation of human CBG with loss 
of binding activity at pH 5.0 and below,
CBG's from several species have been used for assay of 
progesterone. Dog CBG has been used (Martin et al,, 1970), 
but Reeves et al., (1970) compared the sensitivity of dis­
placement in human and dog plasma for amounts of progesterone 
less than 1 ng and reported that only human CBG provided the 
required sensitivity for a precise and accurate assay at these 
low levels of the hormone. In the present study human CBG 
has been used to obtain a highly sensitive assay for progesterone 
and more especially !7<<-hydro3cyprogesterone which is present 
in plasma in lower concentration than progesterone in the luteal 
phase of the menstrual cycle.
The administration of oestrogen and pregnancy increase 
the concentration of CBG in peripheral plasma (De Moor et al*,
1962), Late pregnancy plasma has been used to assay progesterone 
(Martin, 1970b) but was insensitive probably due to the large 
amounts of endogenous steroid present in the plasma. Plasma 
from women taking oral contraceptives has been used by Johansson 
(1970) but his standard protein solution did not keep well for
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longer than 48 hours and ageing was variable. However, 
escsminafcion of the method reveals that he prepared the SPS in 
distilled water, and not in buffer. As distilled water, 
especially if previously deionised is slightly acidic (pH5-6) 
gradual dénaturation of the protein may have occurred. It 
is now not possible to use plasma from women taking oral contra­
ceptives for binding as the îiew low oestrogen 'pill' does not 
produce a suitable titre of CBG (Goutts, 1972). The work of 
Johansson (1970) was performed using the plasma from women 
taking high oestrogen 'pills'.
In the present work CBG was obtained in the plasma of a 
post~menopausal woman treated with ethinyl oestradiol and 
dexaraethasone. Virtually the same process has been used by
Reeves et al., (1970) who treated an ovariectomised woman with 
equine conjugated oestrogen. The plasma produced a sensitive 
SPS which was stable for up to three weeks when prepared in 
buffer at pH 8,0 and stored in a refrigerator. Such plasma 
can be obtained in large quantities by plasmaphoresis and stored 
at -15^ C for long periods of time (at least two years) without 
dénaturation. It is not susceptible to dénaturation by freezing 
and thawing at least three times,
Lipsett et al., (1970) and Reeves et al,, (1970) have 
administered descamethasone when preparing plasma containing
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CBG to prevent the saturation of CBG with endogenous steroid. 
These authors found that this procedure increased the sensitivity 
of the CBG, Administration of dexamethasone following ethinyl 
oestradiol has been used in the present work despite Johansson's 
(1970) inability to demonstrate any improvement in the binding 
properties of his protein after its administration.
Displacement analysis methods rely theoretically on the 
ability of a non«radioactive compound to displace its radio­
active isomer from the CBG. In practice, however, for the 
progesterone and llot-hydroscyprogesterone assay, better initial 
binding and displacement was achieved by displacing 
corticosterone with progesterone or 17o(.-hydro:£yprogesterone 
than wheii progesterone or 17«<'4iydro2^ cyprogesterone
were used for initial binding. Approximately 20% greater 
binding and displacement was achieved by Martin (1970a). All 
CPB metliods for progesterone have used j corticosterone 
(e.g. Neill et al», 1967; Johansson, 1969; Reeves et al,,
1970) with the exception of that of Yoshiml and Lipsett (1968) 
who used %  progesterone for iritial binding. The better
fs 1results obtained using 'H corticosterone can be accounted 
for by the fact that different CBG's bind with different 
affinity to different steroids depending upon the temperature 
and the concentration of substances present, Westphal (1967)
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haa thus shomi that for human CBG at and at a low con- 
centration, progesterone will be bound more strongly than 
corticosterone. This phenomenon has never been successfully 
explained despite the fact that this observation contradicts 
Westphal*s (1961) ’polarity rule*.
Tritiated steroids are most commnly used in displacement 
analysis, compounds could not be considered for the
present ivork since the specific activity of the steroids labelled
with this isotope is too low to give the required sensitivity.
25 1Midgley and Niswender (1970) suggested that [_' Ij or
r  1311  f s  1I X labelling has great advantages over Hj labelling 
for displacement analyses because of the higher specific activity 
and better counting efficiency. However, this is questionable 
since it is not possible to label steroids^  apart from oestro™
genic onces, directly %fith the I atom, and the compounds
produced are thus less stable than those labelled with [^\îj 
More elaborate precautions are also necessary in the handling 
of
their shorter half-lives necessitate more frequent labelling,
xj labelled compounds than |^Hj labelled onces and
[-]
labelled steroids were not considered for the present
work as Hi labelling provided the required sensitivity.
The use of an antibody for measurement of oestradiol is 
particularly suitable as the levels of circulating oestradiol
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in peripheral plasma during the menstrual cycle are very low. 
Radioimmunoassay can provide a highly sensitive and specific 
assay at sub-picomole per ml levels, Uterine cytosol has 
been used in G1?B assay of oestradiol (Corker et al#, 1970), 
but has the disadvantages tliat it is difficult to prepare and 
unstable on storing and binds not only other oostrogens but 
also other, not necessarily steroidal, oestrogenic compounds 
(Jensen et al*, 1963). Radioiimiunoassays have been used by 
many workers to measure oestradiol (Abraham et al., 19705 
Mikhail et al., 1970s Exiey et al.» 19715 Wu and Lundy, 1971) 
although different workers have used different antisera.
To render a steroid molecule antigenic it must be coupled 
to a high molecular weight protein such as bovine or rabbit 
serum albumin. The greatest specificity of antibody fomation 
is generally obtained by conjugating the steroid through a 
position in the steroid nucleus remote from the distinguishing 
functional groups of that steroid. Oestradiol has been con­
jugated to BSA through the *3* position (Thomeycroft et al,, 
1970), the *17* position (tJu and Lundy, 1971) and the *6* 
position of the steroid nucleus (Erley et al., 1971). An 
antiserum produced to a conjugate linked at the *6* position is 
most specific a&id has been aaployed in the present study.
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However, Walker et al., <1973) have shomi that specificity
depends not only on the site of conjugation hut also on the 
carrier protein and on the imwnisation procedure.
The choice of antisera depends upon the estimations to 
be carried out. A relatively non-specific antiserura, such 
as one produced to a conjugate coupled at the *17* position, 
is useful if more than one oestrogen is to be measured in the 
same plasma sample. The oestrogens can then be separated 
by chromatography prior to assay of tîîe different fractions 
with the same antiserura. The *6* linked conjugate produced 
an antiserura suitable for the present work where only oestradiol 
was to be measured. The high specificity rendered a chroma­
tographic purification step unnecessary (Table 3, 4,)
In order to obtain an antiserim of high titre for measuring 
oestradiol, the antiserura can be treated witli BSA (Campbell 
et al., 1964) to precipitate antibodies directed against the 
carrier protein. Treatment with Uivanol (Horesji and Smetana, 
1956) increases the sensitivity of the antiserura by removing 
albumin from the serum, thus limiting the non-specific binding. 
Both of these treatments were used in preparation of the anti­
serim used in this study*
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The attainment of equilibrium, in displacement analyses 
is reported to take longer at higher dilutions and lower tem­
peratures (Murphy, 1970) - seconds to minutes for assays using 
plasma proteins and hours to days for antibodies. The present 
work demonstrates that a shorter time (20 mins) is sufficient 
for equilibrium to be reached using this particular antibody 
(Fig. 3, XXI). Abraham et al., (1970) report that the 
sensitivity and binding of oestradiol increases with time of 
incubation from 2 to 16-20 hours in a solid phase RIA system.
The method reported here does not appear to show this phenomenon, 
although a careful study of sensitivity at different incubation 
times has not been undertaken. It is possible that this 
phenomenon varies with different systems and different antisera.
A temperature of 4°C was employed in the present irork to obtain 
maximum association beti^ een steroid and protein.
The antiserum used was stable on storage, having been 
stored as a 1 in 5 dilution (following Rivanol treatment) 
for two years at -15^ G without noticable deterioration of 
its binding properties. These properties were not affected 
by freesing and thawing of the antiserum up to two times. A 
solution of antiserura could be stored for up to tifo weeks at 4 G^, 
without deterioration, provided the solution contained thimerosal,
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The addition, of thimerosal was found necessary in the pre­
paration of all solutions used for the RIA, prestwiably as it 
inhibited the growth of bacteria in the solutions which contain 
gelatine. Any other antibacterial agent would presumably 
also have been effective in this way,
EXTRACTION m o  PmiPICATIOM OP STSROXDS
Purification of the steroid prior to assay is also important 
in obtaining specificity and sensitivity. Extraction of the 
steroid with a suitable solvent is the initial step in the 
purification. Progesterone has been extracted using a number 
of solvents including light petroleum (Johansson, 1969; Reeves 
et al.j 1970) and ethyl acetate (Martin et al*, 1970), Light
petroleum extracts up to 90% of progesterone (Murphy, 1967) 
and only relatively small amounts of other steroids (Llpsett 
et al*? 1970), This solvent is therefore unsuitable for the 
present work where 17 ck-hydroxy pr o ges ter one must also be extracted. 
Ethyl acetate has been used by Martin et al,, (1970) for extracting 
progesterone. However diethyl ether was found to be a more 
suitable extracting solvent in the present work because of 
the efficiency of extraction of both progesterone and 17d.- 
hydroxyprogesterone and the ease of evaporation. The latter 
consideration is of importance practically, both when high 
demands are made on limited evaporation equipment in the
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laboratory and with regard to total assay time. Lipsett et al,, 
(1970) confirm that diethyl ether gives a high yield extraction 
for steroids of polarity equal to or less than 17oi-hydroxy- 
pregnenolone. Several workers have used more than one 
extraction (Lipsett et al., 1970; Reeves et al., 1970) but 
in the present study a single extraction gave good quantitative 
removal of progesterone and 17«\-I%ydroxyprogesterone from the 
plasma.
Diethylether has frequently been used for extraction of 
oestrogens (Korenraan et al., 1970; Mildiail et al., 1970;
Abraham et al,,^ 970; Wu and Lundy, 1971). Several workers
have made the plasma alkaline either td.th carbonate buffer, 
pH 9.5 (Hildiail et al., 1970) or with (Korenman et al,,
1970) before extraction to increase extraction efficiency.
However ether extraction at neutral pH, gave quantitive recovery 
in the present study. Purification of the steroid involves 
separation from tim types of substance: other steroids x^ ith
high affinity for the binding protein and unlwoxm, probably non­
steroidal materials, that either compete for, or inactivate 
steroid binding sites on the protein. Such materials are
present in many solvents and chromatographic materials. Chroma­
tographic separation is coimonly used to separate the steroid
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of interest from other interfering steroids. Thin layer 
chromatography (Strott and Lipsett, 1968), Sephadex columns 
(Murphy, 1970), paper chromatography (Reeves et al,, 1970;
Martin et al,, 1970) and colite columns (Stone et al,, 1971) 
have been used for the purification of progesterone and I7o<« 
hydroïcjrprosestérone, TLG provides a suitable purification 
of progesterone and partial purification of I7«t-hydroxyprogesterone 
but many xforkers report 'blank* problems even after careful 
and prolonged washing, and poor recoveries from the TLG 
plates (Murphy, 1970; Reeves et al,, 1970), Both Sephadex 
columns (Murphy, 1970) and Celite columns (Stone et al,, 1971) 
have been reported to give this purification without a 'blank* 
problem. However, paper chromatography was the method of 
choice in the present study for several reasons* Firstly, 
the paper could be thoroughly washed in methanol before use 
thus eliminating any blaiilc. Secondly, tlxe method was reasonably 
quick; 36 scmxples could conveniently be applied to paper in 
two hours and the papers could be developed overnight using 
an automatic solvent changer and time clock device. Thirdly, 
paper chromatography systems in general give vary reproducible 
values for steroids. Fourthly, elution from the paper was 
quantitatively efficient and simple using the syringe and bent 
needle technique (p, 23 ),
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The separation of IVo^ -hydroxyprogesterone from testosterone
poses a greater problem. A suitable solvent system, for either 
paper or TLG has not been devised at present for complete 
separation of these Wo steroids. Strott and Lipsett (1968) 
used a 24 hour acétylation technique to acetylate the testosterone. 
This is a lengthy procedure. A five hour acétylation has 
been found to give satisfactory results in the present study 
(Table 3, 2), Holmdahl and SjHvall (1971) separated 17«<- 
hydroxyprogesterotie from testosterone using liquid gel chromato­
graphy on a hydrophobic hydroxy-aItcoxy propyl Sephadex derivative. 
Hoxfover, xAi 1st separation x^ as achieved between 17oi- hydroxy- 
progesterone and testosterone, l7o<-hydro3?yprogesterone was not 
separated from androstenedione xAich may interfere in the CPB 
assay.
Further investigation of the "cross reaction* of testo­
sterone in the CPB assay for 17o<-hydroxyprogesterone has shoxm 
that the acétylation may be unnecessary for measurement in 
normal female plasma. As shoxm in Fig* 3. V. testosterone
appears to displace corticosterone from CBG but this 
esîperiraent was carried out using ttfo times excess of testosterone 
over 17d^ hydroxyprogesterone* Such conditions may be found 
in the follicular phase of the menstrual cycle. Judd and Yen 
(1973) have published values for testosterone in the follicular
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phase of the menstrual cycle of approximately 0.4 ng/ml whilst 
levels of 17(3^“hydro xyprogesteroîic as loxf as 0.2 ng/ml have 
been observed in the present study. CBG binds testosterone to 
a much lesser extent than corticosterone or l7o<“hydroxyprogesterone 
(Lebeau et al., 1969), Competition for binding sites on CBG 
may therefore be negligible in the presence of botlx corticosterone 
and 17o».«hydro3£yprogesterone especially xAen the latter is in 
excess over testosterone as in the luteal phase of the menstrual 
cycle, A preliminary experiment has been performed in which 
several samples from a pool of menstrual cycle plasma have been 
assayed for 17o^ «hydroxyprogesterone with and without acétylation.
No significant difference was found in the two sets of results. 
Measurement of 17oi“hydroxyprogesterone may therefore be possible 
without acétylation but careful consideration must be given 
to the levels of the tt-7o hormones cjcpected in the plasma being 
assayed. The levels of testosterone in several types of plasma 
(e.g. luteal phase menstrual cycle), may be so low in relation 
to levels of 17ok“hydro3£yprogesterone as to be negligible and 
unlikely to interfere.
The e5£traction and purification procedures employed gave 
good overall recovery for progesterone. The lower recovery of 
Ilot-hydroxyprogesterone was possibly due to losses incurred 
through the acétylation and second chromatography. Hoxvever,
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the lower recovery of 17^1 «hydroxyprogesterone may reflect less 
efficient elution of the more polar ITa-hydroxyprogesterone 
from the taper* Vdien ITa-hydroxyprogesterone was assayed 
without the acétylation and second chromatography steps a 
recovery of 7Q.5 4^ 5.5% (n - 50) of added 17«k-
hydroxyprogesterone was obtained. This figure is somewhat 
lower than that for the progesterone assay (p. 37 ),
Complicated purification of the oestradiol e:ctract was 
not required because of the high specificity of the antiserum.
The only compound showing significant cross reaction was 6-oxo 
oestradiol but this has not beenreported in plasma in the non­
pregnant woman. A qualitative assessment of the cross reaction 
of œstrone and oestriol with tlie antiserum was made in Fig.3. IX. 
Idiilst oesttone and oestriol appeared to di 
oestradiol from the antiserum when present alone, Fig. 3, X 
showed that no such displacement occurred in the presence of 
oestradiol. %e quantitative assessment of cross reaction 
(Table 3. 5) therefore probably has little bearing on the 
practical situation. Oestrone and oestriol appear to offer 
no competition for binding sites when present along with oestradiol, 
as in plasma. Absence of significant cross reaction has only 
been verified for equal concentrations of the three oestrogens.
lisplace
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However, the concentrations of unconjugatad oestrone and oestriol 
are lower than the concentration of oestradiol both in the 
menstrual cycle and throughout pregnancy (Tulchinsky et al.,
1972). The method is therefore probably suitable for measure­
ment of oestradiol in pregnancy plasma also. Recently the 
presence of an unknoim substance, in the plasma of women receiving
\ I
treatment with Pergonal, which cross reacts with the antiserum 
has been suggested (Exley, 1973), If this substance is produced 
as a result of stimulation of the ovary it may also be present 
in the plasma of *Clomid* treated women. However, it may
alternatively be a substance produced due to the administration
\ I
of high doses of Pergonal. Exley (1973) has suggested that 
this compound may be 6-oxo oestradiol and work is at present 
in progress in this laboratory to investigate this suggestion.
This observation draws attention to the necessity for checking 
carefully various types of plasma before setting up a routine 
assay.
METHODOLOGICAL INTERFERING FACTORS
One of the most notorious problems in displacanent analyses 
is the removal of unlmoim, non-steroidal materials ^Aich compete 
with the steroid for binding sites on the protein. The problems 
of choosing suitable blanlc samples have been outlined (p. 45 ).
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These problems have not been solved in the present work, as no 
suitable blank plasma has been obtained, 'Water blaiilcs* 
have been used to estimate methodological interfering factors 
due to solvents and other materials used in the assay,
Murphy (1970) reported that most organic solvents give 
rise to positive blatik values. These values vary with batches 
of solvent, are very unpredictable, can be removed by distillation 
but may reappear on storage, Diethyl ether used for RIA 
showed this blank phenomena and was redistilled frequently to 
maintain low blanks. A blank is only subtree table from 
deterTïïinatioîis if the contamination is bound to the protein 
with the same affinity as the steroid, and since this is unlikely, 
blanks are probably not subtractable. To reduce blanks Murphy 
(1970) suggested plastic containers should not be used in contact 
with organic solvents and that glass-ware should be washed in 
an ultrasonic bath. Methodological interfering factors were 
reduced to a negligible level in both the CPB and RIA assays.
This was achieved by using Murphy's (1970) suggestions.
Solvents were redistilled twice before use and chromatography 
paper and glassware were meticulously washed. TLG which is 
notorious for producing high blank vaJ^ttes (Grepy et al., 1969; 
Thompson et al., 1969; Murphy, 1970) was avoided.
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The blank values in both CPB assay and EIA have decreased 
significantly since the assays were first developed, presumably 
due to a greater familiarity with the methods. The blanic 
values quoted for the progesterone and 17e>^ -hydroxyprogesterone 
assay were perhaps erroneously high. Blanks were sometimes 
found to have negative values « i.e. the percentage of 
corticosterone bound in these samples was greater than that of 
the sero point (0 ng of progestogen) of the standard curve.
Such values could not be estimated and therefore were designated 
as aero in calculating mean blank values. The blank values 
obtained probably reflect scatter around aero. The blank in 
the oestradiol assay has never been reduced to zero despite 
meticulous care with solvents, glassware and general handling. 
However, the blank is consistent within an assay.
SEPARATION OF FREE AND BOUND STEROID
Successful and reproducible separation of free and protein 
bound steroid is a critical and often difficult aspect in such 
methods. Methods which have achieved success in displacement 
analyses are protein precipitation and ligand adsorption, Mayes 
and Nugent (1968) used ammonium sulphate to precipitate protein- 
steroid complesces whilst adsorption of free steroid has been
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achieved using Florisil (Frick and Kind, 1969; Libertl et al*, 
1970; Martin et al,, 1970), Fuller's earth (Murphy, 1967),
Sephadex (Kato and Horton, 1968) and dextran coated charcoal 
(Rosenfield et al., 1969),
Florisil has been used extensively but has serious draw­
backs. Strott and Lipsett (1968) have noted differences between 
batches of Florisil and suggested that it may be necessary to 
try several, Murphy (1969) noted that some batches of Florisil 
were 'sticky* due to an electrical charge and that they contained 
excessive 'fines*. Do Sousa et al.? (1970) experienced difficulty 
with two batches of Florisil; one batch began satisfactorily 
but deteriorated over a period of several months whilst the 
other? despite efforts to improve its performance? remained 
unusable, Martin (1970a) was also unable to obtain suitable 
batches of Florisil after publication of his work (Martin et al,,
The separation to be achieved by this procedure is beWeen 
steroid bound to protein vzlth high binding affinity and steroid 
either in solution or bound to protein of high capacity and low 
binding affinity. The use of Sephadex to separate bound and free 
steroid is often unsatisfactory since low affinity proteins will 
often release steroid during passage through a Sephadex column 
(Lipsett et al.? 1970), Yoshimi and Lipsett (1968) used 
Sephadex in a CPB assay for progesterone but discovered that 
Sephadex competed with CBO for progesterone (Lipsett et al.?
1970).
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Charcoal has long been established as an adsorbent material 
for separation of free and bound compounds in displacement 
analyses. Charcoal was originally proposed by Miller (1957) 
for a Vitamin assay and later used by Herbert et al.»
(1964), Rosenfield et al., (1969) demonstrated that charcoal 
could be combined %d.th dextran to give a more viscous, stable 
phase which did not mi:: until shaken. Ekins (1968) and Hunter 
and Ganguli (1971) have emphasised that satisfactory separation 
of free and bound compound could be achieved using charcoal 
alone. However, where adsorption of free hormone is required 
with little adsorption of complex, it may be preferable to use 
dextran coating since the dextran may act as a 'molecular 
sieve* (Gottlieb et al., 1965), excluding the complex while 
permitting adsorption of free hormone. Binoux and Odell 
(1973) have criticised this theory and shorn that, using 
thyroid stimulating hormone RIA as a model, dextran coating 
does not provide any 'molecular sieving* and the best conditions 
for separation of free and bound hormone occur when an appropriate 
concentration of uncoated charcoal is present. These authors 
have shomi the same to be true in an assay for dihydrotesto­
sterone.
Although no detailed study of conditions was undertaken,
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dexfcran coated charcoal was used satisfactorily in both the 
CPB assay and RIA. This step could perhaps have been improved 
by a more careful study of the conditions but this was not 
merited by practical considerations.
De la Pena and Goldzieher (1971) have compared the 
accuracy and sensitivity of Sephadex, dextran coated charcoal 
and aimnonium sulphate as agents for separating free and bound 
steroid in a CPB assay for testosterone» They concluded that 
although accuracy and sensitivity of the three methods were 
identical, the reproducibility and simplicity of the ammonium 
sulphate method were superior and commended it as the method 
of choice. However, the method of choice in an individual 
laboratory will be dependent upon availability of equipment and 
personal preference* The technique chosen must be performed 
under carefully controlled conditions of temperature and time 
in order to obtain reliable and precise results* The 
addition of gelatine solution prior to charcoal has been used 
by several workers (e.g. Wu and Lundy, 1971). Its mode of 
action is obscure. It is coacievably useful in assays employing 
protein precipitation as the method of free and bound hormone 
separation since addition of extra protein may increase the 
precipitation of the very small amounts of protein present in 
the assay system. However many workers, without explanation,
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employ gelatine addition where precipitation of free steroid 
is carried out. It has been used in the present work and has 
been found useful in apparently preventing 'stripping* of the 
bound steroid by the charcoal* It could conceivably provide 
a 'molecular sieving* mechanism and prevent adsorption of 
bound steroid by the charcoal even though this is dextran 
coated* Herbert et al#, (1964) provided evidence in support 
of this hypothesis* They found that, in an assay for Vitamin 
8 2^* charcoal saturated with protein would take up only free 
vitamin but that charcoal alone would also take up vitamin 
bound to its binding protein*
GENERAL CONSIDERATIONS MD CONCLUSIONS
The methods developed for assay of progesterone, 17c(," 
hydroxyprogesterone and oestradiol are satisfactory for the 
purpose for which they were developed and include certain 
features which make them more efficient and quicker to perform 
than other published methods, without loss of specificity or 
sensitivity. Little elaborate equipment is required and the 
methods, once established, require little routine maintenance, 
except due care in general cleanliness, redistillation of 
solvents, washing of chromatography papers and glassware.
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There is no doubt that the 'rapid* CPB method of Johansson (1969) 
is quicker for the measurement of progesterone but specificity 
is sacrificed* The light petroleum used by Johansson extracts 
90% of progesterone (Murphy, 1967) and only small amounts of 
other steroids. However, these other steroids interfere in the 
CPB assay. Light petroleum only extracts 13% of 17pt-hydroxy- 
progesterone (Johansson, 1970), and could therefore not be used 
for a method combining assay of the two hormones, Johansson's 
(1969) method is useful for routine, clinical d«(terminations but 
unsuitable when specificity and accuracy are essential as in 
research work, Johansson's method is inaccurate in the follicular 
phase of the menstrual cycle but during the luteal phase gives 
good agreement with otîner methods. It also relies on obtaining 
suitable light petroleum to achieve the selective extraction.
There are reports that only certain batches %fill behave in this 
way (Murphy, 1967; Johansson, 1970),
The vaorking ranges of the standard curves for progesterone 
and 17<x-hydroxyprogesterone employed in the present study enable 
both Iiormones to be measured in 1 ml of plasma throughout the entire 
menstrual cycle. This is an important consideration as the 
use of different volumes at different stages of the cycle or 
different volumes for the tmo hormones introduces greater vari-
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ability into the assay. The importance of the working range is 
demonstrated by De Souza et al., (1970) whose standard curve 
for progesterone only ranged from 0 to 1 ng. Consequently 
several dilutions of each sample were assayed to ensure tliat the 
unlmoim. sample fell in the correct range for measurement.
Strott and Lipsett (1968) have reported a CPB assay for 
the combined measurement of progesterone and 17oc-hydroxyprogeaterone. 
However, their method has several drawbacks which have been 
eliminated in the method developed here. Firstly their method 
requires 3,5 ml of plasma due to its lower sensitivity.
Consequently 25 ml of ether is required for extraction of 
steroids from this large volume of plasma. Evaporation of large 
volumes of solvent is a time consuming process. They also 
employ TLC for purification of steroids. This is now know to 
introduce methodological Interfering factors in the assay.
They also employ a 24 hour acétylation step, which has been 
reduced to 5 hours in the present work.
The working range for the oestradiol assay enables this 
hormone to be. measured throughout the entire menstrual cycle in 
0,2 ml of plasma. It is important that the volumes of plasma 
used arc as low as is practical, since it is often difficult to 
obtain, in a single sample, sufficient plasma for all of the
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assays to be carried out. Thus the combination of assay of 
progesterone and 17<l-hydroxyprogesterone is particularly useful.
EIA methods for the measurement of progesterone (Youssefnejadian 
et al., 1972a) and 17«^ -hydro:;yprogesterone (Youssefnejadian et 
al., 1972b) have been described. By using a RIA, the volume 
of plasma required could be reduced. However, it is questionable . 
whether such a sensitive method is suitable for assay of progesterone 
and 17(K“hydro3:yprogesterone in human menstrual cycle plasma.
Firstly, the levels of l7o(-hydros^ yprogesterone and more especially 
progesterone are such that either very small initial volumes of 
plasma or fractions of an extract of a larger volume would be 
required for the assay. Either of these procedures may increase 
the errors involved, by multiplication. Secondly, a combined 
RIA for progesterone and 17o<.“hydroxyprogesterone would be com­
plicated by the fact that higher concentrations of progesterone 
than 17c<-hydro2£yprogesterone are present in the luteal phase 
of the cycle. This would involve removing different volimaes of 
extracts for assay of the two hormones. These problems would 
be magnified when dealing with pregnancy plasma when the con­
centration of progesterone vastly exceeds that of 17o(-hydro3:y- 
progesterone. The time taken for the assay would not be reduced 
considerably with EIA since the two hormones would require
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chromatographic separation to measure both in the same aliquot 
of plasma* Antisera are available? however? for 17o(“hydro:îy- 
progesterone, which do not cross react with testosterone (e.g. 
Youssefnejadian, 1972b) and the acétylation step could therefore 
be eliminated,
CPB is probably still the method of choice for the 
combined estimation of progesterone and 17o<-hydroxyprogesterone 
in the human menstrual cycle and/or pregnancy plasma. 36 
samples can be handled in a single assay in both the CPB assay 
and in the EIA for oestradiol. Thus samples from an entire 
cycle can be estimated, in the same assay, together with requisite 
'blanks* and quality control samples. Samples have not been 
assayed in duplicate as this would be impractical in a single 
assay. However, assays have been repeated when blank and/or 
quality control results failed to reach the desired standard.
Many methods (both CPB and RIA) have been published for the 
estimation of these steroids. The methods differ mainly in the 
protein used for binding, the purification of the steroid and 
the separation of free and bound steroid. Different workers 
encounter different problems with various techniques so that 
undoubtedly the method of choice in a specific laboratory will 
differ from that in another. It is likely that any laboratory 
will make modifications to existing methods and it is of utmost
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importance that the method used is evaluated thoroughly, carefully 
controlled, and normal ranges established In each particular 
laboratory.
155
PART II
A. THE NOmiAL MENSTRUAL CYCLE
1) The General Outline of Events
The present study demonstrates the patterns of ovarian 
and gonadotrophin hormones throughout the nojrmal menstrual cycle. 
The mean hormone patterns, shorn in Figs. 4. II to 4. VI, give 
a good general outline of ovarian pituitary inter-relationships. 
The. mean patterns however may mask some of the more subtle inter­
relationships, seen In individual cycles, a knowledge of which 
may he essential in understanding the regulation of the menstrual 
cycle.
Presentation of the mean cycles in this study is necessary 
firstly to obtain normal ranges for each hormone throughout the 
cycle and secondly, for comparison with patterns in infertile 
subjects. The mean patterns and levels of hormones, shorn in 
Figs. 4, II to 4. VI. are in good agreement with those reported 
by other woiicers (e.g. Vande Wiele et al., 1970; Mishe11 et al., 
1971; Abraham et al., 1972). The mean levels f one S.D. 
demonstrate clearly the large individual variation seen in all 
hormones throughout the cycle.
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The only major peak of LH? which occurred in all normal
cycles studied was at mid-cycle (day 0)# The peak level varied 
in magnitude from IS to 32 m.i.u./ml. FSH levels were generally 
higher in the follicular phase than in the luteal phase* A 
mid-cycle peak occurred in all normal cycles* Levels began 
to rise towards the end of the cycle,
Oestradiol levels fluctuated in the follicular phase and 
rose steadily from about day -4 reaching a peak on day -I,
A  drop occurred after day 0, followed by a second rise of less 
magnitude than the mid-cycle rise in the luteal phase* Levels 
fell to early follicular phase values by the end of the cycle*
Progesterone levels were low In the follicular phase and rose 
after day 0 to a peak in the luteal phase. Levels fell to 
follicular phase values by the end of the cycle*
l?p<-hydro3£yprogesterone levels were low in the follicular 
phase and rose to a peak on day 0? coincident with the LH peak* 
They dropped slightly after this peak, and rose to a second peak 
of greater magnitude than the mid-cycle peak in the luteal phase. 
Levels fell to follicular phase values at the end of the cycle. 
These results support the general hypothesis proposed by 
Vande Wiele et al,, (1970) explaining the regulation of the 
menstrual cycle. High levels of FSH at the beginning of the
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cycle stimulate follicular growth and maturation. This is 
reflected in increased output of oestradiol which, after reaching 
a certain level probably stimulates the release of LH, which 
induces ovulation. The formation of a corpus luteum is 
reflected by increased output of progesterone, lyoC-hydroîsyprogest- 
erone and oestradiol. However, this appears to be an over­
simplification of the situation. The hypothesis does not offer 
explanations of several phenomena such as the role or source 
of the mid-cycle peak of lloc-hydroscyprogesterone, the role of 
FSH at mid-cycle or of the mechanism of gonadotrophin release.
In the present study, the sequence of events in the individual 
cycles has been examined to attempt to find answers to these 
problems.
Îi) The occurrence of a Mid-cycle rise in 17o(-hydro3cyprogesterow 
Strott et al., (1969) have reported the pattern of 17o(- 
hydroxyprogesterone in the menstrual cycle. These authors 
reported a mid-cycle rise in all cycles studied. Some cycles 
displayed a discmte mid-cycle peak. The present study supports 
these observations, although the magnitude of this mid-cycle 
peak, or rise, is not as great as that reported by Strott et al,, 
(1969). Discrete peaks were only observed in 5 out of 8 normal
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cycles in the present study. Holmdahl and Johansson (1972) 
also reported that a discrete mid-cycle peak was not apparent in 
every cycle, .hut a significant increase in 1 Toi-hydroscyprogesterone 
was always noted by the day of the LH peak, Holmdahl and 
Johansson (1972) also reported that the peak occurred on the 
same day as the mid-cycle oestradiol peak in the mean of 10 cycles» 
The present study shows the mid-cycle peak to occur on the day 
after the oestradiol peak in the mean of 8 cycles. This is in 
agreement with the findings of Abrahmn et al,, (1972),
However, individual cycles eshibit much variation with regard 
to this peak. In some, the peak occurs on the day before the 
LH peak and in others on the day of the LH peak.
These findings demonstrate that in a normal menstrual 
cycle, a discre te mid-cycle peak of I7oi.-hydroxyprogesterone is 
not always apparent. However, a rise in 17o(.«hydrox5>'progesterone 
is always noted by the time of the LH peak but not before LH 
begins to rise. This pattern of 17(<“hydroxyprogesterone 
suggests either tdiat this steroid has some role in ovarian 
function or that its rise is merely reflecting some physiological 
proce^ possibly follicular maturation, as the rise corresponds 
to that of oestradiol. M  investigation of the source of this 
mid-cycle ITol-hydros^ progesterone may help to elucidate this 
problem.
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ill. The Source of iyo(>-hyclroKypxQgesterone at mid-cycle
The similarity in patterns between X7c<-hyclro3iyprogesteroiie 
and oestradiol at mid-cycle led Strott et al., (1969) to postulate 
that l7£3C"hydroxyprogcsterone was produced by the theca interna 
cells of the developing follicle and secreted as an intermediate 
on the pathway to oestradiol* Uyan et al., (1968) showed that 
only theca cells could produce oestradiol in vitro from acetate 
and that these cells could also produce 17ot-hydroxyprogesterone,
These findings were consistent with Strott et al.'s., (1969) 
hypothesis. However, several observations suggest that the 
secretion of oestradiol and 17oi-hydro:cyproge8terone in the follicular 
phase and at mid-cycle may be unrelated. Firstly, the levels 
of oestradiol fluctuate greatly whilst levels of l7o<»hydroxy- 
progesterone are fairly constant in the follicular phase.
Fluctuations in the secretion of a hormone by the theca cells 
might be expected to be rapidly reflected in fluctuating peri­
pheral levels of the hormone because of the rich blood supply 
to the theca cells. Follicular phase peaks of oestradiol are 
rarely associated ifith peaks of 17o(-hydros£yprogesterone.
Corresponding patterns throughout the follicular phase might be 
expected if the tiTO hormones were related by a common pathway. 
Secondly, the levels of lyot-hydroxyprogesterone and oestradiol
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at mid-cycle are not suggestive of such a relationship. The 
present study shows that the levels of I7ot-hydroxyprogesterone 
are of the order of 10 times those of oestradiol. The hypothesis 
of Strott et al., (1969) would imply the leakage of 90% of 
the products of the pathway as an intermediate. Such a 
biosynthetic pathway would be inefficient and unlikely to function, 
unless the izitermediate had some physiological role. The peak 
blood production rate of 17c<-hydro3^ progesterone has been 
estimated at 4 mg/24 h and that of oestrogens as 0*3-mg/ 24 h 
(Strott et al., 1969), If I7ot-hydro3iyprogesterone was produced 
as an intermediate on the pathway to oestradiol, this would 
imply a rate limiting step at this point in oestradiol bio­
synthesis, Thirdly, 17o<-hydro3^ yprogesterone and oestradiol do 
not always follow the same pattern afta: mid-cycle, Oestradiol 
levels always drop markedly whilst 17<K-hydroxyprogesterone 
levels often continue to rise into the luteal phase.
Although most workers have sought to compare and relate 
oestradiol to 17i<-hydroxyprogesterone it may be pertinent to 
consider also the pattern of progesterone secretion in the 
cycle. Although the mean cycle does not show a rise in progesterone 
levels before the LH peak, this is observed in several individual 
normal cycles. Three cycles exemplify this phenomenon. First,
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in the cycle from subject KK (Fig, 4, IX) a significant increase 
in progesterone occurs from clay -2 to 0; levels rise from 1,2 
ng/ml to 2*4 ng/ml* At the same time 17^-hydroxyprogesterone 
levels rise from 1 ng/ml to 3 ng/ml. Secondly, in cycle 2 from 
subject PH (Fig. 4, XXII), progesterone levels rise from 1.2 
ng/ml on day -3 to 2.0 ng/ml on day 0 and at the same time 17o(" 
hydroxyprogesterone levels rise from 0.35 ng/ml to 1.6 ng/ml. 
Thirdly, in cycle 3 from subject PH (Fig. 4. XIV) progesterone 
levels rise from 1.0 ng/ml on day -2 to 2,0 ng/ml on day 0. 
17tA-hydroxyprogesterone levels rise from 0,1 ng/ml to 0.9 ng/ml 
over the same period. Progesterone levels do not rise 
significantly before LH begins to rise and progesterone is there­
fore unlikely to be involved in LH release. The levels of 
progesterone and 17=t-hydroicyprogesterone and their concomitant 
rises are in much closer agreement than levels of oestradiol and 
l7o(.-hydroxyprogesterone at this time.
Other evidence suggests a pre-ovulatory rise in progesterone. 
Animal studies have shotm that there is an increase in ovarian 
progesterone production before ovulation (Johansson et al., 1968), 
Hiell et al., (1967) and Yoshimi and Lipsett (1968) suggested 
that no such increase occurred in women. However, Johansson 
and Wide (1969) studied in greater detail progesterone and LH
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concentrations in plasma around the time of ovulation and have 
shorn that a pre-ovulatory rise in progesterone occurs in 
some cycles but that a rise in progesterone was never observed 
before the first significant rise in LH, Further evidence 
in support of these findings has been given by Dhont et al,, 
(1974). The results of the present study suggest a possible 
relationship between this pre-ovulatory rise in progesterone and 
that of 17pt-hydro3cyprogesterone. The progesterone rise is most 
likely due either to secretion by the ripe follicle before 
ovulation or to pre-ovulatory lutéinisation of ripe follicles. 
Mikhail reported a high concentration of progesterone (1967) 
and 17p(.-hydro3{yprogesterone (1970) in ovarian vein blood 
draining from an ovary containing a ripe follicle.
It is possible that the increase in 17o<“hydroxyprogesterone 
at mid-cycle could be derived by hydroxylation of progesterone 
produced either by the granulosa cells or the theca cells as 
they mature or become luteiniaed by the first release of LH,
The increased production of both progesterone and 17o4-hydr03oy- 
progesterone of ten continues into the luteal phase. The diverg­
ing patterns of oestradiol and 17o?,«hydro3Eyprogesterone after mid­
cycle, the former always dropping and the latter often rising 
and paralleling the increase in progesterone production, suggest
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that oestradiol and 17<^ -hydroxyprogesterone are produced hy 
different cell types. Hence it is suggested that the granulosa 
cells of the maturing follicle, possibly due to pre-ovulatory 
lutéinisation^are mainly responsible for the mid-cycle 17*<- 
hydrojcyprogesterone production, which is continued into the luteal 
phase, whilst oestradiol is produced by the theca cells which 
are not so readily luteinized. In vitro studies demonstrated 
that granulosa cells were more active in producing progesterone 
and 17ot"hydro2ïyprogesterone from pregnenolone (Ryan and Petro, 
1966) and from acetate (Ryan et al., 1968) than theca cells 
and are thus consistent with the above hypothesis. Hence it is 
suggested that granulosa cells produce 17o«.-hydro:cyprogesterone 
via progesterone, and in amounts similar to that of progesterone 
at mid-cycle. The theca cells on the other hand metabolise 
pregnenolone to oestradiol via the alternate pathway involving 
5-ene compounds. The amount of 17(A-hydroxyprogesterone produced 
as an intermediate in this pathway might be expected to be small. 
These pathways are outlined in Fig. 7, I. The drop in oestradiol
secretion after mid-cycle probably reflects a physiological 
change over from follicular to luteal production.
The fact that the pre-ovulatory rise in progesterone is 
not always apparent whilst the 17c<-hydroxyprogesterone rise is 
always apparent may perhaps be due to individual variations in
FIG. 7> I PATHWAYS OF OVARIAN STEROID HORMONE METABOLISM. THE
DIAGRAM DEMONSTRATES THE MAJOR PATHWAY VIA 4-ene, S-one 
COMPOUNDS AND THE ALTERNATIVE PATHlfAY VIA 5-ene, 3-oI 
COMPOUNDS.
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the ability of the cells to 17 ol'-hydr 03^ 1 a te progesterone. 
Alternatively this could be due to the accuamulation of the 
precursor progesterone in granulosa cells i^ich do not have a 
rich vascular supply* Such accunsnulatipn might lead to increased 
17o^ ™hydro5cylating activity and a subsequent increase in peri- 
pheral levels of 17<K-hydroityprogesterone TVlthout a simultaneous 
rise in progesterone being apparent,
iv. The role of 17o(”!iydroxvi>rogesterone at mid-cycle
It has been established that a rise in 17rf.-hydro2cyprogesterone 
occurs at mid-cycle in the norraal menstrual cycle, and this rise 
possibly reflects either maturation or pre-ovulatory lutéini­
sation of a follicle* However, a role has not been assigned to 
I7(l-hydroxyprogesterone. A possible role in gonadotrophin
release must be considered,
Abraham et al., (1972) reported that in one subject an 
oestradiol peak occurred on day 9 of a 35 day cycle, but was not 
accompanied by an increase in LH, However, during the same 
cycle on day 22, an oestradiol peak of equal magnitude, concomitant 
d^th a significant rise in 17o(-hydro3cyprogesterone was then 
associated with an LH surge and a rise of progesterone in a 
luteal phase of 13 days, An analogous situation occurs in cycle 
1 from subject KB (Fig, 4, VII) in the present study. This
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suggests either that both oestradiol and 1 Vc^ -hydro^ cyprogesterone 
are required to trigger LH release or that lleC-hydroxyprogesterone 
is merely reflecting follicular maturation. Abraham et al*?
(1972) also reported in a short luteal phase cycle, that an FSil 
rise was preceded by a peak of 17otrhydro%yproge8terone and an LH 
rise coincided with a peak of oestradiol. From this evidence 
they suggested a relationship be We en 17tA-hydroxyproges terone, 
oestradiol and gonadotrophin release and proposed the idea that 
17oV'hydro3gprogesterone may be related to FSH release and oestradiol 
to LH release. However, the present study does not support this 
hypothesis since increases in plasma levels of FSH are not always 
preceded by an increase in plasma levels of lloc-hydro^ iy» 
progesterone.
It appears from the present work that oestradiol is the 
most likely trigger of LH release and that 17<4-hydroxyprogesterone 
is not m  essential factor in gonadotrophin release. Oestradiol 
levels are always rising before LH begins to rise, whilst in 
many cycles 17ois-hydro$£yprogesterone levels rise only after the 
LH rise begins* This suggests that IloC-hydroKyprogesterone rises 
as a consequence of the LH rise, perhaps, as previously suggested, 
due to pre-ovulatory lutéinisation.
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V* The Role of FSH In the Follicular Phase and at Mid-cycle
Evidence that FSH stimulates follicular growth is found 
in cycle 1 from subject KB (Fig* 4* VII). There appears to be 
a specific relationship between FSH and oestradiol in the follicular 
phase of this cycle* Discrete peaks of FSH are associated with
peaks of oestradiol. It seems likely that low levels of
oestradiol trigger FSH release which results in stimulation 
of the ovary and subsequent increased oestradiol production*
It may be that in certain individuals the ovary is particularly 
sensitive to FSH stimulation and to ’bursts* of follicular 
growth. As the oestradiol production declines, release of 
FSH may again be stimulated until the growing follicle is 
sufficiently mature to maintain high levels of oestradiol over 
several days.
The role of FSH at mid-cycle has still to be elucidated,
% e  mid-cycle peak of FSH is not always the major peak of the 
cycle. In subject EP (Fig, 4. X) an early follicular phase 
FSH peak is of equal magnitude to the mid-cycle peak and in 
cycle 2 from subject PH (Fig. 4. XIII) the FSH peak plateaus 
over six days. The FSH peak does not bear a consistent relation­
ship in time to the LH peak. In some cases it falls on the same 
day (Subject PH, cycle 3, Fig. 4, XIV) whilst in others it falls
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ôii the day after the LH peak (subject EP, Fig, 4. X) and in 
subject KB (cycle 1, Pig, 4, VII) it falls on the day before 
the LH peak. However ? in all normal cycles where both FSH and 
LH results are available, the mid-cycle rises of the Wo gonado­
trophins begin on the same day. The differences in patterns 
between LH and FSH seen in some cycles (e.g* Subject KB, 
cycle 1, Fig, 4. VII) suggest that the release of the two gonado­
trophins are controlled separately although colncideiitly, at niLd- 
cyele.
There is some controversy over the existence of one or more 
releasing factor, Dhariwal et al., (1965) claimed to have 
separated two distinct hypothalamic factors, one with LH 
releasing activity and another with FSH releasing activity.
However, some workers now believe that only one releasing factor 
exists which triggers both LH and FSH release (e.g. Kastin et 
al,? 1972). The present study is consistent with the view that 
either two separate releasing factors exist, which are perhaps 
produced due to stimulation by two separate ovarian factors, or 
that one factor exists which has both LH and FSH releasing 
activity and can release the tïfo gonadotrophins separately depending 
on the stage of the cycle. Clearly these phenomena are extremely 
difficult to study in the human cycle where much interplay of
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hormones is involved# Even direct measumnent of the releasing
factor(s) in peripheral plasma may be of limited use due to the
very short half-life of the factor(a). Measurement of the
factor(s) in hypothalamic vein samples may help to elucidate
the problem, although this is an impractical task in the human.
Work by Rajaniemi and Vanha-Ferttula (1972) may suggest
a possible role for FSH at mid-cycle. Using autoradiographic
studies they showed that, in rats, different ovarian receptors 
125,exist for I labelled gonadotrophins. LH was taken up 
by theca cells whilst PSH showed a preferential, though weak, 
accummulation in the granulosa cells of the developing follicle.
This might suggest that LH and FSH are required for stimulation 
of different cell types at mid-cycle. However, this evidence 
is not consistent Tvlth the role of FSH in stimulating follicular 
growth by action on the theca cells resulting in increased production 
of oestradiol, The situation could, of course, be different at 
mid-cycle where the two gonadotrophins may stimulate lutéinisation 
of the different cell types. Also a species difference naay 
exist between the rat and the human.
Kammerman et al., (1972) have shorn, on the other hand, tliat 
porcine granulosa cells specifically bound HGG and that LH was 
able to compote for the HGG binding sites# They showed that
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FSH had little binding capacity to these cells and concluded 
that it probably binds at different sites. These Wo pieces 
of evidence appear contradictory to some extent, but both 
indicate the possibility that the two gonadotrophins play different 
but specific roles at mid-cycle.
Mother possible role of FSH at mid-cycle may be in ‘priming’ 
primordial follicles which may develop into Graafian follicles 
in future cycles. It is now well established that a single 
follicle grows to maturity not in one cycle, but over several 
cycles (Govan? 1973). Such follicles may require frequent 
stimulation by FSH and may produce oestradiol as a result of 
this. Their oestradiol production however may be masked by 
that of the corpus luteum. This hypothesis is purely speculative.
vi. The mid-cycle release of LH
There is now much evidence to suggest that oestradiol is 
the trigger of mid-cycle release of LH, both from work such as
the present study, where the chronological sequence of events
has been examined and by observing LH release after administering 
oestradiol (Yen and Tsai, 1972). From the results of the present 
study, whi.ch support those of other workers, n^her progesterone 
nor 17c<-hydroxyprogesterone can be implicated In this mechanism
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as a rise :Ui these hormones is not generally observed prior to 
a rise in LH. Monroe et al., (1972) have suggested that a 
decline in oestradiol from its peak levels could be responsible 
for the release but the present work sliows that a decline in 
peak levels seldom if ever, precedes the first significant rise 
in LH.
In the normal cycle it is observed that mid-cycle peak 
levels of oestradiol are maintained over a number of days before 
LH is released. This suggests tliat the hypothalamus must be 
•primed* in some way with oestradiol before LH release can be 
effected.
There appears to be no correlation between the peak height 
of oestradiol and the peak height of LH, i.e. « high mid-cycle 
oestradiol levels do not necessarily give rise to a high peak 
level of LIU This suggests that a threshold level must be 
reached (and sustained for several days) to bring about release, 
and secretion of oestradiol above this threshold does not 
ellicit further response. From the variation in oestradiol 
values found in the normal cycles, this threshold level appears 
to differ from one individual to another. It seems reasonable 
to postulate that this threshold is reached when the follicle 
is sufficiently mature to respond to LH stimulation. Peak
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oestradiol levels vary greatly from cycle to cycle in the same 
individuals, whilst LH levels are relatively constant (e.g. 
subject PH, cycles I, 2 and 3, Figs. 4, XIX, XIII, and XIV).
This suggests that this threshold level is unique for a particular 
cycle.
In discussing gonadotrophin levels it is important to remember 
that the peripheral levels of gonadotrophins are possibly only 
a reflection of that which is unbound to the follicular cells 
and as such, may not be an accurate measure of its physiological 
action. As the LH ’peak* is short-lived, once daily sampling 
is probably of little use in quantitative assessment of LH 
response. Much more frequent sampling over the 24 to 48 h 
period of the ’peak* must be undertake!?, to obtain a quantitative 
estimate of LH release.
In studying the mid-cycle period, most authors discuss the 
relationships betïfeen peaks in hormone levels xémn correlating 
events. Such relationships possibly have limited meaning when 
the variation in patterns seen in the individual cycles is 
considered. More useful information may have been obtained in 
the present study by relating the first significant rise of one 
hormone with respect to another, over the mid-cycle period.
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vii. The role of LH at mid-cycle
A pre-ovulatory rise in progesterone is now fairly well 
dociiiiiented (see p, 162), If this progesterone is a product 
of lutéinisation occurring before ovulation, the Wo processes 
may be dissociated. This raises the problem of the role of 
LH, xAether it is a luteinising factor, an o\mlatory factor, 
or both* LH could conceivably bring about early lutéinisation 
of the follicle and this lutéinisation may, in turn, bring 
about changes resulting in ovulation. Full elucidation of 
the role of LH is beyond the scope of this study,
viii.Assessment of Corpus Lutema function
The patterns of tlie three steroid hormones, progesterone, 
17t4“hydro3s:yprogesterone and oestradiol are always similar in 
the luteal phase of the cycle. This suggests that the three 
hormones are produced by the corpus luteum and hence that they 
all reflect corpus luteum function. The luteal levels of the 
hormones however, vary greatly from cycle to cycle and there 
is no consistent relationship between relative levels of hormones 
(Table 4.2), High levels of one hormone are not always associated 
with high levels of either of the others. This might suggest 
that the hormones are produced by different cell types of the
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corpus luteum, the cells having different secretory activity from 
one corpus luteum to another. However, aa the pattern of 
hormones is always similar the different cell types appear to 
function as a whole. It is interesting to note that the length 
of the luteal phase appears to he independent of the amount of 
hormone produced (table 4,2). Thus the peak hormone values 
and/or the area under the luteal phase curves may be more important 
in assessing corpus luteum function than the length of the luteal 
phase. There is good agreement, in general, between peak 
height and area under the curves for each hormone taken individ­
ually, This suggests that either of the two criteria could be 
a ’measure* of corpus luteum function in the normal cycle.
It is difficult to assess iAether any one hormone alone 
could be used to ’measure* corpus luteum function. For example, 
if tlie cycles from subjects KïC or KB (cycle 1, Figs. 4. IK and 4. 
VII), are eîîaminod, study of any one of the three steroids would 
be suggestive of an adequate corpus luteupw If, on the other 
hand, the cycle from subject î#îc (Fig. 4, XI) is examined, 
progesterone levels would suggest an adequate corpus luteum 
but 3/M“hydroxyprogesterone or oestradiol levels might suggest
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a poor corpus luteum. It is difficult to decide therefore 
which hormone gives the true picture. Each of these subjects 
had an apparently normal cycle so it must be considered that in 
each case the levels observed were normal. Results in the 
normal cycles suggest that it is necessary to measure all three 
hormones to obtain a detailed picture, but measurement and 
observation of a suitable increase in any one hormone gives some 
evidence of luteal activity. Luteal phase Increases in these 
hormones are generally used as indirect proof of ovulation 
having occurred. However, it must be considered that lutéinisation 
can occur without ovulation if the pre-ovulatory rise in progesterone 
discussed previously (p. 162 ) is produced by luteinized cells. 
Luteal phase increases in steroid hormones may thus provide 
evidence of lutéinisation but not necessarily of ovulation.
The BBT curve was biphasic in all normal cycles in which 
temperature was recorded. This increase in temperature corres­
ponds to an increase in progesterone production by the corpus 
luteum and thus confirms that it may be a rough indicator of 
luteal function. It may not be an indicator of ovulation 
however, if lutéinisation, and thus increased progesterone 
production, can occur witliout ovulation.
The range of hormone levels found in the luteal phase in 
normal cycles is very large. Similar, or in some cases greater,
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variation has been found by other workers (e.g. Mishell et al., 
1971; Abraham et al,, 1972; Thomeycroft et al., 1971),
This great variation in levels of hormones leads to some difficulty 
in assessing corpus luteum function. It may suggest that the 
levels of hormones measured in peripheral plasma are perhaps 
not a true indication of the physiological state, although this 
measurement is the most practical which can be made at present.
The length of the luteal phase appears to be constant from 
one cycle to another in the same individual, even though the 
overall cycle length changes. This is noted in the three 
cycles from subject PH (Figs. 4. XII to 4. XIV). This is in 
agreement with many previous observations of the con±ancy of 
the luteal phase. The length of the follicular phase does not 
appear to be crucial. Cycles ‘îd.th short follicular phases do 
not necessarily show signs of inadequate follicular growth or 
inadequate corpus luteum function. The timing of the life­
span of the corpus lutetmi appears therefore to be more critical 
than the period of follAular growth,
ix. The use of single luteal phase progesterone estimations
to assess corpus luteum function
Israel et al., (1972) have suggested that a luteal phase 
progesterone level of 3 ng/ml or greater betifeen days 11 and 4
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prior to the onset of menses is presumptive evidence of ovulation.
In the present study, several short luteal phase cycles (see p, 82 )
which appear to be ovulatory do not show this level by the 11th 
day before the onset of menses, %e possibility of using 
•spot* progesterone values as an indicator of ovulation must be 
viewed with caution» special attention being given to the time 
of sampling in relation to luteal phase length. Such *spot^  
values are often suggested for use in clinical situations such 
as tlio monitoring of treatment for infertility. It has been 
found that patients treated with ^Pergonal• (Black et al,, 1973) 
often reach these levels in apparently anovulatory cycles, so that 
•spot* levels in such cases must be carefully evaluated. This 
practice is of little use when a detailed examination of hormone 
status is required.. Used carefully, however, it may be useful 
when facilities are not available for assaying large numbers of 
samples,.
B, •ABmmiAL* CYCLES AND CONDITIONS
i. Selection of normal cycles
One of the major problems in presenting the results of a 
study, such as the present, is the definition of •normal*. Based 
upon the broad criteria laid dom (p. 65 - a luteal phase of
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least 13 days and no knot-m abnormality or special peculiarity) 
only 8 out of 19 cycles studied could be considered normal*
This is not an uncommon finding - Newton et al., (1971) using 
similar criteria for normality rejected 5 out of 11 cycles 
studied. The only true indicators of ovulation are pregnancy 
or the isolation of an ovum following ovulation. Since the 
latter is impractical, the former must be regarded as the only 
true indicator. Only one of the subjects in the 'normal * group 
in the present study subsequently became pregnant and is perhaps 
the only one who should be categorised as definitely normal.
Mien two cycles from the same person were studied (e.g. 
subject HI, Figs, 4. XII and XXV) the results indicated that 
not only are patterns and levels of hormones different from 
individual to individual but also from one cycle to another in 
the same individual. Similarly patterns may differ from cycle 
to cycle even in subjects of proven fertility. Thus there 
would appear to be no suitable alternative to selecting normal 
cycles on the basis of clinically accepted criteria.
The normal cycles have been used in the present study to 
establish patterns and levels of hormones and to form hypotheses 
concerning the regulation of the cycle. Several of the •abnormal* 
cycles also yield some interesting results concerning ovarian 
function.
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11* The short luteal phase cycles
The short luteal phase cycle must he carefully classified.
In short luteal phase cycles described by Strott et al*, (1970) 
and Abraham et al*, (1972) it was not certain whether ovulation 
occurred or whether increased progesterone output in the 'luteal* 
phase was associated with luteinization of atretic follicles 
without ovulation. In several short luteal phase cycles examined, 
in the present study, hormone patterns and levels suggest normal 
ovulatory cycles (e.g. subject MA, Fig, 4. XV and subject CM,
Fig, 4, )OI^ III). Johansson et al., (1971) also reported cycles 
ifith normal hormone levels but with luteal phases of less than 
13 days. These results suggest that in this type of cycle there 
is no real basis for selecting a minimum of 13 days as being 
required for an adequate luteal phase.
Some of the short luteal phase cycles also showed other 
abnormalities. In cycle 1 from subject BN (Fig. 4. XVI) the 
oestradiol pattern in the luteal phase was abnormal, higher 
levels relative to the mid-cycle level were observed than in 
the normal cycle. Comparison of the two cycles (Fig, 4, XVI 
and 4. XVII) from this subject again shows that cycles may vary 
in the same subject. This is especially exemplified by the LH 
level at mid-cycle, the peak being twice as high in cycle 2 as
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in cycle 1, tAilst FSH patterns were similar in the two cycles.
The mid-cycle level of oestradiol in the two cycles are of similar 
magnitude which again suggests that the peripheral level of 
oestradiol at mid-cycle is not related to the corresponding 
peripheral level of LH measured.
The two cycles from subject JG (Figs, 4, XIX and 4.}CX) 
show wide variation in length of luteal phase. Cycle 2 (Fig, 
4.XÎ0 has a normal length (14 days) luteal phase whilst cycle 1 
(Fig, 4, XIX) has only a 9 day luteal phase. Both cycles appear 
to have poor corpus luteum function on the basis of progesterone 
levels in the luteal phase. This suggests the hypothesis that 
length of luteal phase alone does not necessarily indicate a 
normal cycle.
An early transient rise in oestradiol in cycle 1 from subject 
JG (Pig, 4, XXX) is not associated with LH release. However, on 
day -2, a rise in oestradiol occurs which is again not sustained 
but is followed by release of LH and FSH. However, the luteal 
phase pattern of hormones suggests that a poor corpus luteum 
is produced, possibly by luteinization of an immature follicle.
In this case, the ovarian/hypothalamic 'fail safe* threshold 
device may not have functioned and thus allowed LH to be released 
when the follicle was in an immature state, being unable to bind 
LH and produce an adequate corpus luteum. Thus the sustained
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high level of oestradiol seen in a normal cycle and absent in 
this cycle, may well indicate follicular maturation. However, 
a rise in 17ok-hydro3Eyprogesterone does not necessarily indicate 
follicular maturation as suggested by some authors (e.g. Strott 
et al,, <1969 ). The source of the 17o(.-hyttro2syprogesterone in
this case is obscure*
ill. Tlie effect of pregnancy on a subsequent cycle.
A cycle from subject KB (Fig. 4. XXXIX) after termination 
of pregnancy when normal menstruation had been resumed, was 
studied. The results indicated some differences from the pre­
pregnancy cycle (Fig. 4. VII). Cycle 2 had a short luteal 
phase and 'abnormal* steroid hormone patterns. As this is the 
only cycle studied from a subject following pregnancy it is 
difficult to draw conclusions. However, a more detailed study 
of this phenomenon is obviously required and in the meantime 
results from studies where cycles from both parous and non- 
parous women have been included in establishing hormone ranges, 
must be viewed in this light (e.g. Mishell et al., 1971;
Johansson et al., 1971).
The pregnancy of this subject was terminated by infusion 
of prostaglandin As the half-life of prostaglandin is
approsçimately five minutes It seems unlikely that this could still
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be upsetting the cycle after the elapse of six months. However, 
some long term affect on the ovary cannot be ruled out* 
Prostaglandins are reported to be luteolytic in rhesus monkeys, 
as indicated by a reduction in plasma progesterone levels and the 
premature onset of menstruation (Kirton et al., 1970), A 
luteolytic effect has not been demonstrated by administration of 
prostaglandin in the luteal phase of the human menstrual cycle 
(Le Claire and Shapiro, 1972),
iv. The effect of an I.tJ.D. on the menstrual cycle.
There is some discrepancy as to the mode of action of the 
intra-uterine device in preventing pregnancy. Some authors 
suggest tliat its mode of action is purely by mechanical inter­
ference with implantation (e.g. Tiotze, 1966) whilst others 
suggest that the device causes histological changes and effects 
hormone sensitivity of the endometrium (e.g. Bonney et al.,
1966). Besides uterine effects, direct action on the ovary 
must be considered. Faucher et al., (1969) have shown that 
after insertion of an X.U.D. the luteal phase of the cycle was 
shorter and urinary pregnanediol output slightly reduced when 
compared with pre-I.U.D. values.
The cycle from subject SR (Fig. 4, XXXI) who had an I.U.D,
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pïQsetitj suggests that even though the cycle had a short luteal 
phase (12 clays) the I.U*D, had no dramatic effect on hormone 
levels or patterns. It is difficult to comment on the effect 
on length of luteal phase as a control cycle from this subject 
Is not available. In the present cycle the high peripheral 
level of oestradlol observed* could conceivably reflect a decrease 
in the binding of oestradlol to endometrial tissue* thus indicating 
an effect on endometrial sensitivity. The present results, 
although from only one cycle, confirm the conclusions of Martin 
and Brovm (1973) ^Ao suggest that the shortening of the luteal 
phase is not due to hormonal changes. These authors suggest 
that it is due to local effects of the I.U.I), which cause 
premature- shedding of the endometrium.
V .  The effect of aspirin administration on luteal function.
Subject H6 (Fig. 4. 3ŒIV) took large doses of aspirin during 
the luteal phase of this cycle. It seems unlikely that 
this had any effect on corpus lutetnn function. The hormone levels 
were low in the luteal phase but no changes appeared to be assoc­
iated with the beginning of aspirin adminiatration. The low 
hormone levels may however have been associated with tlie fact 
that the subject was unwell throughout the cycle which could have
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had a psychosomatic effect on ovarian function,
vi. A possible anovulatory cycle
The cycle from subject DB (Pig, XXV) may exemplify the 
dissociation of ovulation and lutéinisation. The steroid hormone 
levels throughout this cycle are low and are not suggestive of 
a normal ovulatory cycle. The results of this cycle may be 
interpreted in the following way. The follicle does not 
respond adequately to FSH stimulation in the follicular phase, 
resulting in low production of oestradlol at mid-cycle. 
Nevertheless, LH and FSH release is triggered but the gonado­
trophins are not adequately bound to the follicle as the cells 
are immature. This inadequate binding is reflected in high 
peripheral levels of LH and FSH, The steroid hormone levels 
are all below the normal range in the luteal phase which suggests 
that a *poor* corpus luteum is present due to inadequate lutéin­
isation or that the steroids are produced by luteinised cells 
not necessarily associated with ovulation. Separate phenomena 
may be required to establish the occurrence of these two events 
in the menstrual cycle.
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vil. A comment on abnormal cycles
Although more than half of the cycles studied in Chapter 4, 
have been classified as abnormal., it seems unlikely that so many 
subjects would prove infertile. This suggests that the present 
criteria for assessing normality are too strict. The difficulty 
in selecting normal cycles has been mentioned, but the necessity 
of establishing this normal group for comparison with infertile 
patients for clinical endocrinological reasons must be emphasised.
Much variation in patterns of hortuones is seen in the abnormal 
cycles. This leads again to the conclusion that patterns of 
hormones in peripheral plasmaa.^ .^ not necessarily a direct indicator 
of a physiological state. It may be misleading and impossible 
to interpret every hormonal change observed in peripheral plasma.
viii, Anorenis nervosa
The hormone patterns found during the period of anorexia 
nervosa in subject PH (Fig. 4. XXVI) are difficult to interpret.
The high progesterone levels at the beginning of the sampling 
period may have been responsible for depression of gonadotrophin 
levels. However, the source of this progesterone is unclear.
The cortisol levels do not suggest adrenal over-activity. The
elevated progesterone levels were associated with moderately high
185
oestracliol leve3,$ and with low 17ot.-hydroxyprogesfcerone levels* 
Six days after the last blood sample was collected, 
the subject menstruated normally. The hormone patterns 
over the second half of this sampling period can therefore be 
çîiplaitied as relatively normal cycle patterns, A peak of LH 
appeared on day 32, together with oestradlol and l7p;-hydroxy-“ 
progesterone peaks. 'Luteal phase' rises in each steroid 
hormone occurred from day 34 onwards. However, the mechanism, 
by which tdie cycle was suddenly 'switched on* is difficult to 
establish, but could have been due to the drop in progesterone 
level on day 13.
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PiUlT III
às, HOmom PATTSRHS IN INFERTILE PATIENTS
The results presented in Chapter 5 indicate that there is 
great individual variation in the infertile patients. Comparison 
of the mean infertile cycles with the mean normal cycles (Figs,
5, VII to 5,XI) outlined the major differences between the W o
groups. However, in order to establish the possible cause of 
infertility in these patients, it may be useful to discuss each 
patient separately,
i. Individual Patients
Mrs. B, (Fig, 5, I. p, 97 ): Oestradlol levels in the
follicular phase are indicative of poor follicular growth, but 
by mid-cycle the oestradlol peak suggests adequate maturation,
A 'norital* mid-cycle LH peak suggests that the cycle is ovulatory 
and that lutéinisation should proceed normally (Abraham et al,,
1972), Luteal phase levels of oestradlol and lld-hydroxyprogesterone 
are within normal limits and show normal patterns. The luteal 
phase progesterone pattern however, is suggestive of a corpus 
luteum slightly retarded in growtli* which takes a longer time 
to reach peak progesterone levels than does a normal corpus luteum.
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The peak levels however, are within the norraaJ- ranges. The 
rise In 17o(«hydroxyprogesterone prior to the LH peak coincides 
with a rise in progesterone. This may indicate pre-ovulatory
lutéinisation as suggested in some of the normal cycles. In 
general the cycle appears to be ovulatory and does not have any 
major abnormality. It is therefore Impossible to account for 
the infertility in this patient in temis of inadequate secretion 
of endocrine hormones.
Mrs. He (Fig. 5. XV. p. 102 ): In this patient, low
follicular phase levels of FSH were found. Suppression of FSH 
secretion may have been due to the relatively high progesterone 
levels circulating in the early follicular phase. The low FSH 
levels however, did not appear to limit follicular growth as 
reflected in oestradlol production. A high mid-cycle level of 
oestradlol suggests adequate follicular maturation. Ho signif­
icant rise in tie 17 -^hydroxyprogesterone (or progesterone) 
occurred prior to the LH peak. This is further evidence that 
oestradlol and lld-hydrozcyprogesterone emanate from different 
cell types. A normal LH peak suggests that the cycle may he 
ovulatory. Although all steroid hormones reach normal levels 
in the luteal phase, they indicate retardation or, in the case of
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oestradlol, fluctuations, in the development of the corpus 
luteum. This cycle raises the question of significance of the 
mid-cycle 17cl«hydroxyprogesterone rise. Since such a rise is 
found in all normal cycles, hut not in this infertile cycle, it 
should perhaps he considered as a marker of 'normal * ovarian 
function. The absence of a 17oi-hydroxyprogesterone rise at mid­
cycle is here associated with a possible reduced function of the 
corpus luteum, hut not with reduced function of the growing 
follicle, since oestradlol secretion is no^nal, 17c<-hydroxy-
progesterone may perhaps be reflecting the first stage of lutein- 
ication and as such may be useful not as a marker of folliular 
maturation but as an early indication of subsequent Ixiteinication. 
Alternatively, mid-cycle l7c«.-hydroxj?‘progesterone may be considered 
as a marker of follicular maturation by indicating that the 
growing follicle has reached a state in which it can respond 
to gonadotrophin stimulation.
Ho mid-cycle FSH peak is present which may indicate that 
FSH at mid-cycle is required for some process involved in steroid 
secretion by the corpus luteum.
Infertility may therefore be accounted for in tîils patient 
by retarhd corpus luteum growth. It is difficult to explain the 
reason for this phenomenon especially as there is no indication 
of poor follicular growth.
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Mrs. G. (Fig. 5, XXX, p.lOO ): Low follicular phase
levels of oestradlol presumably in response to low FSH levels were 
observed. It is not possible to comment on the mid-cycle level 
of oestradlol as the sample which was lost was likely to have been 
the mid-cycle peak sample, This result would presumably have 
been low compared to the normal cycle. However, very high levels 
of FSH and LH occurred at mid-cycle. Steroid hormone patterns 
in the luteal phase suggest formation of a poor corpus luteum 
which takes a longer time to reach peak steroid production than 
does a normal corpus luteum. The high peripheral gon&dotrophin 
levels may indicate low binding of gonadotrophin to the ovarian 
ceils resulting in poor luteiniaation. A rise in 17ot-hydropsy- 
progesterone occurs at mid-cycle but it is not accompanied by a 
rise in progesterone. The results in this cycle suggest that 
events occurring in the follicle before ovulation have much bearing 
on the 'quality' of corpus luteum fomed, A follicle which does 
not grow efficiently will not luteinise efficiently. This 
suggests that the follicular cells must reach a certain state 
of maturity before they are able to bind gonadotrophin and fom 
an adequate corpus luteimi,
Mrs. T, (Fig, 5. V, p. 103 )t Despite normal FSH levels 
in the follicular phase, oestradlol levels are very low, ,
190
probably indicating poor follicular growth. In this case, the 
cells o£ the follicle do not appear to respond to FSH stimulation, 
Levels of oestradlol are low at mid-cycle, but a normal rise in 
17oC-hydro3cyproseeteroiie occurs which is not accompanied by a rise 
in progesterone. High mid-cycle LH levels may again reflect 
low binding of LH to immature follicular calls, However, in 
spite of poor follicular growth, steroid levels in the luteal 
phase are within the normal range. The mid-cycle 17oi-hydroxy•» 
progesterone peak may again be signifying the first stages of 
.lutéinisation rather than maximum follicular growth. There are 
signs that the corpus luteum takes longer to reach maturity than 
a normal corpus luteum.
Mrs, kv (Fig, 5, XX,. p. 99 )t FSH and oestradlol levels 
are low in the early follicular phase. However, by mid-cycle 
oestradlol levels are high. No rise in 17c<-hydroxyprogesterone 
occurs at mid-cycle again suggesting that oestradlol and I7«A- 
hydroxyprogesterone emanate from different cell types. Although 
the significance of this 17<-hydro:gprogesterone peak is not 
clear, its absence is again associated with an 'infertile* 
cycle. If l7a-hydroxyprogesterone is an early indicator of 
lutéinisation, absence of this peak may be expected to indicate 
retarded luteal growth. Although the steroid hormones fall 
within the nomal range in the luteal phase, a retarded rate of 
growth is apparent.
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It is Interesting to note tliafc in this cycle, as in Mrs.
Me*8 cycle, relatively high progesterone levels in the early 
follicular phase may have an inhibiting effect on levels of FSH. 
High early follicular phase, levels of PSH may be required to 
stimulate the follicle early in its growth period. In these 
patients, the pituitary threshold for LH release may possibly 
be too low so that release occurs before the follicle is 
sufficiently mature*
Mrs* 0. (Fig, 5. VI, p. 105 ): This cycle appears to
be anovulatory* FSH levels arc normal in the early follicular 
phase which suggests that either FSH may not be the only factor 
essential for the follicular growth or idiat the cells of the 
ovary are unable to respond to FSH stimulation. No mid-cycle 
rise in oestradlol is seen and hence no LH peak. However LH 
levels rise gradually throughout the cycle. The reason .for 
this rise is difficult to explain. It is also difficult to 
account for menstruation in this cycle on the basis of trad­
itional concept of oestrogen and progesterone withdrawal.
This may suggest that the levels of these hormones measured in 
peripheral plasma are not an accurate indicator of levels 
affecting the endometrium. It may also indicate that in some
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imlivldiials the endometrium is extremely sensitive to hormonal 
influences and that menstruatioîi can be associated with very 
small changes in hormone levels which are perhaps too small to 
measure in peripheral plasma.
The occurrence of menstruation in this cycle may, on the 
other hand, indicate that tliere is some other control miechanism 
functioning in tîie menstrual cycle besides tlie hormone relation­
ships which have been examined in the present study* Prosta­
glandins for example, may be concerned in menstruation.
Pickles et al*, (1965) have identified prostaglandins in the 
endometrium and menstmal fluid in normal women.
ii. General Reasons for Infertility
It is difficult to draw general conclusions about the cause 
of infertility. The problems seem to lie, in some cases, in 
inadequate follicular growth which is accounted for either by 
low FSH levels or by a poor response to FSH by the follicular 
cells. It is apparent that the events of the follicular phase 
predetermine the luteal phase to some extent.
In the normal cycle, a sustained rise in oestradlol occurs 
at mid-cycle, and the maintenance of peak levels for several 
days appears to be required to produce LH release. This sus­
tained rise is absent in some of these Infertile patients.
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This may suggest that there is a low threshold of LH release 
in these patients which allows release of LH before the follicle 
is mature. This may lead to lutéinisation possibly %^thout 
ovulation, if the ovum is under-developed. In some cases high 
peripheral LH levels at mid-cycle may reflect poor binding of 
the LH to cells which are not sufficiently mature.
In some cases an inadequate corpus luteum with a retarded 
rate of growth may be forraed by lutéinisation of a poorly 
grom follicle.
The reason for the poor follicular growth may lie in the 
selection of the particular follicle which matures in each 
cycle. It is well documented in the human that several follicles 
grow to a certain stage of development but only one is selected 
each month to grow to maturity. The mechanism of this selection 
is unknomi but presumably, this particular follicle has some 
special characteristic. This follicle may be the only one 
capable of successful maturation and ovum fertilisation. 
Conceivably, this 'selection* mechanism may not function in 
these patients and the *%nrong* follicle may grow and in some 
cases appears to reach maturity but is not capable of normal 
function. This abnormality may be concerned with the ovum,
;o"hich might account for the comparatively normal hormone patterns 
which are sometimes found in cycles from these patients.
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Such a suggestion cannot be tested until the mechanism of 
follicle selection Is elucidated,
ill. Assessment of Go^us Luteum Function in Infertile Patients 
The comparison of hormone peak heights to areas under the 
luteal curves (Table 3, 1.) indicates that there is good 
correlation in these patients between peak height and area; 
hence the higher the peak height, the greater the area under 
the curve. This evidence does not support Newton's (1973) 
idea that the total area is a more useful measure of corpus 
luteum function than peak height, but is of course, only valid 
in this particular group of patients. As in the normal cycles, 
there is little correlation between peak height or area for one 
hormone and those for another. It is difficult to decide 
which hormone is the most useful measure of corpus luteum 
function. Indeed each must be measured to obtain a complete 
picture of luteal phase in these patients*
It is interesting to note, although difficult to eicplain, 
that levels of 17d-hydroscyprogesterone often appear normal 
whilst other hormones show abnormality in pattern and level in 
the luteal phase.
All of the infertile patients have 'normal* length luteal 
phases. This suggests that the length of the luteal phase 
cannot be used as a criterion for the adequacy of the corpus
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luteum. The follicular phases also are of 'normal* length 
but this is not necessarily associated with adequate follicular 
growth,
iv. Correlation of Hormonal and Morphological Changes
The clinical reports on several of these patients suggest' 
that much variation occurs from cycle to cycle. For example*
the biopsy report on Mrs. B, (Fig, 5, I, p. 97 ) suggested 
that ovulation had not occurred recently prior to the cycle of 
study. It is surprising therefore* that the cycle studied was 
apparently ovulatory. This suggests that either ovulatory 
cycles occur randomly and infrequently in this patient or that 
the cycle which showed presumptive signs of ovulation was in 
fact* anovulatory. There was no direct evidence of ovulation - 
a corpus luteum was not observed. It is possible that 
hormone patterns in such a cycle result from follicular growth 
with subsequent oestradlol production* LH release and the 
formation of a secretory body Indistinguishable from a normal 
corpus luteum formed by lutéinisation of follicular cells, 
without ovulation. If this were the case, LH would be implicated 
as a luteinising rather than an ovulatory factor. The apparently 
normal output of progesterone and oestradlol would account for
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the presence of a secretory endometrium and the temporal pattern 
of the cycle. Previous suggestions that the LH peak may he 
a presumptive marker of an ovulatory cycle (Abraham et al.* 1972) 
must thus be viewed with caution.
Biopsy reports on the other patients suggested in general* 
normal ovarian morphology. There is therefore* no reason to 
suspect anovulatory cycles* However* in the one patient who 
was almost certainly anovulatory in the cycle studied* Mrs. 0.
(Fig, 3* VI, p. 105 )j biopsy revealed a corpus luteum, indicating 
previous recent ovulation. It appears therefore that in this 
patient variation occurred from one cycle to another* If, in 
some of these patients, ovulation does not occur in every cycle, 
this will obviously limit their fertility. It may be difficult 
to differentiate therefore between an infertile and a sub» 
fertile condition,
lit EFFECTS OF *CLOMXD* TEEATONT
i. Mode of Action
Hornione patterns during cycles in which 'Clornid* was ad­
ministered were compared to the pro-treatment cycles and to the 
normal cycle in Chapter 6,
In general, treatment with 'Clomid' is only recommended in 
cases of anovulation (Bishop, 1970), However, a close examination
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of its possible mode of action in patients in this study suggests 
that it may be useful in their treatment.
'Clomid* is thought to act either by stimulation at the 
hypothalamus-pituitary level or at tïie ovarian level. Jacobson 
et al.* (1968) and feyton and Dixon (1971) have induced changes 
in blood concentration of LH and FSH which were similar to those 
found in the normal cycle. Smith (1966) and Hamaerstein (1969) 
have shorn increased output of oestrogens on treatment, suggesting 
a direct ovarian effect. An oustancling feature of the present 
results was the xrXde variation in response to 'Glomid*. Such 
variation was also noted by Adaniapoulos et al.* (1972), It is 
difficult to assess whether 'Glomid* has any direct effect on 
FSH levels. The increase in early follicular FSH levels, 
in subjects Mrs. Me (Fig. 6. VI) and Mrs. T. (Fig. 6. IV) 
cannot be accounted for by 'Cloraid* treatment as the levels were 
elevated before treatment was begun. The results may suggest 
that these patients normally differ greatly from cycle to cycle 
in their FSH patterns. Even in Mrs, 0.* (Pig. 6. VII. p. 122) 
who bectane pregnant, no increase in levels over the pro-treatment 
cycle was seen. However, in this patient, the sharp drop in 
FSH levels in the pre-treatment cycle* was modified to a more 
gentle decline in the treatment cycle. In only one patient* Mrs. 
G. (Fig. 6. Ill, p. 116 ) was a rise in FSH associated with 
'Clomld* treataient and in this case, tree Went was administered
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from day 6 to day 10. The results do not suggest that 'Clomid* 
elevates FSH levels In the early follicular phase*
*Clomid* does appear to have a direct effect on oestrogen 
production* It was conceivable that the increased oestradlol 
levels are an artefact duo to cross reaction of 'Glomid* with 
the oestradlol antiserum. However, Table 3,5, Indicates that 
*Clomid* has no cross reaction with the antiserum used in the 
RXA, In all patients* except Mrs* R, (Fig* 6* V* p, 119 )
tree Went with 50 mg of 'Clomid* increased the production of 
oestradlol. The mid-eyele peak height was elevated in most 
cases, but not in every case. However, in all cases the high 
levels were maintained for a longer time than in the pre­
treatment cycles and appeared similar to the normal cycles.
It is interesting that one patient (Mrs, R.) did not respond 
to treaWent with 50 mg of 'Clornid*. However, this patient 
was treated from day 6 to clay 10 of the cycle. In this
individual, the ovary may not have been responsive to this dose
or to the later starting time. The effects appear to be very 
individual since when Mrs. C, (Fig, 6, XXX. p. 116 ) was treated
from days 6 to 10, the ovarian response was as great as that
seen in any of the other patients.
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Corresponding increases in mid-cycle levels of either LH 
or FSH are not generally associated with the elevated oestradü 
levels. In only one subject? Mrs. B, (Fig. 6. 311. p. 1x5 )
was there an elevation in LH but tîiis could be due to the normal 
variation which might be expected from one cycle to another in 
the same individual* The mid-cycle FSH level is considerably 
lower in Mrs. G, (Fig. 6, III. p. 116 ) after treatment with
'Clomid*. Mid-cycle FSH levels appear to be elevated in Mrs*
Me. (Fig. 6. VI. p. 120 ) and Mrs, T. (Fig. 6. IV. p. 118 )*
after treatment.
A second major effect of 'Clomid' appears to be on luteal 
phase levels of steroid hormones. In most cases the luteal 
phase progesterone levels are vastly increased after 'Clomid' 
treatment* often to above normal levels* However? in some 
patients major luteal phase increases in oestradiol and 
hydroxyprogesterone do not accompany the progesterone increases 
(e.g. Mrs. B.? Fig. 6, II. p. 115 ? and Mrs. T.? Fig. 6. IV. p.
118 ), This may suggest that 'Clomid* is altering the 
metabolic capabilities of luteinized cells. The increases in 
progesterone may suggest either the formation of a 'better* 
corpus luteiuB or the presence of more than one corpus luteum.
In view of the high progesterone levels reached,the latter 
possibility cannot be excluded* In Mrs. C. (Fig, 6, III. p.
116 ) for example* the results could depict stimulation of the
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ovary resulting in the maturation of more than one follicle? 
reflected in the high mid-cycle oestradlol output. Perhaps 
none of these follicles properly reach maturity hut lutéinisation 
of several follicles result in the presence of several corpora 
lutea. If the luteal progesterone pattern signifies multiple 
ovulation? the drug must obviously be used with care to avoid 
multiple pregnancies. It is difficult to assess whether the 
increased luteal activity is directly due to 'Clomid* or whether 
it merely arises from previous follicular stimulation, Herrman
(1963) suggested that a direct effect on the corpus luteum could 
occur as he produced further increases in pregnanediol excretion 
by starting administration after ovulation. The metabolic half- 
life of 'Clomid* in the human body when administrerod orally, 
is five days (Merrell-National Labs. Ltd., 1966), It seems 
unlikely therefore, that when given from days I to 5 of the cycle, 
there would be sufficient remaining in the body in the luteal 
phase to have a direct effect on the corpus luteum* As the 
luteal phase progesterone increases are always associated with 
increased mid-cycle secretion of oestradiol, it seems more 
likely that increased luteal activity results from increased 
follicular growth. In some cases, peak luteal phase progesterone 
levels were reached earlier in 'Clomid* treaWent cycles than
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In the pro-treatment cycle* but the peak levels were often short­
lived (e.g. Mrs. T.5 Fig. 6* XV. p. 118 ). Lengthening of the 
luteal phase was not observed on treatment.
In several treatment cycles a pre**LH peak rise in progesterone 
was observed xghich corresponded to simultaneous increases in 
l7e(«hydro3;yprogesterone (e.g. Mrs. B., Fig. 6. II, p. 115 ;
Mrs, C. Fig, 6. Ill, p. 116 ; Mrs. E., Cycle 2, Fig. 6. Vc,
p. 119 ). These pre-ovulatory rises in progestogen could 
signify early luteinization of pre-ovulatory follicles. Major 
changes in I7«-hydro2£yprogesterone levels are not generally 
induced on 'Clomid* treatment. A rise prior to the LH peak 
was induced in Mrs. He. (Fig. 6. VI, p. 120 ) and in all cases 
pre-ovulatory rises in 17<A-hydroxyprogesterone in treatment cycles 
did not occur until well after the oestradiol rise was established. 
I7o^ .-hyclro2£yprogesterone does not appear to inmediately reflect, 
follicular growth.
Thus the mode of action of 'Clomid* appears, from the results 
of the present study, to be directed at the ovarian level.
There is little evidence for action on gonadotrophin levels 
either directly or by prior ovarian stimulation. Jaffa and 
Hidgeley (1970) reported that when given to normally menstruating 
Xfomen on days 5, 6 , and 7 of the cycle, no consistent differences 
in goimdotrophin pattern could be found between that, and the
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control cycle* An effect on the luteal phase is generally 
observed but the present results do not indicate whether this 
effect is direct or indirect* The possibility of multiple 
ovulations cannot be ruled out*
ii. Success of 'Clomid' Treatment
The only true indicator of the usefulness of 'Clomid' 
treatment in these infertile patients would be the occurrence 
of pj^ îiancy. It is perhaps very significant tliat the only 
patient to become pregnant in this study X7às the anovulatory 
patient. Hence this may indicate that 'Clomid* is only 
useful in treatment of anovulatory infertility. Each of the 
other patients have now undergone several courses of 'Clomid* 
therapy without success. At the present time this is the only 
xmll established treatment available for these patients, 
Preliminary trials have been carried out in women by Klopper 
and Hall (1971), using the compound ICI 46474 (p«p-dimethylamino- 
ethoxyphenyl«l,2-diphenylbut-l« one) for the treatment of 
infertility and have found it to be successful in inducing 
ovulation. However, this compound has not had such widespread 
use as 'Clomid*.
Tine results indicate much variability in individual response 
to 'Clomid' and suggest that each patient must be treated indiv­
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idually and carefully monitored during treatment. Sufficient 
results are not available to decide if one treatment regime is 
better than another. It is unlikely that increasing the 
dosage would be useful in these patients. This may simply 
produce greater risk of multiple ovulations.
Even though pregnancies have not resulted, there is 
evidence to suggest that the cycles have been improved by 
'Clomid* therapy as indicated by homone secretion both in 
follicular and luteal phases, though in some cases levels of 
hormones above the normal ranges have resulted. This is 
perhaps, sufficient indication that 'Clomid* treatment should 
be attempted in patients such as these.
In the present study, clomiphcne citrate which is a 1:1 
mixture of cisclomiphene and transelomiphene has been employed. 
Van Gampenhout et al*, (1973) reported that cisclomiphene was 
more potent than the transisomer for induction of ovulation.
It would be interesting to compare the effect and thus the mode 
of action, of the cis»isomer in these patients.
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PART IV 
âs. OEMEML COMMENTS
There are many factors which must he taken into consider­
ation when interpreting results from a study such as this.
One of the most important of these may be the possible effect 
of daily vene-puncture in these subjects* Johansson et al.,
(1971) suggested that daily vene-punetures may be a profound 
stress factor in women not familiar with hospital routine and 
that this factor may effect hormonal events during the menstrual 
cycle.
Another factor which must be considered is the number of 
subjects included in the study. A large proportion of tlie 
'normal* volunteer subjects had to be rejected from the normal 
series so that the final number on x^ hich mean levels and ranges 
were based was small* In view of the variation observed, as 
many subjects as possible must be included in such a study.
The number of infertile patients studied was also small* It 
is no doubt necessary to study many more patients who fit into 
this category in order to build up a complete picture of the 
condition.
One criticism of the work may be that the samples have 
not been assayed in duplicate. This decision was not taken
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X'yithout careful consideration but it was decided that a greater 
error might be introduced by assaying samples from a cycle in 
txcro assays rather than in the same assay# It would have been 
impractical to measure in duplicate, samples from a complete 
cycle, together x\rith blanks and quality control samples in a 
single assay.
The gonadotrophin results were obtained in other laboratories. 
It is therefore difficult to criticise or comment on these.
Some of the FSH results were difficult to interpret. However, 
it is easier to criticise ones oxm. results than those of others.
Although subtle differences have been found betxToen the 
normal and infertile patients? no gross abnormality in the hormones 
measured accounts for their infertility. It is possible tliat 
in these patients some other factors must be examined xdiich 
might account for their condition. Psychological factors 
might be expected to have -tlieir effect through the hypothalamic- 
pituitary axis? causing inhibition of ovulation. Since these 
patients appear to ovulate such factors can probably be ruled 
out.
It is possible that other hormoties must be studied in these 
patients to complete the picture. Conceivably abnormalities in 
androgen patterns could account for abnormal ovarian function.
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Androgens have been shoxm to affect ovarian function in rats 
(Pels and Bosch, 1971). Advances in RÏA have made androgen 
estimation throughout the menstrual cycle possible (Judd and 
Yen, 1973). Androgen levels must be established in normal 
women and in infertile xmmen and at the same time the possible 
role of androgens in fmale reproductive physiology must be 
investigated.
The abnormalities in these infertile Xfomen may? on the 
other hand? not be hormonal. The possible formation of 
antibodies to their husband's sperm (e.g. Pranlclin and Dukes, 
1964; Pacheco-Romero et al., 1973) has not been eliminated 
nor has the possibility of some abnomality in the husband? in 
spite of normal sperm counts.
Willst hormone patterns have been related to expected 
morphological changes? these changes have not been physically 
monitored in either normal or infertile subjects. Ovarian 
and endometrial biopsies were performed in infertile patients 
prior to study but not in the cycle of study. Willst increased 
levels of hormones in the luteal phase of the cycles has been 
associated witli a corpus luteum, the presence of corpora lutea 
have never been visually established. There is no direct 
evidence that any of the cycles studied were ovulatory except 
in ;the one subject xdio became pregnant.
207
Stuàles of this type on the human obviously have some 
short-comings^  However, these are not easily overcome.
Sarapling of ovarian vein blood may provide more useful results 
than peripheral sampling but this would be clinically impractical 
in the human. This type of study is perhaps the best which 
can be carried out in humans ii% vivo.
hu smmmY of results
The results and conclusions reached in this study are 
suimnarised with reference to the aims of the work set out in 
Chapter 1 (p. 18 )*
1. Accurate, precise and reliable methods have been developed 
and evaluated for the measurement of progesterone, I7o<"* 
hydroxyprogaaterone and oestradiol in human plasma.
These methods are suitable for routine use in the laboratory 
and give results comparable to those of other workers*
2, Ovarian and pituitary function has been studied in a group 
of 'normal' volunteer subjects. These studies have yielded 
much iïîformation about t!ie normal menstrual cycle and also 
about cycles which could not be considered normal by the 
definition accepted for the purposes of this study (p. 65 )* 
Normal ranges for each hormone have been established.
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3, Hormone patterns and levels have been studied in a selected 
group of infertile women and compared to the normal group. 
The results indicate that subtle differences exist between 
the normal and the infertile which could account for the 
infertility* Poor follicular groïfth and maturation 
followed by the formation of an inadequate corpus luteuiu 
may explain the condition,
4, Treatment of these patients with 'Gloraid* has resulted in 
better follicular growth and apparently improved corpus 
luteum function. However, it is undecided whether the 
increases in hormone levels represent 'better* growth of one 
follicle, followed by the formation of a better* corpus 
luteum or whether more than one owlation is involved.
No dramatic effect on gonadotrophin levels was detected. 
Hormone levels in the luteal phase were frequently elevated 
above normal levels in 'Glomid* treatment cycles.
5, In these patients it is concluded that the mode of action 
of 'Glomid* lies at the ovarian rather than the hypo« 
thalamic-pituitary level, 'Glomid* appears, in general, 
to be a useful form of treatment in these patients in so
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far as Improved follicular and corpus luteum function is 
concerned. However, the treatment has not succeeded in 
stimulating pregnancies (except in one case).
6, The use of measurement of oestradiol, progesterone and 17®t- 
hydrossyprogesterone as markers of presumptive morphological 
changes has been assessed, Oestradiol reflects follicular 
growth as an increase in the levels of this hormone precede 
ovulation of a mature follicle. The mid-cycle rise in 
l7oL-hydroxyprogesterone may reflect follicular maturations 
as this rise in 17c^ -hydro2<yprogesteroiie frequently precedes 
ovulation. However, this peak appears more likely to be 
a marker of pre-ovulatory lutéinisation of a mature follicle 
rather than a reflection of Increased oestradiol production.
All three steroid hormones appear to reflect corpus luteum 
function. An increase in all three is associated with 
presumptive formation of a corpus luteum. However, all 
three should be measured to accurately assess corpus 
luteum function especially in the 'Glomid* treated patient,
c^ FUTUEH worn 
Several problems concerning the regulation of the human
menstrual cycle remain to be elucidated. The major ones are
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The Source and role of mid-cycle lA/rhydroxyprogesterone.
The role of mid-cycle FSH*
The mechanism of luteiniaation and ovulation.
The mechanism of follicle 'selection* in the menstrual
cycle.
The role of the oocyte in ovarian function.
Metabolic studies on isolated ovarian cells seems an obvious 
continuation of this project. Some work in the human has been 
reported (e.g. Ryan and Petro, 1966; Ryan et al., 1968) in which 
granulosa and theea cells have been separated and their metabolism 
studied by incubation with steroid precursors in vitro.
However, in these previous studies with human follicles, the 
patients have been pro-treated with 'Pergonal* before the ovaries 
were removed. Channing et al., (1968) report that such treatment 
may cause alterations in steroid production. Work is at present 
in progress in this laboratory to separate granulosa and theca 
cells from normal, untreated human ovaries at various stages of 
the cycle and to incubate them in vitro* with various precursors. 
This study will be aimed initially, at investigation of the
211
hypothesis concerning the source of mid-cycle 17o(-hydroxyprogesterone, 
by study of the predominant pathways in the two cell types.
It is envisaged that such in vitro systems will be useful in 
studying binding of gonadotrophins to different cell types in 
follicles at various stages of development. This may lead to 
elucidation of the role of FSH at mid-cycle and to a fuller 
understanding of the lutéinisation process* However, it must 
be borne in mind in such studies that the demonstration of the 
capacity of a cell to synthesise a substance in vitro, or of a 
process to occur iii vitro cannot be used as proof of the occurrence 
of that same synthesis or process in vivo,
A fuller understanding of the regulation of the normal 
cycle must be achieved before the condition of infertility can 
be explained*
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APPENDIX
CALCULATION OF RESULTS IN THE
COMPETITIVE PROTEIN BINDING ASSAY
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CALCULATION OF RESULTS IN THE
PROTEIN BINDING ASSAY
CALCULATION OF H INTERNAL STANDARD RECOVERED
steroid added as InternalIf X is the total dpm of 
standard and y is the dpm in a 0.2 ml aliquot from 1 ml of 
eluatOp the % recovery of steroid will he
100 % z %
C a lc u la t i o n  o f  % hJ bound i n  th e  CPB a s s a y
I f y .  f o l l o w i n g  d e x t r a n  c o a te d  c h a r c o a l p r e c i p i t a t i o n ,  a i s  th e  mean 
dpm c o n ta in e d  i n  an a l i q u o t  o f  s u p e r n a t a n t  i n  th e  ’ No c h a r c o a l*  tu b e s ,  
and b dpm a r e  c o n ta in e d  i n  an a l i q u o t  o f  s u p e r n a t a n t  fro m  th e  sam p le  
a s s a y e d , th e  % bound i n  t h a t  sam p le  w i l l  b e :
X 100 %
STANDARD CURVE
The dpm in an aliquot of supernatant from each sample 
comprising the standard curve is calculated as a percentage of the 
mean dpm in an aliquot of supernatant from the 'No charcoal*
tubes. The resulting % H bound is plotted against mass
of *cold* steroid in each sample.•
235
CORRECTION FOR EXCESS ADDED AS INTERNAL STANDARD
3H tracer in X/5thSince the dpm originating from added 
of the final eluate is y , the excess dpm present in the remaining 
4/5 of the sample which was subjected to CPB assay will be î™
y X 4 X % bound
, \ y % 4 X - excess dpm/aliquot of supernatant
since only b/a % of the excess dpm were bound.
The corrected dpm is then obtained by subtraction of the 
excess dpm from the total dpm (b), in the aliquot of the super­
natant of the sample.
i.e. corrected dpm == b - (y x 4 x & )
This corrected dpm is then used to calculate a new % & bounds»
FINAL RESULT
The mass of steroid, c, corresponding to the % bound
calculated above is obtained from the standard curve. Correction
is then made for procedural losses.
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Since only 4/5 of the total sample was assayed and g 
was the % of sample recovered throughout the purification step
, - c X 100mass in sample
A final correction is made, where necessary, to take into 
account the volume of plasma used in the assay, the final result 
being expressed in ng/ml plasma.
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